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MORE CONFIDENCE IN A N T I T H R O M B O T I C  TH ER A PY
In Surgical Cases
The American College of Chest Physi­
cians and the National Heart, Lung and 
Blood Institute recently issued, new 
guidelines for antithrombotic therapy.1 
There were four Grade A recom­
mendations for the use of warfarin 
(Coumadin®) in surgical cases. In each 
of these four (and other Grade A and B 
recommendations for Coumadin®) a PT 
ratio of 1.2-1.5 (rabbit brain) was 
emphasized for clinical efficacy and 
reduced side-effects risk.
INDICATIONS: Elective hip surgery/ 
surgery for fractured 
hips.
"  ■ . . patients undergoing elective hip surgery 
should be pretreated prophylactically with 
adjusted-dose heparin or moderate-dose war­
farin sodium . .
patients undergoing surgery for fractured 
hips should be treated prophylactically with 
moderate-dose warfarin.
INDICATION: Prophylaxis of venous 
thromboembolism.
"It is strongly recommended that the 
therapeutic range for prophylaxis . . . in high- 
risk medical or surgical patients should be 
equivalent to an INR o f 2.0-3.0 (corresponding 
rabbit brain thromboplastin ratio 1.2-1.51."
CONDITION: Bioprosthetic heart valves.
• ■ all patients with bioprosthetic heart valves 
in the mitral position be treated for the first 
three months after valve insertion with less
W:re believe these recommendationswill be of value to practicing physicians.ff
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CONDITION: Prophylaxis of venous 
thromboembolism.
"It is recommended that anticoagulant therapy 
should be continued for three months using 
oral anticoagulants to prolong prothrombin 
time . . ."
1. Chest 1986;89(2);1S-106S
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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
The Carotid Endarterectomy Study
Stroke remains the commonest cause of 
disability and the third commonest cause 
of death in our society, despite a 5 % 
annual decline in deaths and occurrence 
since 1968.1-4 Its changing natural his­
tory makes it imperative that we study the 
effects of stroke treatment in a scientific 
and logical manner. There are no well- 
designed controlled prospective trials 
proving the efficacy of carotid endarterec­
tomy among patients with recent transient 
ischemic attacks. Despite this, carotid en­
darterectomy is a very commonly per­
formed procedure. In the Division of Neu­
rosurgery at the University of Toronto, 
approximately 360 carotid endarterecto­
mies have been performed annually since 
1980 (Table I). An audit of all carotid 
endarterectomies performed in this divi­
sion in 1982, recently reported by the 
Toronto Cerebrovascular Study Group 
(headed by D. Rowed), reaffirmed that 
carotid endarterectomy could be per­
formed safely and highlighted the need 
for a prospective study of this pro­
cedure.5
Recently, the National Institutes of 
Health in Bethesda have granted full 
funding by form for a randomized
prospective clinical trial assessing the 
benefits of carotid endarterectomy. The 
principal investigators are H.J.M. Barnett 
and S.J. Peerless at the University of 
Western Ontario. The primary questions 
of the study are as follows:
• Does the addition of carotid endar­
terectomy to current medical care reduce 
stroke occurrence and stroke-related 
death in patients with recent transient
Table 1-Carotid Endarterectomies in the 
Division of Neurosurgery, 
University of Toronto and in Ontario*
Division Neurosurgery,
Year University of Toronto Ontario
1980 365 1125
1981 403 1221
1982 387 1311
1983 372 1352
1984 385 1346
1985 333 1274
1986 262 961
*Data supplied by Professor A.R. Hudson, 
Department of Surgery, University of Toronto 
and Dr. S.J. Kovacs, Ontario Health Insurance 
Plan, Toronto.
ischemic attack or partial stroke and 
ipsilateral carotid stenosis?
• Which subgroups (severe versus 
moderate stenosis, presence or absence of 
ulceration) of patients will benefit most 
from carotid endarterectomy?
The secondary questions of the study 
are: does carotid endarterectomy change 
the functional status of patients? and 
what is the more cost effective, carotid 
endarterectomy with optimum medical 
therapy or optimum medical therapy 
alone?
The study will be limited to North 
American centres with a documented sur­
gical morbidity and mortality of 6% or 
less in at least 50 patients consecutively 
accumulated in the 2 years before the 
trial. Individual surgeons will be required 
to report a morbidity and mortality less 
than 4°7o. Surgeons, neurologists and neu­
roradiologists at the participating centre 
will have to agree to randomize a ll 
patients who would now normally be con- 
si J "red for surgery and to maintain a log 
of all patients who undergo carotid endar­
terectomy whether or not they are 
included in the study. Patients consent­
ing for the study must have had nondisa-
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bling stroke, transient ischemic attack, 
resolved ischemic neurologic deficit, 
amaurosis fugax or retinal infarction and 
ipsilateral operable carotid stenosis within 
the 4 months preceding randomization.
The angiographic imaging modality 
used will be left up to the participating 
centre, but all films will be reviewed by 
a central monitoring committee and their 
quality be deemed appropriate or not. 
The degree of stenosis will be calculated 
by a newly devised mathematical for­
mula. Doppler or high-quality intra­
venous angiography will be used for 
follow-up at 1 month and 2 years 
postoperatively as well as for follow-up 
of any stroke or repeated transient 
ischemic attacks.
Randomization will be carried out by 
the computer at the central office in Lon­
don, Ont. Approximately 3000 patients 
will be randomized during a 2-year entry 
period and will be followed up for 5 
years.
The surgical procedure will be left to 
the discretion of the surgeon. Monitor­
ing, shunting and patch grafting will be 
recorded on a surgical report form. 
Simultaneous coronary artery bypass or 
bilateral carotid endarterectomy will not
be permitted. Patients with bilaterally 
symptomatic carotid disease will be ran­
domized only once, and, if randomized 
to the surgical group, will undergo 
bilateral carotid endarterectomy. Surgery 
will be performed as soon after randomi­
zation as possible, preferably within 48 
hours.
Medical therapy for both groups will 
consist of standard optimization of risk 
factors (hypertension, diabetes, hyper­
lipidemia, smoking, polycythemia) and 
1300 mg of acetylsalicylic acid (ASA) 
daily. If the British ASA trial demon­
strates that a lower ASA dose is as effi­
cacious or better, the dosage of ASA may 
be altered.
Follow-up will be by an independent 
neurologist at 32 days and at 3, 6, 9 and 
12 months. Thereafter, patients will be 
seen at 4-month intervals until a 5-year 
follow-up is completed. End-points in the 
study will be stroke and death from 
stroke.
It is hoped that we will define certain 
subgroups for which the procedure will 
prove efficacious and others that will der­
ive no benefit from the procedure. Those 
of us in neurosurgical training programs 
are being taught to make clinical decisions
as much as possible on scientific grounds. 
We therefore welcome this initiative of 
senior Canadian neuroscientists. I 
encourage all surgeons to support this 
scientific study and especially encourage 
all vascular and neurosurgeons to partic­
ipate.
Michael D. Cusimano, md 
Resident,
Division of Neurosurgery,
University of Toronto,
Department of Pathology,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
M5B 1W8
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CORRESPONDENCE
Contributions to the Correspondence section are welcomed. 
They should be typewritten and double spaced.
Algebraic Confusion
To the editors.—I write to correct an 
error in the formula for laminar flow as 
printed on the first page of Landow’s arti­
cle on perioperative hemodilution (Can J  
Surg 1987; 30: 321-325). Incorrectly 
placed brackets inevitably cause algebraic 
catastrophe.
The formula for flow printed on the 
first page should be
= 7r(P, -  P2)R4 
8VL
Even someone who knows absolutely 
nothing about laminar flow and that it is 
proportional to the fourth power of the 
radius may recognize that the formula as 
printed is incorrect. The dimensions of 
items to be added or subtracted must be 
identical. Multiplying P2 by 3.14R4 
changes its dimensions and means it can­
not be subtracted from P,. It also makes 
basic common sense for Q to be propor­
tional to (P, -  P2), the pressure gra­
dient.
A further suggestion relates to the use 
of 3.14 in the numerator, particularly
when there is an 8 in the denominator. 
Why not divide the two and replace them 
with 0.39 in the numerator? The reason, 
of course, is the need to remind us of the 
theoretical basis for this number 3.14. 
Using |  tells it all?
James C. Fallis, md, frcsc
Director,
Emergency Medical Services,
The Hospital for Sick Children,
555 University Ave.,
Toronto, Ont.
M5G 1X8
[Dr. Landow replied: “Dr. Fallis has cor­
rectly noted an obvious error in the 
Poiseuille-Hagen equation as printed in 
the article ‘Perioperative hemodilution’. ”]
Cholecystectomy 
for Asymptomatic Cholelithiasis
To the editors.—I congratulate Saade and 
his colleagues on their article “ Should 
cholecystectomy be done en passant for
asymptomatic cholelithiasis” (Can J  Surg 
1987; 30: 350-353) which confirms our 
beliefs.1
To avoid perpetuating an error I would 
like to point to an oversight made in 
Table V of the article, where Biggers and 
colleagues2 are quoted as having done 
242 concomitant cholecystectomies with 
colorectal surgery. The correct number is 
81 concomitant cholecystectomies and 
colectomy.
H. Shennib, md, frcsc
Department of Surgery,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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SURGEONS’ UPDATE
What s new in surgery is the subject of this column. The short items are designed to let readers know 
who s doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
The Future of Health Care in Canada
Canada has an effective health-care sys­
tem, Jake Epp, the Minister of National 
Health and Welfare, told the Americas 
Society in a recent address in New York 
City, since it “ provides excellent care to 
all our residents on a fully prepaid basis, 
imposes no upper dollar limits on cover­
age, and this is achieved at a cost the tax­
payers and the country can afford” . 
Increasing demands on the system, 
however, mean that “ to ensure that we 
continue to provide quality care at 
reasonable costs...we must make some 
adjustments in certain areas” .
The Minister outlined three factors that 
are putting a strain on the health-care sys­
tem: the increasing number of elderly 
citizens (soon 1 in 10 Canadians will be 
over the age of 65 years) since this group 
utilizes health-care services disproportion­
ately to its size in the general population; 
advances in medical technology, espe­
cially in areas such as neonatal care, 
transplantation and reproductive technol­
ogy that have proven to be expensive; and 
new health hazards and diseases, such as 
acquired immune deficiency syndrome, 
which create challenges in the areas of 
■ research, care and treatment.
He made two proposals to meet the 
increasing demands, while at the same 
time containing costs. One is the use of 
alternative forms of health-care delivery 
which will help to relieve some of the bur­
den on hospitals. He cited Quebec’s com­
munity health centres and New Brun­
swick’s “ extramural hospital” concept, 
in which patients are provided hospital 
services in their own homes under a phy­
sician’s care, as examples of alternatives 
to traditional hospitalization.
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
The second proposal is an emphasis on 
health promotion and disease prevention. 
Universal health care alone has not been 
sufficient to ensure equal levels of health 
among individuals since, said Epp, “ a 
man in a high income bracket can expect 
to live some 6 years longer than a man 
with a low income” . Since the early 
1970s, he said, there has been success in 
encouraging people to adopt healthier 
life-styles by exercising, eating well 
and following physicians’ instructions. 
The proposed ban of tobacco advertis­
ing would also be a continuation of 
this policy of combatting preventable 
disease.
The Ontario government is also 
promoting healthy life-styles. The Minis­
try of Health has established a new health 
promotion branch, a $2.5 million pro­
gram of community health promotion 
grants has been implemented and 
materials will be left in the community 
enabling local organizations to carry out 
their own health promotion. Said the 
Minister of Health, Elinor Caplan, “ peo­
ple should be given the tools...to take 
more personal responsibility for their own 
health” .
Computer Allows Patients 
to See the Results 
of Plastic Surgery
Nabil Fanous, FRCSC, assistant 
professor of otolaryngology at McGill 
University, is now able to show patients 
considering plastic surgery what they will 
look like after the procedure. He is one 
of the first in Canada using a new com­
puter which, when attached to a camera, 
takes a picture of the patient’s face and 
displays it on a television screen. The sur­
geon uses an electronic pen to alter the
patient’s features on the screen, allowing 
the patient “ to visualize more readily 
what improvements are possible and what 
are not” . With realistic expectations of 
the surgery’s outcome, the patient is then 
able to make a decision on whether to 
proceed.
Ontario’s Hospitals Are 
Increasingly Smoke-Free
The Ontario Hospital Association has 
released the results of its survey, con­
ducted in May 1987, of smoking policies 
and practices in Ontario’s hospitals. Of 
the 213 hospitals surveyed, 180 (85%) 
have prohibited smoking except in desig­
nated rooms or areas. This is a substan­
tial increase since the last survey, in 1983, 
when 89 (50%) of the hospitals surveyed 
had a designated-area smoking policy. 
Four hospitals have imposed, since the 
1983 survey, a total ban on smoking and 
seven have announced plans to do the 
same. Forty-seven percent of hospitals 
surveyed indicated that the ultimate goal 
of their smoking policy was a complete 
ban.
Heart-Drug Trial
Bruce Sussex, FRCPC, a cardiology 
specialist at Memorial University, St. 
John’s, Nfld., will be one of the principal 
researchers in a 4-year trial of the heart 
drug Captopril. One-hundred patients 
who have had recent, moderate to severe 
heart attacks will participate in the New­
foundland part of the study, which will 
determine whether treatment with Cap­
topril, when started soon after a heart 
attack and continued for several years, 
can prevent heart enlargement and con­
gestive heart failure. A total of 4000 
patients in 35 centres across Canada and 
the US will be involved.
Laurel Williamson
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COUMADIN
(Warfarin sodium) ANTICOAGULANT
INDICATIONS: The prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary 
embolism, atrial fibrillation with embolization, and as an adjunct in the prophylaxis of systemic embolism 
after myocardial infarction. Some of the more common clinical disorders which may be associated with 
or predispose patients to the above indications are: Thrombophlebitis; Congestive heart failure; Surgical 
procedure or trauma associated with a high risk of thromboembolism; Myocardial infarction; Cerebral 
embolism. It may also be useful as an adjunct in the treatment of transient cerebral ischemic attacks due 
to intravascular clotting.
CONTRAINDICATIONS: Any localized or general physical condition or personal circumstance in which 
the hazard of hemorrhage might be greater than the potential clinical benefits of anticoagulation, such 
as: Pregnancy: COUMADIN* is contraindicated in pregnancy because the drug passes through the 
placental barrier and may cause fatal hemorrhage to the fetus in utero. Also, there have been reports 
of birth malformations in children born to mothers who have been treated with warfarin during pregnan­
cy. Women of childbearing potential who are candidates for therapy should be carefully evaluated and 
the indications critically reviewed with the patient. If the patient becomes pregnant while taking this drug, 
she should be apprised of the potential risks to the fetus, and the possibility of termination of the pregnancy 
should be discussed in light of those risks. Hemorrhagic tendencies or blood dyscrasias. Recent or 
contemplated surgery of: 1. central nervous system; 2. eye; 3. traumatic surgery resulting in large 
open surfaces Bleeding tendencies associated with active ulceration or overt bleeding of: 
gastrointestinal, genitourinary or respiratory tracts; cerebrovascular hemorrhage; aneurysms -  cerebral, 
dissecting aorta; pericarditis and pericardial effusions; bacterial endocarditis. Threatened abortion, 
eclampsia and preeclampsia. Inadequate laboratory facilities or unsupervised senility, alcoholism, 
psychosis, or lack of patient cooperation. Spinal puncture and other diagnostic or therapeutic procedures 
with potential for uncontrollable bleeding. Miscellaneous: major regional, lumbar block anesthesia and 
malignant hypertension.
WARNINGS: The most serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis 
and/or gangrene of skin and other tissues. Risk of hemorrhage is related to the level of intensity and duration 
of therapy. Hemorrhage and necrosis have in some cases been reported to result in death or permanent 
disability. Necrosis appears to be associated with local thrombosis and usually appears within a few days 
of the start of therapy. In severe cases of necrosis, treatment through debridement or amputation of the 
affected tissue, limb, breast or penis has been reported. Careful diagnosis is required to determine whether 
necrosis is caused by an underlying disease. Therapy should be discontinued when warfarin is the 
suspected cause of developing necrosis and heparin may be considered. Although various ones have 
been attempted, no treatment for necrosis has been considered uniformly effective. See below for infor­
mation on predisposing conditions. These and other risks must be weighed against the risk of throm­
bosis or embolization in untreated cases. COUMADIN is a potent drug with a half-life of 2.5 days; therefore 
effects may become more pronounced as daily maintenance doses overlap. It cannot be emphasized 
too strongly that treatment of each patient is a highly individualized matter. Dosage should be con­
trolled by periodic determinations of prothrombin time or other suitable coagulation tests. Determina­
tions of whole blood clotting and bleeding times are not effective measures for control of therapy. Heparin 
prolongs the one-stage prothrombin time. When heparin and COUMADIN are administered concomitantly, 
referto CONVERSION FROM HEPARIN THERAPY for recommendations. Caution should be observed 
when COUMADIN is administered in any situation or in the presence of any predisposing condition where 
added risk of hemorrhage or necrosis is present. Administration of anticoagulants in the following con­
ditions will be based upon clinical judgement in which risks of therapy are weighed against the risk of 
thrombosis or embolization in untreated cases. The following may be associated with these increased 
risks Lactation. Severe to moderate hepatic or renal insufficiency. Infectious diseases or distur­
bances of intestinal flora -  sprue, antibiotic therapy. Trauma which may result in internal bleeding. 
Surgery or trauma resulting in large exposed raw surfaces. Indwelling catheters. Severe to moderate 
hypertension. Known or suspected deficiency in protein C: This hereditary or acquired condition, 
which should be suspected if there is a history of recurrent episodes of thromboembolic disorders in the 
patient or in the  family, has been associated with an increased risk of developing necrosis following war­
farin administration. Tissue necrosis may occur in the absence of protein C deficiency. It has been reported 
that concurrent anticoagulation therapy with heparin for 5 to 7 days during initiation of therapy with 
COUMADIN may minimize the incidence of this reaction. Warfarin therapy should be discontinued when 
it is suspected to be the cause of developing necrosis, and heparin may be considered. Miscellaneous: 
polycythemia vera, vasculitis, severe diabetes, severe allergic and anaphylactic disorders. Patients with 
congestive heart failure may become more sensitive to COUMADIN, thereby requiring more frequent 
laboratory monitoring, and reduced doses. Concurrent use of anticoagulants with streptokinase or 
urokinase is not recommended and may be hazardous. (Please note recommendations accompanying 
these preparations.)
PRECAUTIONS: Periodic determination of prothrombin time or other suitable coagulation test is 
essential. Numerous factors, alone or in combination, including travel, changes in diet, environ­
ment, physical state and medication may influence response to anticoagulants. It is good practice 
to monitor the response with additional prothrombin time determinations in the period immediately 
after discharge from the hospital, and whenever other medications are initiated, discontinued or 
taken haphazardly. The following factors are listed for your reference; however, other factors may 
also affect the anticoagulant response.
The following factors, alone or in combination, may be responsible for INCREASED pro­
thrombin time response: ENDOGENOUS FACTORS: cancer, collagen disease, congestive heart failure, 
diarrhea, elevated temperature, hepatic disorders: (infectious hepatitis, jaundice), poor nutritional state, 
steatorrhea, vitamin K deficiency. EXOGENOUS FACTORS: a lcohol,t allopurinol, aminosalicylic acid, 
amiodarone HCI, anabolic steroids, anesthetics, inhalation, antibiotics, bromelains, chloral hydrate,t chlor­
propamide, chymotrypsin, cimetidine, clofibrate, COUMADIN overdosage, dextran, dextrothyroxine, diazox- 
ide, diflunisal, diuretics,! disulfiram, ethacrynicacid, fenoprofen, glucagon, hepatotoxic drugs, ibuprofen, 
influenza virus vaccine, mefenamic acid, methyldopa, methylphenidate, metronidazole, miconazole, 
monoamine oxidase inhibitors, nalidixic acid, naproxen, narcotics, prolonged, pentoxifylline, 
phenylbutazone, phenytoin, pyrazolones, quinidine, quinine, ranitidine,t salicylates, sulfinpyrazone, 
sulfonamides, long-acting, sulindac, thyroid drugs, tolbutamide, trimethoprim/sulfamethoxazole, other 
medications affecting blood elements which may modify hemostasis. Also: dietary deficiencies, prolonged 
hot weather, unreliable prothrombin time determinations.
The following factors, alone or in combination, may be responsible for DECREASED prothrom­
bin time response: ENDOGENOUS FACTORS: edema, hereditary coumarin resistance, hyperlipemia, 
hypothyroidism. EXOGENOUS FACTORS: adrenocortical steroids, a lcohol,t antacids, antihistamines, 
barbiturates, carbamazepine, chloral hydrate,! chlordiazepoxide, cholestyramine, COUMADIN under­
dosage, diuretics,! ethchlorvyno! glutethimide, griseofulvin, haloperidol, meprobamate, oral contracep­
tives, paraldehyde, primidone, ranitidine,! rifampin, vitamin C. Also: diet high in vitamin K, unreliable PT 
determinations. Because a patient may be exposed to a combination of the above factors, the net effect 
on PT response may be unpredictable. More frequent laboratory monitoring is, therefore, advisable. 
Coumarins may also affect the actions of other drugs. Hypoglycemic agents (chlorpropamide, tolbutamide 
and glyburide) and anticonvulsants (phenytoin and phenobarbital) may accumulate in the body as a result 
of interference with either their metabolism or excretion.
ADVERSE REACTIONS: Potential adverse reactions may include: • Hemorrhage from any tissue or organ. 
This is a consequence of the anticoagulant effect. Signs and symptoms will vary according to the loca­
tion and degree or extent of bleeding. Therefore, the possibility of hemorrhage should be considered 
in evaluating the condition of any anticoagulated patient with complaints which do not indicate an ob­
vious diagnosis. Bleeding during anticoagulant therapy does not always correlate with prothrombin activity. 
(See SYMPTOMS AND TREATMENT OF OVERDOSAGE.) Bleeding which occurs when the prothrom­
bin time is within the therapeutic range warrants diagnostic investigation, since it may unmask a
previously unsuspected lesion, e g. tumor, ulcer, etc. •  Necrosis of skin and other tissues. (SEE WARN­
INGS). • Other adverse reactions are infrequent and consist of alopecia, urticaria, dermatitis, fever, nausea, 
diarrhea, abdominal cramping, a syndrome called "purple toes,”  cholestatic hepatic injury, and hypersen­
sitivity reactions. • Priapism has been associated with anticoagulant administration, however, a causal 
relationship has not been established.
DOSAGE AND LABORATORY CONTROL: Administration: Administration and dosage must be 
individualized. Adjust the dosage according to results of the one-stage prothrombin time (PT) with 
commonly used rabbit brain thromboplastin. There is ample evidence that prolongation of the prothrombin 
time 1.2 to 1.5 times control is sufficient for prophylaxis and treatment of venous thromboembolism, 
minimizing the risk of hemorrhage associated with more prolonged PT values. Where the risk of throm­
boembolism is great, such as with recurrent systemic embolism, a PT of 1.5 to 2.0 times control should 
be maintained. A ratio greater than 2.0 appears to provide no additional therapeutic benefit in most patients 
and is associated with a higher risk of bleeding.
Clinical State
Table o f Recommended Therapeutic PT Ranges*
Rabbit Brain PT Ratio**
Prophylaxis -  venous thromboembolism
High-risk surgery 1.2-1.4
Hip surgery 1.3-1.5
Treatment-deep vein thrombosis or pulmonary embolism 1.2-1.5
Prevention of systemic embolism in patients with:
• atrial fibrillation,
•  tissue heart valves, or
• acute myocardial infarction 1.2-1.5
Recurrent systemic embolism 1.5-2.0
'Modified from Chest, ACCP-NHLBI National Conference on Antithrombotic Therapy, volume 89, 
number 2, page 14S, 1986.
“ For the three thromboplastins currently used in North America, a PT with rabbit brain thrombo­
plastin of 1.3 to 2.0 is equivalent to an International Normalized Ratio (INR) of 2.0 to 4.0. For other 
thromboplastins the INR can be calculated as: INR = (observed PT).ISI The ISI (International 
Sensitivity Index) is available from the manufacturers of thromboplastin.
INITIAL DOSAGE: Is commonly started above anticipated maintenance dosage levels. A commonly-used 
regimen is I0mg/day for 2 to 4 days, with daily adjustments based on the results of PT determinations. 
A large loading dose (i.e., 30mg) may increase the incidence of hemorrhagic and other complications, 
does not offer more rapid protection against thrombi formation, and is not recommended. Lower doses 
are recommended for elderly and/or debilitated patients and patients with increased sensitivity (see 
PRECAUTIONS). Maintenance: Most patients are satisfactorily maintained at a dose of 2 to 10mg daily. 
Flexibility of dosage is provided by breaking scored tablets in half. The individual dose and interval should 
be gauged by the patient's prothrombin response. Duration of therapy: The duration of therapy in each 
patient should be individualized. In general, therapy should be continued until the danger of thrombosis 
and embolism has passed. Treatment During Dentistry and Surgery: Management of patients who 
undergo dental and surgical procedures requires close liaison between attending physicians, surgeons 
and dentists. In patients who must be anticoagulated prior to, during, or immediately following dental or 
surgical procedures, adjusting the dosage to maintain the PT at the low end of the therapeutic range, 
may safely allow for continued anticoagulation. The operative site should be sufficiently limited and 
accessible to permit the effective use of local procedures for hemostasis. Under these conditions, dental 
and surgical procedures may be performed without undue risk of hemorrhage. Conversion from Heparin 
Therapy: Since the onset of COUMADIN’S effect is delayed, heparin is preferred initially for rapid anti­
coagulation. Conversion to COUMADIN may begin concomitantly with heparin therapy or may be delayed 
3 to 6 days. As heparin may affect the PT, patients receiving both heparin and COUMADIN should have 
blood drawn for PT determination, at least: • 5 hours after the last IV bolus dose of heparin, or •  4 hours 
after cessation of a continuous IV infusion of heparin, or • 24 hours after the last subcutaneous heparin 
injection. When COUMADIN has produced the desired therapeutic range or prothrombin activity, heparin 
may be discontinued.
SYMPTOMS AND TREATMENT OF OVERDOSAGE: Symptoms: Suspected or overt abnormal bleeding 
(i.e., appearance of blood in stools or urine, hematuria, excessive menstrual bleeding, melena, petechiae, 
excessive bruising or persistent oozing from superficial injuries) are early manifestations of anticoagulation 
beyond a safe and satisfactory level. Treatment: Excessive anticoagulation, with or without bleeding, 
may be controlled by discontinuing therapy and if necessary, by administration of oral or parenteral vitamin 
K, 2.5mgto 10mg. (Please see recommendations accompanying vitamin K, preparations prior to use.) 
Use of vitamin K, reduces responses to subsequent COUMADIN therapy. Patients may return to a pretreat­
ment thrombotic status following the rapid reversal of a prolonged PT. Resumption of COUMADIN ad­
ministration reverses the effect of vitamin K ,, and a therapeutic PT can again be obtained by careful dosage 
adjustment. If rapid anticoagulation is indicated, heparin may be preferable for initial therapy. If minor 
bleeding progresses to major bleeding, give 5 to 25mg (rarely up to 50mg) parenteral vitamin K,. In 
emergency situations of severe hemorrhage, clotting factors can be returned to normal by administering 
200 to 500mL of whole blood or fresh frozen plasma, or by giving commercial Factor IX complex. Packed 
red blood cells may also be given if significant blood loss has occurred. Infusions of blood or plasma 
should be monitored carefully to avoid precipitating pulmonary edema in elderly patients or patients with 
heart disease.
DOSAGE FORMS: COUMADIN TABLETS are single-scored, and are imprinted as follows:
SIZE: 2mg 2.5mg 5mg 10mg
CODE: 0101 0201 0301 0401
COLOR: lavender orange peach wnite
IMPRINT: 
Side 1: COUMADIN COUMADIN COUMADIN COUMADIN
bisected 2 bisected 2 1/2 bisected 5 bisected 10
Side 2: Du Pont Du Pont Du Pont Du Pont
Supplied in bottles of 100.
increased  and decreased prothrombin time responses have been reported.
Reference:
1 . O'Reilly RA, Aggeler PM: Studies on coumarin anticoagulant drugs: initiation of warfarin therapy 
without a loading dose. Circulation 38:169-177, 1968.
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Tetanus —  a C ontinuing Problem  in M in o r In juries
Tetanus is rare in North America because 
of highly effective specific immunization 
programs. Nevertheless, 15 patients with 
generalized tetanus were treated at the 
Vancouver General Hospital over a 
20-year period; 10 of them were over 50 
years of age. Tw o patients had no injury 
and 12 had suffered only minor wounds. 
None had received previous immuniza­
tion and, even after wounding, 
prophylaxis w as unsatisfactory in all 
cases. Nine patients required intensive 
care and two died. Positive cultures 
were obtained in only tw o  cases.
Four recommendations are made to 
prevent tetanus; (a) all w ounds should 
be considered "tetanus-prone” , (b) an 
accurate history of immunization should 
be obtained, (c) more attention should be 
given to prophylaxis at the time of injury 
and (d) patients should record vaccina­
tions.
Grace & des programmes d'immunisation 
specifiques tres efficaces, le tetanos est 
devenu rare en Amerique du Nord. Nean- 
moins, sur une periode de 20  ans, 15 
patients souffrant de tetanos generalise 
ont ete traites au Vancouver General 
Hospital; 10 d'entre-eux avaient plus de 
50  ans. Deux patients n 'avaient subi 
aucune blessure et 12 n 'avaient que des 
lesions superficielles. Aucun  n 'avait ete 
prealablement immunise et, apres la bles­
sure, le traitement prophylactique s'etait 
avere inefficace dans tous les cas. Neuf 
malades ont necessity des so ins intensifs
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et deux sont decedes. Deux cas seule- 
ment ont donne des cultures positives.
On formule quatre recommandations 
destinees a prevenir le tetanos: a) toutes 
les blessures doivent etre considerees 
comme pouvant etre une porte d 'entree 
pour le tetanos, b) on doit viser a obtenir 
des antecedents d 'im m unisation precis, 
c) une plus grande attention doit etre 
accordee a la prophylaxie au moment de 
la blessure, et d) les patients devraient 
conserver un dossier d 'immunisation.
Tetanus is a potentially fatal complication 
o f wounds. The disease still represents a 
serious health problem in developing 
countries, but because o f the widespread 
availability o f highly effective immuniza­
tion it has now become relatively rare in 
North America. Each new case is a cause 
for concern because the disease is so read­
ily preventable and so often is caused by 
an otherwise trivial injury.
The aim o f this report is to focus atten­
tion on the idea that minor wounds are
just as tetanus-prone as major injuries 
and the finding that, despite widespread 
immunization, there are still people, espe­
cially those over 50 years o f  age, who are 
not immunized and are, therefore, at risk.
Patients and Methods
This paper reviews the hospital records 
o f all 15 patients (8 men, 7 women) with 
a clinical diagnosis o f tetanus managed 
at the Vancouver General Hospital over 
the 20-year period between 1961 and 
1981. Isolation o f Clostridium tetani or 
a previous injury was not necessary for 
inclusion in the series. The following fac­
tors were analysed: age, sex, immuniza­
tion status, type o f wound, bacterial cul­
tures, presentation, clinical course and 
final outcome.
Findings
The ages o f the 15 patients ranged 
widely but the majority were over 50 years 
old (Table I). Predisposing wounds
Table I -Injuries and Tetanus Prophylaxis 
Clinical Tetanus
in 15 Patients With
Age,
yr Sex Injury
Immunization
status
Prophylaxis
received
40 F Surgical mid-tarsal fusion. Unknown None
81 M
Skin necrosis in cast 
Surgical excision of None None
79 M
plantar warts 
Forearm abrasion None None*
2 M 2nd degree burn to chest None None*
74 F Leg abrasion None None*
50 M Lacerated scalp One injection! None*
72 M Fingertip injuries None 1 ml ATT
34 F Open fracture of toe One injection! None*
68 F Puncture wound to foot None 1 ml ATT
68 F Puncture wound to foot Unknown 1 ml ATT
64 F Puncture wound to thigh None 1 ml ATT 2
57 M Puncture wound to cheek Unknown
d later 
1 ml ATT
30 M Puncture wound to arm One injection! None*
67 F None known One injection! None*
6 M None known None None*
"Patient did not seek medical attention for wound. 
tOne injection many years ago.
ATT -  antitetanus toxin.
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varied, but 11 were only minor. In two 
patients there was no history or physi­
cal sign of a wound and two others had 
undergone elective surgery, one for exci­
sion of plantar warts as an outpatient. 
The patient’s immunization status was 
recorded in only 12 cases. At the time of 
wounding, none of these patients had 
previously received adequate antitetanus 
prophylaxis. Even after injury, tetanus 
prophylaxis was unsatisfactory in all 
cases. Six patients sought no initial treat­
ment for their wounds, two who under­
went elective surgery were not protected 
at the time of operation, four were given 
their first dose of active immunization on 
the day of injury and one was given a 
first dose of active immunization 2 days 
after injury. No patient received passive 
immunization with human tetanus im­
mune globulin.
Tetanus was generalized in all 15 
patients. It presented with trismus and 
dysphagia in 13, dyspnea in 1 and coma 
in 1. In 9 of the 15 patients the tetanus 
was severe, and 7 of these patients were 
managed with intensive care, paralysis 
and ventilatory assistance. They remained 
in the intensive care unit for 20 to 74 days 
but all 7 survived. The other two patients 
with severe generalized tetanus died 
before reaching the intensive-care unit; 
one arrived in the emergency room mori­
bund and could not be resuscitated and 
the other died of a cardiac arrest immedi­
ately after arrival at the hospital.
Cultures positive for Clostridium tetani 
were obtained in only 2 of the 15 cases.
Discussion
The clinical features and current 
methods of treatment of tetanus have 
been reviewed by Alfery and Rauscher.1 
They indicated that the majority of cases 
are generalized, that the diagnosis is 
usually made from clinical signs rather 
than laboratory investigations and that the 
best management is a team approach in the 
intensive-care unit.
Antitetanus immunization has been 
available since the 1940s. Its effectiveness 
prompted Furste,2 in 1970, to express the 
hope that “ by 1980 tetanus would be a 
disease of only historical significance in 
the United States of America” . Unfor­
tunately, this prediction has not been real­
ized as cases are still being reported.
The sporadic cases that occur in North 
American hospitals are worrying because 
the death rate from generalized tetanus 
is still 45% to 50%3 despite the 
widespread availability of respiratory 
assistance and intensive-care facilities 
which, together with an aggressive surgi­
cal approach,4 have reduced the overall 
death rate.5-7 Deaths, nowadays, usually 
result from cardiovascular instability.
Tetanus is common in underdeveloped 
countries because large populations are
8
not immunized. Throughout North 
America and especially in Canada, immu­
nization programs have been in place for 
many years, and yet tetanus is still seen. 
Why is this? Is it related to the wounds 
or to a failure of immunization?
The wounds themselves are an impor­
tant factor and in this series were almost 
always minor in nature. Others5,8-11 have 
documented this finding. That such a seri­
ous disease can follow otherwise trivial 
injuries is distressing, particularly when 
the condition is preventable and, theoret­
ically, could be eliminated. Prevention 
immediately after wounding was not pos­
sible in half our patients as they did not 
seek medical attention, presumably 
because of the trivial nature of the inju­
ries. Failure to seek medical advice and 
the emphasis on ensuring that large 
“ tetanus-prone” wounds receive ade­
quate prophylaxis in emergency depart­
ments has led to a situation where minor 
wounds have become the most tetanus- 
prone.
Tetanus prophylaxis has been studied 
extensively in various populations. 
Researchers have analysed serum anti­
body levels,12-15 conducted immunization 
status surveys16,17 and examined the ade­
quacy of prescribing tetanus prophylaxis 
in hospital emergency rooms.18 Others 
have discussed the necessity for 
reimmunization14,19 and the problems of 
excess administration of antitetanus tox- 
oid.11,18,20,21 A study of cases seen in the 
US armed forces over more than 20 years 
has clearly documented the efficacy of a 
well-organized primary immunization 
program.10
Unfortunately these data apply only to 
people who have been immunized. None 
of our 15 patients had been given a 
primary course of immunization. Other 
recent studies of tetanus patients in coun­
tries with well-developed health-care sys­
tems also documented that the disease is 
seen in patients who are not adequately 
immunized.3,5 Once immunized, a per­
son’s serum antibody level may decline 
with time,13 but Canadian surveillance 
data19 suggest that despite decreased 
antibody levels, immunologic memory 
remains good enough to prevent people 
moving from the immune to the suscept­
ible category. Data from population sur­
veys have demonstrated that a consider­
able number of people are not immunized 
against tetanus15,17-22 and the opportuni­
ties to do so are missed. The prevalence 
of inadequate immunization status (not 
being immunized rather than declining 
serum antibody levels) is high in the older 
population and accounts for the preva­
lence of tetanus in this group.9,17,23,24 
Failure to receive an adequate primary 
course of immunization, therefore, is still 
the main cause of tetanus in North 
America despite the widespread availabil­
ity of adequate immunization and
prophylactic regimens being publicized by 
the American College of Surgeons.25
The problems of the gap in immunity 
in adults and vague immunization histo­
ries have been tackled in Czechoslovakia. 
Between 1973 and 1975, a vaccination 
campaign was carried out and, since 1973, 
immunization has been recorded on per­
sonal identification cards. In a subsequent 
report,10 Mazar demonstrated not only a 
notable decrease in the incidence of teta­
nus but also that the identification cards 
were being used correctly, thus providing 
highly reliable and readily available vac­
cination records at the time of injury.
We have four suggestions to make that 
may help to prevent tetanus occurring, 
especially after trivial injuries.
• All wounds, however trivial and 
from whatever cause, should be consi­
dered tetanus-prone.
• A tetanus vaccination history should 
be taken from every patient seeking med­
ical care for any reason. This history 
should determine: (a) if the patient ever 
had a complete primary vaccination ser­
ies, (b) when the patient received the most 
recent booster. It has been suggested11 
that the best person to take this history 
and record the answers is the admitting 
clerk or receptionist, and it should be 
done at the time other details (e.g., name, 
address) are being recorded.
• Correct prophylaxis should then be 
prescribed by the attending physician 
either to initiate a primary vaccination 
series or as a booster according to the 
guidelines laid down by the American 
College of Surgeons.
• Patients should be encouraged to 
keep records of their vaccination status 
and to carry them with their hospital iden­
tity cards.
References
1. ALFERY DD, RAUSCHER LA: Tetanus: a review. Cril 
Care Med 1979; 7: 176-181
2. FURSTE W: Tetanus: by 1980, a disease of only histori­
cal significance in the United States of America. J Trauma 
1970; 10: 831-838
3. Faust RA, Vickers OR, Cohn I jr : Tetanus: 2,449 
cases in 68 years at Charity Hospital. J  Trauma 1976; 
16: 704-712
4. PERCY AS, Kukora JS: The continuing problem of teta­
nus. Surg Gynecol Obstet 1985; 160: 307-312
5. Edmondson RS, Flowers MW: Intensive care in teta­
nus: management, complications, and mortality in 100 
cases. Br Med J  1979; 1: 1401-1404
6. TRUJILLO MJ, Castillo A, Espana JV, et al: Teta­
nus in the adult: intensive care and management 
experience with 233 cases. Crit Care Med 1980; 8: 419-423
7. PESSI T, HONKOLA H, Liikala E: Results of treatment 
of patients with severe tetanus. A study of 18 cases. Ann 
Chir Gynaecol 1981; 70: 182-186
8. Patel JC, Mehta BC: Tetanus: study of 8697 cases. 
In: Proceedings o f  the Fourth International Conference 
on Tetanus, Dakar, 1975, Fondation Merieux, Lyon, 
1975: 233-241
9. Atrakchi SA, WILSON DH: Who is likely to get teta­
nus? (E). Br Med J 1977: 1: 179
10. FURSTE W: The Fifth International Conference on Teta­
nus, Ronneby, Sweden, 1978. J Trauma 1980; 20: 
101-105
VOLUME 31, NO. 1, JA N U A R Y 1988 /  THE CANADIAN JOURNAL OF SURGERY
NOTICES
11. LINDSEY D: Tetanus prophylaxis — do our guidelines 
assure protection? J Trauma 1984; 24: 1063-1064
12. CROSSLEY K, Irvine P, Warren JB, et al: Tetanus and 
diphtheria immunity in urban Minnesota adults. JAMA 
1979; 242: 2298-2300
13. SEKLA L, Stackiw W, Drewniak M: An evaluation 
of the immune status of Manitobans to diphtheria, per­
tussis & tetanus. Can J  Public Health 1980; 71: 277-280
14. SlMONSEN O, Kjeldsen K, HERON 1: Immunity against 
tetanus and effect of revaccination 25-30 years after 
primary vaccination. Lancet 1984; 2: 1240-1242
15. Varela LR, Black FL, Mendizabal-Morris CA: 
Tetanus antitoxin titers in women of childbearing age 
from nine diverse populations. J  Infect Dis 1985; 151: 
850-853
16. TRINCA JC: Immunity to tetanus in Victoria, 1973. Med 
J  Aust 1974; 2: 595-598
17. SCHER KS, Baldera A, WHEELER WE, et al: Inade­
quate tetanus protection among the rural elderly. South 
Med J  1985; 78: 153-156
18. Brand DA, Acampora D, Gottlieb LD, et al: Ade­
quacy of antitetanus prophylaxis in six hospital emergency 
rooms. N  Engl J  Med 1983; 309: 636-640
19. Mathias RG, SCHECHTER MT: Booster immunisation 
for diphtheria and tetanus: no evidence of need in adults. 
Lancet 1985; 1: 1089-1091
20. FURSTE W: The Sixth International Conference on Teta­
nus, Lyon, France, 1981. J  Trauma 1982; 22: 1032-1035
21. SHAVELSON L: Antitetanus prophylaxis (C). N  Engl J 
Med  1984; 310; 467
22. FOLAN JC: Anti-tetanus immunisation in orienteers. Br 
J  Sports Med 1985; 19: 39-40
23. NEWTON-JOHN HF: Tetanus in Victoria, 1957-1980. 
Review of 106 patients managed in one hospital. Med J 
Aust 1984; 140: 194-200
24. Tetanus surveillance and prophylaxis. Br Med J [Clin ResJ 
1982; 284: 1715-1716
25. Committee on Trauma of the American College of Sur­
geons: A Guide to Prophylaxis Against Tetanus in Wound 
Management, American College of Surgeons, Chicago, 
1984 revision
University of Toronto — 
Continuing Education
The Faculty of Medicine of the Univer­
sity of Toronto has scheduled two courses 
to be presented this spring. The first will 
take place May 19 and 20, 1988, at the 
Mount Sinai Hospital and is entitled 
“ Allografts in Orthopaedic Surgery — 
Banking and Clinical Applications” . On 
May 31 and June 1 at the same location, 
a course entitled “Advances and Con­
troversies in Vascular Surgery” will be 
held. Further information on both of 
these courses can be obtained by writing: 
Continuing Medical Education, Faculty 
of Medicine, University of Toronto, Med­
ical Sciences Building, Toronto, Ont. 
M5S 1A8 or by calling: (416) 978-2718.
Eleventh Annual Conference 
on Shock
Fontana, Wisconsin will be the site of the 
Shock Society’s 11th annual conference 
on shock, June 5-8, 1988. Symposia 
include such topics as “ Organ Blood 
Flow and Metabolism in Shock” and 
“ The Effects of Endotoxemia in Humans 
and in Experimental Septic Shock” . The 
keynote speaker will be John J. Spitzer 
of the Louisiana State University Medi­
cal Center and workshops entitled
“Animal Models That Simulate Circula­
tory Shock in Humans: Fact or Fan­
tasy?” and “ Use of Hypertonic Solutions 
for Shock Resuscitation” are planned. 
For further information, contact: Dr. 
Sherwood M. Reichard, Shock Society, 
Medical College of Georgia, Augusta, 
GA 30912, USA.
Extended Programs in 
Medical Education
The University of California in San Fran­
cisco is sponsoring a postgraduate course 
in general surgery, April 14-16, 1988. 
Further information can be obtained by 
writing: Extended Programs in Medical 
Education, University of California 
School of Medicine, Room 569-U, San 
Francisco, California 94143 or calling: 
(415) 476-4251.
International Symposium
Paris is the location of a symposium on 
therapeutic progress in urological cancers 
scheduled for June 29-July 1, 1988. For 
details contact: Dr. Gerald P. Murphy, 
Professor of urology, School of Medi­
cine, State University of New York at 
Buffalo, 139 Parker Hall, Buffalo, NY 
14214; telephone: (716) 831-2338.
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Cesarean section has become a common 
operation, but its complexity should not 
be underestimated. Often it must be 
done as an emergency without skilled 
assistants; at the same time the surgeon 
must deal with the maternal disorder 
that prompted the cesarean section and 
ensure the well-being of the fetus. Of 
further concern is the operative blood 
loss, which can be massive, and the 
postoperative morbidity, which is often 
high. The operative technique has 
evolved from an intraperitoneal vertical 
incision on the body of the uterus (clas­
sical cesarean section) to a near- 
complete reliance on a retroperitoneal 
transverse incision (lower segment 
cesarean section). The historic reason for 
this change was the fear of peritonitis 
postoperatively. Present-day practice 
favours the lower segment operation and 
emphasizes the reduced operative blood 
loss and the more secure uterine scar as 
reasons for the choice. Operative compli­
cations (injury to the fetus, lacerations of 
the uterus and vagina) are the result of 
inadequate uterine incisions. The classi­
cal incision has the advantage of being 
easily extended and thus has a continued 
purpose. Postoperative febrile morbidity 
is attributed to endometritis; the mixed 
aerobic and anaerobic bacteria of the 
vagina are the causal organisms. Febrile 
morbidity can be prevented by antibiotics 
given prophylactically.
Bien que I'accouchement par cesarienne 
soit devenu une operation courante. on 
ne doit pas sous-estimer sa difficulty. II 
doit souvent etre pratique en urgence 
sans le soutien d'assistants experimen­
t's; le chirurgien doit en meme temps 
faire face au probleme maternel qui aura
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Cesarean Section
provoque la cesarienne et s'assurer du 
bien-etre du foetus. La perte de sang 
peroperatoire qui peut etre massive et la 
morbidity post-operatoire souvent elevee 
sont d'autres sources d'inquietude. La 
technique operatoire a evolue: d'une inci­
sion intraperitoneale verticale sur le 
corps de I'uterus (la cesarienne haute), 
elle est devenue, dans presque tous les 
cas une incision retroperitoneale trans- 
versale (cesarienne basse). La crainte 
d'une peritonite postoperatoire est a 
I'origine de ce changement. La pratique 
courante favorise la cesarienne basse; 
elle s'applique a reduire les pertes de 
sang peroperatoires et vise a obtenir une 
cicatrice uterine plus sure. Les complica­
tions peroperatoires (blessures du foetus, 
lacerations de I'uterus et du vagin) sont 
le resultat d'incisions intra-uterines ina- 
dequates. L'incision haute presente 
I'avantage de pouvoir etre elargie facile- 
ment et continue de la sorte a avoir une 
utilite. La morbidity febrile post- 
operatoire est attribute a I'endometrite. 
La flore bacterienne mixte, aerobie et 
anayrobie. du vagin en est a I'origine. La 
morbidity febrile peut etre prevenue par 
une antibiotherapie prophylactique.
In communities of less than 10 000 peo­
ple, cesarean section is the fourth most 
common operation that general surgeons 
will be called upon to perform.1 This 
paper will outline the concerns for the 
general surgeon at the time of cesarean 
section and explain the rationale govern­
ing the choice of operation, but will con­
centrate on operative and postoperative 
management. The objective is to demon­
strate means of decreasing the two major 
complications — hemorrhage during the 
operation and infection postoperatively. 
Operative injury to the urinary tract is less 
common but will also be discussed. In 
Canada a recent consensus report has 
reviewed indications for the operation,2 
so these will not be considered.
Complications
In addition to the complications 
associated with the operative procedure,
there are those inherent to the obstetri­
cal problem itself. The fragile patient with 
pre-eclampsia who has a threatening cere­
brovascular accident, reduced intravascu­
lar volume and possible platelet dysfunc­
tion has an increased operative risk. 
General anesthesia is dangerous, for the 
pregnant patient is more likely to vomit 
and runs a high risk of aspiration. The 
patient’s position on the operating table 
is different; the table must be tilted later­
ally or a wedge fixed beneath one of the 
patient’s hips, because when the woman 
is supine and not tilted the pregnant 
uterus markedly impedes venous return.3 
Fetal well-being is an added responsibil­
ity for the surgeon. The fetus is subject 
to operative trauma and blood loss. The 
likelihood of postoperative respiratory 
distress is increased if the cesarean sec­
tion is done before term. When the 
cesarean section is elective, the gestational 
dates should be confirmed by ultrasonog­
raphy performed in early pregnancy4 or 
the onset of labour should be awaited.5 
The surgery itself may cause excessive 
blood loss and be associated with high 
morbidity. The average blood loss dur­
ing cesarean section is 0.9 to 1.0 litres,6 
which is higher than that anticipated dur­
ing most surgical operations, and the 
postoperative morbidity is even higher 
than that which may follow gunshot 
wounds of the abdomen.7 The conse­
quences of an inappropriate or poorly 
performed operation are such that a 
recent review demonstrated that nearly 
one-third of maternal deaths were 
associated with cesarean section.8
Choice of Operation
The classical cesarean section has been 
superseded by the lower segment opera­
tion, which has a number of advantages. 
One of these is reduced blood loss because 
of the lower segment’s decreased vas­
cularity and because the wound edges can 
be more accurately approximated. The 
resultant scar is less likely to rupture in 
subsequent pregnancies and, if so, only 
in labour. This is in contrast to the scar 
of the classical operation which may rup­
ture before the onset of labour. The 
degree of risk between the two major inci-
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sions has not yet been properly assessed 
and was subject to debate even when last 
documented 29 years ago.9 The classical 
operation allows the continued seepage of 
blood and possibly infected uterine con­
tents into the peritoneal cavity postoper- 
atively with the concomitant danger of 
peritonitis. This risk is reduced with the 
lower segment operation because the uter­
ine incision’s placement behind the 
peritoneum stops the discharge. This was 
crucial in the pre-antibiotic era, but is less 
important now.10
There are, however, advantages of the 
classical cesarean section over the lower 
segment technique. In some circum­
stances, it will allow the child to be deli­
vered with less risk to the mother and less 
trauma to the infant. The classical inci­
sion will not tear into the broad ligament 
causing hemorrhage and can safely be 
extended to allow easy delivery. Serious 
operative complications can be reduced 
by more frequent use of the classical 
cesarean section.11-13
The most common indication for the 
classical cesarean section is prematurity. 
The lower segment of the premature 
uterus is thick and vascular and only a 
few centimetres wide. Attempts to per­
form a lower segment cesarean section in 
this case can lead to trauma to the infant 
and uterine tears or extended incisions, 
often a vertical incision into the upper 
segment. An infant of 28 weeks cannot 
be delivered through a 1.0-cm-long lower 
segment.12 Other indications for classical 
cesarean section include disease in the 
lower segment (adhesions or myomas), 
abnormal fetal presentation (transverse) 
or placenta previa.
Technique
Lower Segment Cesarean Section
A Pfannenstiel incision is generally 
used. The skin incision is traced with a 
marker, for with the patient in a lateral 
tilt and draped it will be difficult to ensure 
an even incision. On opening the 
peritoneal cavity, the uterus is often 
found twisted to the right. As a result, the 
uterine arteries, which are on the lateral 
aspect of the uterus, are brought into the 
operative field. The rotation need not be 
corrected but must be recognized so that 
the uterine vessels may be safeguarded.
The bladder is mobilized by first mak­
ing an incision in the peritoneum of the 
vesicouterine fold between the round liga­
ments. The vesicocervical space is 
entered; it is a potential cleavage plane 
between the bladder and uterus, separat­
ing the veins on the uterine surface from 
those on the bladder. Dissection of the 
loose areolar tissue with a forefinger 
allows the gentle downward mobilization 
of the bladder for approximately 5.0 cm. 
The lateral margins of the bladder must 
be included in the mobilization. In cases
of obstructed labour, mobilization can be 
overdone, displacing the bladder to such 
a degree that the subsequent incision may 
be made in the vagina rather than the 
uterus.14 Blood loss will be excessive, 
delivery difficult and the inferior aspect 
of the incision may disappear behind the 
bladder, causing the upper portion of the 
incision to be mistakenly sutured to the 
bulging posterior uterine wall. On the 
other hand, the uterine incision can be 
made too high and too close to the 
peritoneal reflection, resulting in 
increased operative blood loss. A further 
disadvantage of a too-high incision is 
that, following reperitonealization, the 
uterine incision will lie immediately 
beneath the suture line (on the uterovesi- 
cal peritoneum) and uterine contents may 
seep into the peritoneal cavity. The uter­
ine incision should be placed so that it will 
be located 2.0 cm inferior to the 
peritoneal incision following closure.
A horizontal incision, 3.0 cm long, is 
then made starting at the midway point 
of the lower segment. To control bleed­
ing, an assistant presses the uterine wall 
against the presenting part both above 
and below the site. If the incision is too 
short, funnelling of the side wall occurs 
and visibility is reduced. After each cau­
tious stroke careful inspection and palpa­
tion can avoid serious fetal injury which 
may result from careless hurried incisions. 
The fetus is at risk both when the uterine 
wall is thick (bleeding obscures vision) 
and when the lower segment is thin and 
closely applied to the fetus. Incision is dis­
continued when the membranes bulge in 
the wound or when the fetal scalp is seen.
Traditionally, the incision was extended 
by tearing it laterally with the forefingers. 
Such a maneuver may result in uncon­
trolled tears of the lower segment, extend­
ing down behind the bladder or laterally 
through the uterine vessels. Deliberate 
cutting of the lower segment with band­
age scissors allows a gentle convex inci­
sion which encourages any extension in 
a similar direction. With two fingers 
beneath the uterine wound to protect the 
infant, the cuts are made in a crescent 
fashion, first to the right, then to the left, 
stopping short of the uterine vessels. The 
opening must be adequate, for most of 
the problems encountered during delivery 
are associated with incisions that are too 
short.
The time from uterine incision to deliv­
ery of the vertex should if possible be 
no longer than 90 seconds,15 but con­
sideration of time should not be reason 
for hurried maneuvers. In obstructed 
labour the head is often deep in the pelvis 
and the lower segment wrapped tightly 
around it. Complications increase with 
the descent of the vertex.16 There is 
clearly no room for the simultaneous 
accommodation of the whole hand and 
the fetal vertex in the lower uterine seg­
ment and extensive tears result from 
rough and rapid insinuation of the hand 
beneath the vertex. To avoid such 
damage, it has been suggested that an 
assistant, with a hand in the vagina push 
upwards on the head, or that the opera­
tor try a similar maneuver with a hand 
outside the lower segment. While most 
helpful, neither maneuver is essential. The 
delivery can be achieved by gently insinu­
ating the fingers through the incision and 
beneath the vertex; this is surprisingly 
easy once the “ vacuum” between the ver­
tex and the lower segment has been 
broken. The key is gentle persistent 
effort.
Once the vertex is elevated to the level 
of the uterine incision, delivery follows. 
This is normally achieved by exerting fun- 
dal pressure, the uterine hand serving only 
as a guide. Delivery in this manner is not 
always straightforward. The operator’s 
hand may impede progress through the 
uterine incision or the size of the fetus 
may be such that delivery does not fol­
low fundal pressure. In such cases, deliv­
ery in a controlled fashion and without 
extension of the wound is accomplished 
with the use of obstetric forceps. 
Familiarity with forceps delivery allows 
for their easy use in difficult cases. The 
right hand is inserted into the uterus 
beneath the vertex and covers the 
posterior ear — the fetal head is usually 
in a transverse position — and the first 
blade is directed posteriorly. Both uterus 
and infant are protected by the surgeon’s 
hand from inadvertent trauma. The 
anterior blade is then applied directly and 
easily. Delivery of the vertex now takes 
place in a controlled fashion.
The shoulders are most easily delivered 
by exerting traction with a finger in the 
posterior axilla and thus easing the 
posterior shoulder through the incision. 
The placenta and membranes are immedi­
ately removed manually. The uterus is 
now delivered onto the anterior abdomi­
nal wall. It used to be thought that this 
maneuver resulted in postoperative mor­
bidity; this is not the case.17 The advan­
tages of the maneuver include control of 
uterine hemorrhage (by exerting traction 
on the uterus) and improved operative 
exposure, which allows easy and accurate 
approximation of the incision. In the 
meantime, oxytocin (Syntocinon; Sandoz 
Canada Inc., Dorval, PQ) 20 units/1000 
ml is infused rapidly intravenously.
The inferior margin of the incision is 
identified by running the fingers from the 
upper to the lower segments, with one 
finger inside and the other outside the 
uterus. The inferior margin is then tagged 
by sponged forceps. Failure to identify 
this margin properly has led the inex­
perienced surgeon to suture the upper 
wound edge to the bulging posterior wall. 
Polyglycolic acid (Vicryl 00) is appropri­
ate suture material — its tensile strength
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is stronger than the pull-through strength 
of the uterine muscle and it is of suffi­
cient calibre to prevent the suture from 
cutting through the muscle. A single full­
thickness marker suture approximating 
the uterine wound edges is placed at the 
end of the incision closest to the opera­
tor. Care is taken to avoid the uterine ves­
sels, which are just lateral to the end of 
the incision, and the sigmoid colon, which 
lies immediately behind the broad liga­
ment. The placement of this suture may 
be difficult if the uterine vessels were torn 
during delivery and are bleeding pro­
fusely. In this case, two fingers are placed 
behind the broad ligament, lifting the 
lateral part of the uterus forward, thus 
compressing and elevating the torn blood 
vessels. Sutures can now be accurately 
inserted, bilaterally if necessary.
Closure of the uterine wound is now 
begun at the angle away from the opera­
tor. Present practice favours a full­
thickness continuous suture, non-locking 
and not excessively tight. The sutures are 
somewhat farther apart (more than 1.0 
cm) on the longer lower margin than on 
the shorter upper wound edge (1.0 cm).
A second layer, a vertical Lembert 
suture, is begun approximately 2.0 to 3.0 
cm medial to the tagged lateral edge. 
Injury to the uterine vessels, which have 
apparently moved medially with further 
contraction of the uterus, is avoided by 
palpation and the medial placement of the 
second layer.
Finally, a third layer of polyglycolic 
(Vicryl 3-0) is used to approximate the 
thick well-developed fascia (De Lee’s fas­
cia) on the uterine wall over the second 
layer. With this final suture the uterine 
incision should be just visible. If hemosta­
sis is not complete, further fine sutures 
are inserted; deep heavy figure-of-eight 
sutures through the full thickness of the 
uterine wall are both unnecessary and 
harmful in that they impede healing of the 
uterine incision.18 When hemostasis is 
assured, the bladder is repositioned and 
the visceral peritoneum approximated 
with 3-0 Vicryl. The peritoneal cavity is 
cleansed of blood and amniotic fluid.
Classical Cesarean Section
Formerly, the incision was begun on 
the most prominent part of the uterine 
body and continued downward; now we 
advocate starting as low as possible on the 
anterior uterine wall and extending it 
upward. The bladder is first dissected off 
the lower uterine segment and a small ver­
tical incision made in the middle portion 
of its inferior aspect. The level of the inci­
sion may be influenced by the presence 
of disease in the lower segment. The 
opening is then extended upward, using 
bandage scissors, to a level that will allow 
easy delivery. Although vertical lower seg­
ment cesarean sections are described, in
practice the incisions must extend into the 
thick muscle of the upper segment and are 
in effect classical operations. The infant 
is often most readily delivered by extract­
ing the upper pole first (i.e., the breech 
in vertex presentations). The placenta is 
removed manually. Closure of the uter­
ine portion of the incision is less ana­
tomic, more tim e-consum ing and 
associated with more blood loss than the 
lower segment. Closure with 00 poly­
glycolic acid (Vicryl) is done in three 
layers — the first layer is continuous and 
includes the decidua and the inner third 
of the myometrium, the second layer is 
of interrupted sutures which include the 
remaining myometrium and the third con­
tinuous layer of fine hemostatic sutures 
beneath the serosa. The second layer 
sutures are tagged individually and not 
tied until they all are in place. The uter­
ine serosa is then approximated with 4-0 
Vicryl Lembert sutures. Hemostasis must 
be ensured. The bladder is pulled up and 
sutured to the uterine surface covering as 
much of the incision as possible and thus 
extraperitonealizing the wound.
Placenta Previa
Even the most experienced surgeon is 
challenged by the massive hemorrhage 
that may accompany cesarean section for 
placenta previa; its management, there­
fore, deserves special mention. Blood loss 
may result from the uterine incision, 
injury to the placenta, incomplete 
removal of the placenta as a result of its 
deep invasion into the myometrium 
(placenta accreta) or from post-delivery 
atony. Correct management lies in the use 
of the classical cesarean section with 
ready acceptance of the need for hysterec­
tomy. With this technique, the placenta 
can usually be avoided, but if it is encoun­
tered it should be pushed aside, the mem­
branes ruptured and the infant delivered. 
Incision of or tearing through the 
placenta is not encouraged, as marked 
fetal hemorrhage may result in addition 
to poor visibility and delayed delivery. If 
placenta previa occurs after a previous 
cesarean section it may deeply invade the 
attenuated uterine wall19 and massive 
hemorrhage can accompany its attempted 
removal. Blood loss may only be con­
trolled by hysterectomy, which is usually 
straightforward.20 Care must be taken 
not to injure the ureters or bladder. The 
cervix should be removed, but may be left 
if the patient is in a precarious condition. 
If the uterus must be saved, the uterine 
arteries can be ligated at the lateral uter­
ine margins with single large sutures that 
incorporate the myometrium. Another 
option is ligation of the internal iliac 
arteries, which should be combined with 
the ligation of the ovarian vessels, medial 
to the ovary and inferior to the fallopian 
tube.
Injury
During the course of cesarean section, 
injury to the bladder, ureter or large intes­
tine is possible. Most injuries occur dur­
ing efforts to control intraoperative 
hemorrhage, which usually results from 
poorly performed or ill-chosen lower seg­
ment operations.21 A minority result 
from mobilization of the bladder in 
patients who have had previous cesarean 
section.
Injury to the bladder or ureter is seri­
ous only when not recognized at the time 
of surgery. If there is any suspicion of 
injury, the bladder should be inspected 
through a vertical incision in its dome to 
spot any damage or inadvertent suture 
placement. The ureters’ integrity and 
patency may also be demonstrated at the 
time of cystotomy by observing the efflux 
of urine from the ureteric orifices or by 
their catheterization. Confirmation that 
the sigmoid colon has not been sutured 
is sought by inspecting the posterior sur­
face of the broad ligament.
Infection
The morbidity that often accompanies 
cesarean section is mainly due to 
endometritis. Cesarean section performed 
on a patient who has had ruptured mem­
branes and nonprogressive labour is 
associated with morbidity in 85% of 
cases.22 If the operation is done by an 
inexperienced surgeon the rate may reach 
100%.23 Other identified risk factors 
include general anesthesia, obesity and 
anemia.24 Endometritis follows uterine 
contamination by the normal vaginal 
flora — a mixed aerobic-anaerobic infec­
tion of two or three organisms. Inocula­
tion of this sort must occur after every 
delivery, but in cesarean section the pro­
tective uterine decidua has been disrupted 
by an incision that contains traumatized 
necrotic tissue and foreign material 
(sutures).
To prevent spillage of uterine contents 
into the peritoneal cavity, extraperitoneal 
cesarean sections or ingenious modifica­
tions have been devised,25 but these 
procedures are seldom used. Postopera­
tive morbidity is controlled through the 
prophylactic use of antibiotics. They were 
first suggested 18 years ago26 but only 
gained widespread acceptance recently 
following their success after vaginal hys­
terectomy. Antibiotics should be given to 
all patients who undergo nonelective 
cesarean section. They are started 
immediately after delivery of the fetus. 
First-generation cephalosporins have been 
effective but marginally better results 
have been reported27 with cefoxitin, a 
second-generation cephalosporin. It has 
also been shown that there is some advan­
tage in giving three doses rather than 
one.28
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If an infection develops postopera- 
tively, the antibiotic combination of 
choice is clindamycin with gentamicin. 
Results with this combination are better 
than those obtained with a first- 
generation cephalosporin29 and equal 
those with third-generation cephalospo­
rins.30 Should diarrhea or other com­
plications cause clindamycin-gentamicin 
to be discontinued, cefoxitin or ureido- 
penicillin are possible substitutes. 
Abdominal wound infection or the 
presence of resistant enterocci should be 
considered if there is no response to 
antibiotic therapy within 72 hours.
Summary
The safety o f cesarean section depends 
on selection of the appropriate procedure 
and prevention of hemorrhage, infection 
and urinary tract injury. While the choice 
of the lower segment operation is most 
often correct, the classical incision is espe­
cially useful for delivery of a premature 
infant. Excessive operative blood loss is 
usually the result of an inadequate uter­
ine incision which tears during delivery of 
the fetus. Control of postoperative infec­
tion depends on the prophylactic use of 
antibiotics. Urinary tract continuity is 
assured, if necessary, through the use of 
intraoperative cystotomy.
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Epidural Morphine for Postoperative Analgesia
Generally, postoperative pain is poorly 
controlled by the intramuscular injection 
of narcotics, administered either at 
predetermined intervals or on patient 
demand. When given intramuscularly, 
plasma and brain concentrations of nar­
cotic are unpredictable due to variations 
in the degree and rate of absorption. Fur­
therm ore, severe pain after major 
thoracic or abdominal surgery may 
require a dosage sufficient to depress 
respiration and necessitate ventilatory 
support.
Epidural opiates, first used clinically in 
1979,1 have rapidly become popular and 
are now used in many institutions for the 
relief of postoperative pain. Narcotics, 
given by either the subarachnoid or 
epidural route, act on the opiate recep­
tors in the dorsal horn of the spinal cord 
rather than the opiate receptors of the 
brain.2 Continuous, satisfactory analge­
sia, lasting from 8 to 24 hours without 
motor or sympathetic blockade, may be 
achieved with a single epidural injection 
of morphine. Local anesthetics injected 
into the epidural space produce analge­
sia accompanied by motor and sym­
pathetic blockade leading to immobility 
of the patient and sometimes to hypoten­
sion. Comparison of the effects of the 
same drug administered epidurally, 
intramuscularly or intravenously has 
shown that patients who receive epidural 
opiates are more alert and consequently 
are capable of cooperating with the recov-
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ery room team and of communicating 
with their relatives early after operation.
Indications
A partial list of the indications for 
epidural morphine analgesia is noted in 
Table I. In our institution, it is used 
mainly after major abdominal and 
thoracic surgery to achieve adequate pain 
control in order that the patient can be 
extubated early and subsequently be 
maintained on oxygen by mask. It also 
permits cooperation in early postopera­
tive breathing exercises and chest phys­
iotherapy.
Technique
The rationale for epidural analgesia is 
explained to the patient during the 
preoperative visit by the anesthetist. In the 
operating room, after an intravenous 
infusion is established and before the 
induction of general anesthesia, a catheter 
is placed in the epidural space at the low 
thoracic or lumbar area. Then 5 mg of 
preservative-free morphine are injected 
through the epidural catheter approxi­
mately 1 hour before the anticipated com­
pletion of the operative procedure. If the 
time of administration is considered to 
have been too close to completion of the 
general anesthetic, 5 to 6 ml of 0.25% 
bupivacaine are injected through the 
epidural catheter when skin suturing is 
completed. The local anesthetic produces
Table I—Indications for Epidural Morphine 
Administered for Postoperative Analgesia
Major orthopedic surgery 
Major gynecologic surgery 
Major urologic surgery 
Major abdominal procedures 
Pulmonary resection 
Vascular surgery
sufficient analgesia to bridge the gap 
between conscious emergence from the 
general anesthetic and the onset of the 
morphine analgesia. The endotracheal 
tube is removed when respirations are 
judged satisfactory after recovery from 
anesthesia and the antagonism of the 
muscle relaxant.
Patients are nursed in the head-up posi­
tion in the recovery room to improve 
respiration and supplemental oxygen is 
supplied by face mask in all cases. Deep 
breathing is encouraged and incentive 
spirometers are used as early as possible, 
usually within 1 to 2 hours of operation. 
Arterial blood gases are monitored as 
required. The respiratory rate is counted 
every 15 minutes for the first 2 hours and 
every half hour thereafter. Patients are 
usually discharged from the recovery 
room the following morning after 
removal of the epidural catheter. Occa­
sionally, an additional 1 to 2 mg of 
epidural morphine are required within 1 
to 2 hours of operation to supplement 
analgesia and in 8 to 10 hours for pain 
relief during the night.
Complications
The side effects of this type of analge­
sia that the recovery room team should 
recognize include pruritis, especially of 
the face and thorax, nausea and vomit­
ing, urinary retention and delayed respira­
tory depression.3 Intravenous droperidol 
(0.5 to 1.0 mg) has been successful in 
managing the nausea and vomiting. After 
major abdominal or thoracic surgery 
many patients have indwelling urinary 
catheters which obviate the potential 
problem of urinary retention. Pruritis has 
not presented a problem in any of our 
patients.
The most serious complication is late 
respiratory depression, usually occurring 
within 6 to 10 hours of injection of mor­
phine. Patients should be monitored over-
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night in the recovery room or in an 
intensive-care unit because o f this poten­
tial problem. Respiratory depression, due 
to the morphine in the cerebrospinal fluid 
reaching the central respiratory centres, 
is characterized by an increasing arterial 
carbon-dioxide tension and a decreasing 
respiratory rate. Naloxone (0.4 to 0.8 mg 
intravenously) is effective in treating this 
complication without altering the degree 
of pain relief. Some investigators have 
advocated a continuous intravenous infu­
sion of naloxone to antagonize the 
respiratory depressant effects. This seri­
ous complication has not occurred in our 
experience because the dose o f epidural 
morphine we use is relatively low.
Future Prospects
The problem faced by anesthetists is 
that many patients must be discharged to 
the ward when they could obtain effec­
tive relief of pain from epidural analge­
sia for up to 48 hours. In the future, 
patients might be monitored in step-down 
recovery units or on the ward. The latter 
is feasible with the proper training o f
ward personnel. Furthermore, the safety 
of the procedure can be enhanced by 
using commercially available monitors 
with alarms activated when the respira­
tory rate declines below a preset limit.
R eferences
1 . BEHAR M, Magora F, OLSHWANG D, et al: Epidural 
morphine in treatment of pain. Lancet 1979; 1: 527-529
2. Yaksh TL: Spinal opiate analgesia: characteristics and 
principles of action. Pain 1981; l l :  293-346
3 . BROMAGE PR: The price of interspinal narcotic analge­
sia: basic constraints. Anesth Ana/g 1981; 60: 461-463
BOOK REVIEWS
CONGENITAL DISPLACEMENT OF THE 
HIP JOINT. John A. Wilkinson. 153 pp. 
Illust. Springer-Verlag New York, Inc., 
New York, 1985. $96. (US). ISBN 
0-387-13947-8.
In this monograph on congenital displacement 
of the hip, Wilkinson presents a concise review 
of a difficult and diverse topic. The first four 
chapters discuss the experimental and clinical 
observations that have formed our current 
knowledge of the genetic and environmental 
causes and pathologic development of congen­
ital hip displacement. Included is a review of 
the author’s own extensive research in these 
areas. The description of abnormal hip 
development due to breech malposition is excel­
lent. He emphasizes that when subtle mould­
ing and postural deformities are present in the 
newborn, a diagnosis of associated congenital 
displacement of the hip should be suspected. 
He stresses the importance of associated 
familial joint laxity, which may make early 
diagnosis and management difficult.
The remaining four chapters review the diag­
nosis and management of congenital displace­
ment of the hip from the newborn to the adult. 
Although there is discussion of other accepted 
treatments, the emphasis is on the author’s 
preferred management and clinical results. 
Description of operative procedures is limited 
to the author’s modifications of standard oper­
ations described in general orthopedic text­
books. He compares the various types of splints 
available for treatment in the newborn and the 
complications and causes of failure using these 
methods. It is generally accepted that the goal 
of any surgical management is to obtain and 
maintain a concentric reduction. However, he 
acknowledges that his methods of posterior 
arthrotomy, limbusectomy and capsulorrhaphy 
to achieve reduction are not yet advocated in 
North America. His discussion of residual bony 
incongruity in the 10-month to 3-year age 
group emphasizes pelvic rather than femoral 
osteotomies. A good review of the options in 
pelvic osteotomies is provided.
This monograph is a concise review for the 
orthopedist trained in the management of con­
genital hip displacement. For in-depth study, 
however, the reader should refer to more 
definitive texts.
J a n et  L. W a lk er , md
Clinical fellow,
Division of Orthopaedics,
Department of Surgery,
The Hospital for Sick Children,
555 University Ave.,
Toronto, Ont.
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MANUAL OF GYNECOLOGIC SURGERY. 
2nd ed. Comprehensive Manuals o f Surgi­
cal Specialties. Edited by Byron J. Master- 
son. 379 pp. Illust. Springer-Verlag, New 
York, 1986. $209.75 (US). ISBN  
0-387-96193-3.
This is a book that one likes to own for its own 
sake. The binding is solid, the paper substan­
tial, the printing clear and the illustrations, 
most of which are in colour, are remarkable. 
Furthermore, the text is well written and there 
is something of interest in each chapter.
I have some ambivalence about recommend­
ing the book for purchase since it is unclear 
who the primary audience is. Although it is 
apparently aimed at “gynecology residents and 
practicing gynecologists” the editor has writ­
ten a section for “ all physicians involved in 
ambulatory gynecologic surgery” and a large 
portion is devoted to the general surgeon. The 
result is that there is too much for the inex­
perienced but not enough for the seasoned 
practitioner. For example, the management of 
a breast mass is described in a single page but 
28 pages are devoted to radical vulvectomy and 
radical hysterectomy which will only be per­
formed by a gynecologic oncologist who would 
not need this guide anyway.
The book is divided into three sections. The 
first is concerned with ambulatory gynecologic 
surgery, the second with vaginal surgery and 
the last with gynecologic abdominal surgery. 
There are many interesting points and the fol­
lowing are only some that caught my eye.
The description of endometrial biopsy in the 
ambulatory section is excellent, and the editor 
calls attention to the infrequent need for dila­
tation and curettage. The complications of this 
procedure are only briefly mentioned and he 
seems reluctant to state that curettage has lit­
tle or no therapeutic value.
In this second edition, a new authoritative 
author describes laparoscopy in a chapter that 
is greatly improved over the original. The 
descriptions of use of local anesthesia for 
laparoscopy, direct insertion of the trocar and 
the management of incomplete placement of 
a Falope ring were new for me. On the other 
hand, 1 can’t imagine how one is able to insert 
a Hulka uterine manipulator blindly.
Of the three sections, that on vaginal sur­
gery is the weakest. Masterson has a long­
standing interest in wound healing, suture 
selection and surgical instruments but the dis­
cussion on these subjects is unnecessary. Dis­
courses on preoperative evaluation and the 
preparation for bowel surgery are also super­
fluous. In my experience, the danger of hemor­
rhage after conization of the cervix is after days 
9 to 10; keeping the patient in hospital for the 
first 48 hours postoperatively as recommended 
is not helpful. The described entry into the 
peritoneal cavity during vaginal hysterectomy 
is unorthodox and the need for transfusion of 
35% to 80%, supported by a reference that is 
nearly 30 years old, is unheard of today.
The editor correctly emphasizes the frequent 
ill effects of rectocele repair on subsequent sex­
ual function. During the description of rec­
tocele repair, the use of 0 chromic catgut is 
advocated. In an earlier chapter, the use of 
such sutures is stated to have “ little justifica­
tion when tissue strength, knot-pulled break­
ing strength and modern wound data are 
reviewed” . Sacrospinous fixation is com­
mended as the method of choice in managing 
vaginal vault prolapse; however, there is little 
in the text that would make me comfortable 
with such a selection.
The abdominal section opens with a first-rate
continued on page 69
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THE ONLY THING 
COMPETITIVE ABOUT 
BECTON DICKINSON 
IS THE PRICE.
AT EVERYTHING ELSE WE 
BEAT THE COMPETITION 
HANDS DOWN.
We can sharpen our pencil with the 
best of them.
Price is important! We know that! When 
you’re shopping around, you'll find we're as 
competitive as anyone.
But price isn't everything. What 
really counts is value; knowing that when 
you place an order, you'll be getting 
superior quality products backed by a com­
pany that’s in business for the long term.
That describes Becton Dickinson. 
We’ve been in business in Canada since 
1951 and we plan to do business here for 
many years to come. If we didn’t intend 
staying around, we wouldn't be undergoing 
a major expansion of our office, ware­
house and production facilities.
So while it’s nice for you to know 
that we’re just as price conscious 
as you are, it’s also good to 
know that we refuse to 
compromise on 
quality and
Product service,
quality puts us 
out ahead.
At Becton Dickinson, we base our 
success on a reputation for product 
quality, innovative design and unequalled 
quality control.
It’s these high standards that 
have made B-D* the world’s leading 
producer of disposable hypodermic 
syringes and needles. We’re also 
a world leader in evacuated blood col­
lection systems. Our BARD-PARKER* 
surgical blades have been the choice of 
leading surgeons around the world for 
over 75 years. In hospitals, clinics and 
physicians’ offices, TRU-TOUCH* brand vinyl 
medical gloves are providing the protection 
that health care professionals require.
That’s the Becton Dickinson differ­
ence. We stand behind our products after 
they’ve left our plant.
A winning nationwide distribution 
network.
When you deal with Becton Dickinson, you’re 
dealing with a sophisticated, integrated, 
manufacturing/distribution delivery system.
Our large and expanding warehouses 
in Mississauga and in Calgary provide fast, 
easy access to inventory.
Our network of established distribu­
tors work with us to ensure that you get 
the supplies you need promptly and efficiently.
For you it means no waiting for 
deliveries. For us it means satisfied customers 
who keep coming back.
We lead the field in technical 
support services.
You get more than 
quality health care 
products when
you buy from 
Becton Dickinson. 
Every product we sell 
is backed by highly experi­
enced support professionals.
Technical support specialists will help 
you with advice and assistance on the use 
of our products. Our own sales force, located 
in major centres across the country, backs 
the efforts of our distributors. Our personnel 
are always available to provide in-service 
training in the use of our products.
You're assured of on-the-spot back­
up service. There are no overseas phone 
calls to track down a manufacturer. No frus­
trating, time-consuming wait to get an 
answer. At Becton Dickinson we’re just a 
phone call away.
So if you’re buying from one of our 
competitors now, give us a call.
We thrive on competition.
*BARD-PARKER, B-D and TRU-TOUCH are registered 
trade marks of Becton Dickinson and Company 
reg. user Becton Dickinson Canada Inc.
HEALTH CARE DEMANDS THE BEST
BECTON
DICKINSON
Becton Dickinson Canada Inc. 
2464 South Sheridan Way 
Mississauga, Ontario L5J 2M8 
416-822-4820
SESAP V Question
Items 51-53
A 37-year-old woman has a one-month history of chronic intermittent abdominal pain, watery 
diarrhea, anorexia, and weight loss. She has developed a fever over the last 24 hours, and 
pain in the right lower quadrant has worsened. Examination reveals tenderness in the right 
lower quadrant, with a suggestion of a mass, but no peritoneal signs. WBC count is 18,000/cu 
mm. Chest and abdominal roentgenograms are normal. Contrast studies of the gastrointesti­
nal tract show a cobblestone appearance of the ileum with rose thorn ulcerations, but no string 
sign. The purified protein derivative (PPD) is negative and the stool is negative for pathogens.
51. The most likely diagnosis is
(A) sarcoidosis
(B) regional enteritis
(C) tuberculous enteritis
(D) small bowel lymphoma
(E) Whipple’s disease
52. Corticosteroid therapy is begun. The patient’s condition deteriorates rapidly. Gross find­
ings at celiotomy include a thickened cecum and ileum with enlarged lymph nodes and sub- 
serosal nodules. Because of these findings, the presumptive diagnosis is
(A) sarcoidosis
(B) regional enteritis
(C) tuberculous enteritis
(D) small bowel lymphoma
(E) Whipple’s disease
53. The next step in the operation should be
(A) ileocecectomy with primary anastomosis
(B) ileocecectomy and ileostomy
(C) small bowel resection and anastomosis
(D) small bowel biopsy
(E) mesenteric lymph node biopsy
For the incomplete statements above, select the one completion for each that is best of the 
five given.
For the critique of Items 51-53 see page 68.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and Self-Assessment 
Program No. 5. For enrolment in the Surgical Education and Self-Assessment Program No. 
5, please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Staple Versus Suture Closure of Skin Incisions in a Pig Model
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The purpose of this study was to find 
out whether skin staple closure was a 
reasonable alternative to conventional 
nylon suture closure. Mechanical 
strength, histologic characteristics and 
time of closure were compared in skin 
incisions made on the backs of Yorkshire 
swine. The results showed that stapled 
and sutured wounds have similar 
mechanical strength up to 21 days. Sta­
pled wounds are substantially narrower 
and are associated with less inflamma­
tion than sutured wounds. Staple closure 
is much less time-consuming than suture 
closure.
Le but de cette etude consistait a verifier 
si les agrafes cutanees representent une 
alternative valable aux sutures conven- 
tionnelles de nylon pour refermer les 
plaies. La force mecanique, les caracte- 
ristiques histologiques et le temps pour 
que se referme la plaie ont ete compares 
sur des incisions faites sur la peau du 
dos de pores Yorkshire. Les resultats 
demontrent que jusqu'au 21 e jour, les 
plaies refermees avec des agrafes ou de 
sutures ont la meme force mecanique.
Les plaies refermees avec des agrafes 
sont beaucoup plus etroites et elles sont 
associees a moins d'inflammation que les 
plaies refermees par des sutures. L’utili- 
sation d'agrafes prend moins de temps 
que les sutures.
Surgical skin staplers are often criticized 
as having no advantage over nylon
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sutures for wound closure. The time­
saving benefits of skin closure with sta­
ples has been well documented by Meir- 
ing and colleagues1 who compared 
staple- and suture-closed elective laparo­
tomy incisions in adults. They concluded 
that the cosmetic result was as good if not 
better than that with nylon sutures and 
that a time saving of 80% was possible 
with staples.
The purpose of this study was to deter­
mine whether there are histologic and 
mechanical advantages of skin staples 
over skin sutures and to determine 
whether skin staples are a reasonable 
alternative to sutures.
Materials and Methods
Four incisions 8 cm long and 0.5 cm 
deep were made on the backs of six pigs. 
Two wounds were closed with skin sta­
ples (Appose disposable skin stapler, 
Davis & Geek, Willowdale, Ont.) and two 
with 3-0 nylon sutures (Dermalon, Davis 
& Geek) on each pig (Figs. 1 and 2). The 
time taken to close each wound was 
recorded. Two pigs were killed at 5, 10 
and 21 days after wound closure and 
autopsies performed. Eight 1-cm strips 
were cut from each wound perpendicu­
lar to and including the incision (Fig. 3); 
six strips were studied mechanically and 
two histologically. All tissue deep to the 
panniculus carnosus was excised using 
operating microscope magnification in 
the strips intended for mechanical testing 
in order to obtain a standard width and 
depth. Load-to-failure was determined 
with a loading rate of 2 mm/s as 
described by Forrester.2 Mechanical test­
ing was performed on a Material Test Sys­
tem (MTS Systems Corp., Minneapolis, 
Minn.) within 4 hours of death.
Specimens intended for histologic 
evaluation were fixed in 10% phosphate 
plus formalin and then embedded in 
paraffin. Subcutaneous tissue was left in 
place. Specimens were stained with stan­
dard hematoxylin and eosin and Movat’s 
stains for light microscopy.
All histologic specimens were assessed 
by one examiner (B.H.W.) and given to 
the examiner blind. Wound width, the in­
flammatory process, epithelial response, 
degree of fibroplasia, collagen content 
and matrix organization were assessed for 
each specimen.
Results
Observation of the wounds showed 
good eversion of the edges in both stapled 
and sutured wounds. Staples did not cross 
the incision at its depth. Mechanical test-
FIG. 1—Two wounds were closed with skin 
sutures positioned 1 cm apart. Technique was 
as illustrated.
FIG. 2—Two wounds were closed with skin 
staples placed I cm apart.
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FIG. 3—Eight 1-cm strips perpendicular to and including incision were cut. Six strips were 
tested mechanically. Two were examined histologically.
Table 1 -R esu lts
T im e, d
5 10 21
Tes ts Suture Staple Suture Staple Suture Staple
M echanical
Load to failure, N 5 .6 9 3 .9 2 19 .2 2  2 3 .0 5 5 9 .8 2 6 4 .7 2
In - 2 4 )
Histologic, 0 - 4  (min to max)
In flam m atory response 3 1 2 1 2 1
Epithelial response 3 2 3 2 2 2
Fibroplasia 4 4 3 3 2 2
Collagen content 0 0 2 2 3 3
M atrix  organization 0 0 1 1 3 3
M ean wound w idth , mm ( n - 8 | *
Superficial 0 .7 5 0 .4 5 1.0 0 .5 1.5 0 .5
Deep 0 .5 0 .3 0 .4  0 .3 0 .5 0 .3
‘ D ifferences betw een  the suture and staple groups w ere s tatis tica lly  significant (p <  0 .0 2 ).
FIG. 4—Histologic features of sutured wound. Note width of wound (helween arrows) 
(hematoxylin and eosin and Movat’s stain, original magnification x 100).
ing (Table I) demonstrated that all 
wounds gained strength progressively and 
that there was no significant difference in 
the load-to-failure between wounds closed 
with skin staples and those closed with 
sutures. All sections failed through the 
incision.
Histologically, there was no difference 
in wounds closed with sutures and those 
closed with staples in terms of superficial 
epithelialization, fibroplasia, collagen 
content and matrix organization. 
However, the inflammatory response of 
the wounds was uniformly less in those 
closed with staples. The stapled wounds 
were consistently tighter at both the 
superficial and deep levels (Table 1). The 
difference in wound widths between sta­
ples and sutures was statistically signifi­
cant (p < 0.02) (Fig. 4). The mean closure 
time was significantly different (p < 
0.02), being 6 minutes and 4 seconds for 
suture closure and 2 minutes and 35 
seconds for staple closure.
Discussion
Our study shows that, in the pig model, 
stapled and sutured wounds have the 
same strength up to 21 days after closure.
Staples appear to be superior to sutures 
histologically with respect to inflamma­
tory response and tightness of wound 
closure. Sutures, by way of suture tracks, 
allow deep epithelialization which crosses 
the incision line with resultant increased 
inflammatory reaction as compared to 
staples. Staple-closed wounds are tighter, 
which may mean greater resistance to bac­
terial contamination from the surface, 
resulting in a further decrease in inflam­
mation.
The times taken for wound closure in 
this study correlate well with the clinical 
studies of Meiring and colleagues.1 A 
shorter period of anesthesia is important 
and, in patients with large areas of split­
thickness skin grafts, staples can greatly 
shorten the closure time.
Conclusions
In this pig model, stapled and sutured 
wounds have the same strength up to 21 
days after closure. Stapled wounds are 
significantly tighter and have less inflam­
matory reaction than sutured wounds. 
Staple closure is significantly less time- 
consuming than suture closure. Skin sta­
ples are a reasonable alternative to sutures 
in the closure of wounds.
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Osteomyelitis Due to Kingella kingae Infection
A case of osoteomyelitis due to Kingella 
kingae is presented to illustrate the 
insidious onset and indolent course typi­
cal of bone infections caused by this 
organism. The frequently negative result 
obtained with Gram's stain and the 
fastidious nature of the organism makes 
diagnosis difficult. Initial therapy with an 
aminopenicillin such as ampicillin in addi­
tion to antimicrobial drugs for 
Staphylococcus aureus should be effec­
tive in resolving bone and joint infections 
in children.
Un cas d'osteomyelite due a Kingella 
kingae permet d'illustrer le debut insi- 
dieux et 1'evolution silencieuse typiques 
des infections osseuses causees par cet orga- 
nisme. Les colorations Gram donnent 
souvent des resultats negatifs et la 
nature fastidieuse de ce microorganisme 
rend le diagnostic difficile. Le traitement 
initial avec une aminopenicilline telle que 
I'ampicilline et I'addition d'un antibacte- 
rien efficace contre Staphylococcus 
aureus devraient permettre de venir a 
bout des infections osseuses et articu- 
laires chez I'enfant.
Kingella (Moraxella) kingae is a rare cause 
of infection in children.12 In one of the 
first reports o f osteomyelitis due to K. 
kingae, Davis and Peel3 included 96 iso­
lates reported by the Centers for Disease 
Control (CDC) in Atlanta, Ga., o f which 
75 had known sources — 35 from blood, 
21 from bone and joint and 14 from 
throat.
We report a case o f osteomyelitis of the 
distal right ulna due to K. kingae to bring 
to the attention of physicians the serious
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nature and indolent presentation o f such 
infections.
Case Report
A 2 Vi-year-old girl sustained minor trauma 
to the right wrist, after which she suffered mild 
pyrexia and, within a couple of days, swelling 
and discomfort in the area. X-ray films of the 
wrist, ordered by a local physician, appeared 
normal and no treatment was considered neces­
sary. A few days later, because of persistent 
swelling, discomfort and self-protection of the 
wrist, more x-ray films were obtained and a 
cast was applied. Her temperature and erythro­
cyte sedimentation rate were normal.
Two weeks after the onset of symptoms she 
was admitted to the University Hospital, Saska­
toon. On examination after removal o f the 
cast, the wrist was found to be swollen and 
painful on palpation over the distal ulna but 
not the radius. There was a full range of pas­
sive movement. Lymphadenopathy was noted 
in the right epitrochlear and axillary areas but 
she was afebrile.
A repeat x-ray film (Fig. 1) was obtained and 
a technetium bone scan (Fig. 2) showed 
increased uptake over the distal ulna. Her leu-
f  lG. 1—Lytic lesions of distal ulna from 
which Kingella kingae was recovered.
kocyte count was 8.3 x 109/L  and erythro­
cyte sedimentation rate 20 to 30 mm/h. Gram’s 
stain of the aspirate from the right ulna 
showed no bacteria, but a subsequent culture 
grew K. kingae, confirmed by the Laboratory 
Centre for Disease Control in Ottawa.
At the time of admission the child was 
started on cloxacillin (50 mg/kg daily) 
intravenously, later changed to ampicillin (300 
mg/kg daily) when culture reports and sensi­
tivities were available. She continued to receive 
ampicillin intravenously for 3 weeks and when 
she was discharged, ampicillin orally was 
prescribed for another 3 weeks. Follow-up 
showed continued improvement. At 21/2 years, 
range of motion of the wrist was normal and 
repeat x-ray films showed no evidence of 
growth disturbance of the distal ulnar 
epiphysis.
Discussion
Kingella kingae is a fastidious, aerobic, 
gram-negative coccobacillus that occurs 
in pairs or short chains not seen consis­
tently on stained smears o f primary iso­
lation material. It resembles Moraxella 
and Neisseria sp and has been mistaken 
for Haemophilus sp.4'5 Kingella kingae 
can be differentiated from Kingella 
denitrificans by hemolysis, acid produc­
tion from maltose and absence o f nitrate 
reduction. It appears to be associated with 
serious infections much more frequently 
than K. denitrificans. Both organisms 
have been recovered from the oropharynx
♦
FIG. 2—Technetium bone scan showing 
increased uptake of isotope over distal ulna.
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and the source of infection for K. kingae 
is probably the respiratory tract with 
hematogenous dissemination. Due to its 
fastidious nature, however, the actual 
number of infections due to Kingella may 
be much higher than those infrequently 
reported.
Our case demonstrated many charac­
teristics of infection due to Kingella. The 
most frequently reported infections 
include endocarditis, osteomyelitis and 
septic arthritis, with the mean age of 
patients with bone and joint involvement 
being much lower than th a t for 
endocarditis.1'2,6 Onset may be insidious 
with a milder course than that seen with
the usual organisms responsible for such 
infections.4,6,7
Kingella kingae is uniformly sensitive 
to the aminopenicillins such as ampicil- 
lin or amoxicillin and, if recognized, 
should not present a management 
problem.
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Bladder-Outlet Reconstruction in Neurogenic Bladder
Due to Myelomeningocele
In a subgroup of children with 
myelomeningocele, urinary incontinence 
cannot be managed by clean intermittent 
catheterization and anticholinergic medi­
cation. The authors report on 24 such 
children who required bladder-outlet 
reconstruction. Twelve boys underwent 
the Young-Dees/Leadbetter procedure, 8 
girls underwent the Burch procedure and 
the remaining 4 had a combination of 
the two. Augmentation cystoplasty was 
also carried out in seven girls and one 
boy.
Results were most favourable in the 
girls, with improvement in 92% , in con­
trast to the boys in whom only 58%  
were improved. Artificial sphincter place­
ment may be a more beneficial alterna­
tive for boys.
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II existe un sous-groupe d'enfants souf- 
frant myelomeningocele chez qui I'incon- 
tinence urinaire ne peut etre traitee par 
cath£terisme propre intermittent ou par 
medication anticholinergique. Les auteurs 
decrivent 24 cas de ce genre qui neces- 
siterent une reconstruction de I'orifice 
vesical. Douze garcons subirent une ope­
ration de Young-Dees/Leadbetter, 8 filles 
eurent une intervention de Burch alors 
que les 4 dernieres furent soumises a 
une association des deux. Une cystoplas- 
tie augmentative fut aussi pratiquee chez 
sept filles et un garcon.
Les meilleurs resultats furent obtenus 
chez les filles avec une amelioration chez 
92% d'entre-elles, par rapport aux gar- 
cons dont seulement 58% furent amelio- 
res. La pose d'un sphincter artificiel 
pourrait etre davantage benefique pour 
les gargons.
Primary management of urinary incon­
tinence in children with myelomenin­
gocele includes clean interm ittent 
catheterization and anticholinergic medi­
cations to increase bladder capacity and 
reduce intravesical pressure. This regimen 
fails when urethral competence is reduced 
due to involvement of the nerve roots 
responsible for urethral and pelvic floor 
contractures. Urodynamically, urethral 
resistance and maximal urethral closing
pressures are low, resulting in loss of 
urine before the potential bladder capac­
ity is reached. Under these circumstances 
a bladder-neck reconstruction that 
lengthens the urethra and increases ure­
thral closing pressure has been carried 
out.1 In boys, a modification of the 
Leadbetter operation, omitting the ure­
teral reimplantation, has been used. 
Wedges of uroepithelium are excised 
from each side of the bladder neck leav­
ing a strip of epithelium on the trigone, 
then the muscle of the bladder neck and 
trigone are overlapped to form a muscu­
lar tube.2,3 In girls, a urethrovesical sus­
pension (Burch procedure) was included 
to increase urethral resistance and 
improve continence.4 In patients with 
small non-compliant bladders with 
reduced functional capacity, an augmen-
FIG. I—Urethral luminal reduction and 
lengthening (modified Young-Dees/Leadbet- 
ler procedure).
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tation cystoplasty has been per­
formed. I’5,6 While there are several 
reports of bladder-outlet reconstruction 
in epispadias, there are few published 
results for children with myelomenin­
gocele.1
FIG. 2—Urethrovesical suspension (a) sagit­
tal view and (b) anteroposterior view (Burch 
procedure).
Patients and Methods
The British Columbia Children’s 
Hospital meningomyelocele clinic is cur­
rently following up more than 200 
referred children. Between the years 1982 
and 1985, 24 children with myelomenin­
gocele, 12 boys and 12 girls, underwent 
bladder-neck reconstruction. Their ages 
ranged from 5 to 18 years (mean 10 
years). The indication for outlet recon­
struction included unacceptable inconti­
nence while on an established program of 
clean intermittent catheterization and 
anticholinergic medication, a low or 
absent maximal urethral closing pressure 
and an initial bladder capacity greater 
than 100 ml. Augmentation cystoplasty 
was used in bladders with low capacity 
and compliance.
A modified Young-Dees/Leadbetter 
procedure was performed on each of the 
12 boys (Fig. 1). After adequate exposure, 
a wedge of bladder and urethral mucosa 
was excised from the urethrovesical junc­
tion and a multilayered overlap was car­
ried out over a no. 12 French Foley 
catheter (Fig. 1). In contrast to the Lead- 
better procedure alone, ureteral reimplan­
tation was done in only one of these 
patients.
The Burch urethrovesical suspension 
was performed in the 12 girls (Fig. 2). 
Four girls also underwent a modified 
Young-Dees bladder-neck reconstruc­
tion. Augmentation cystoplasty was car­
ried out in eight patients, seven girls and
one boy; in three this was done at the time 
of bladder-neck reconstruction and in five 
at a later stage. These five were seen early 
in the series. Now we perform this 
adjunctive procedure at the time of recon­
struction as we recognize the value of 
increasing bladder capacity and compli­
ance. Seven of these patients (five girls, 
two boys) underwent simultaneous un­
diversion.
The augmentation in all cases was by 
ileocystoplasty. A segment of ileum, iso­
lated on its mesentery, is opened on the 
antimesenteric border and fashioned into 
a cup. The bladder is split from dome to 
trigone and the bowel anastomosed to fill 
the opening.
Urodynamic assessment was carried 
out in all patients to assess bladder capac­
ity, cystometries and maximal urethral 
closing pressure. Postoperative documen­
tation was adequate for review in 14 
patients. Postoperatively, continence was 
graded as follows; dry if wearing normal 
underwear, using clean intermittent 
catheterization and anticholinergics with 
minimal problems including occasional 
wetness. If, in addition, the child had to 
wear a minipad, the result was classed as 
improved. Treatment failure was defined 
as complete incontinence.
Results (Tables I to 111)
Preoperatively, all children were in 
diapers or wore a collection device. It 
should be noted in Table II that girls
Table 1— Bladder-Neck Reconstructive Procedure in 
Myelomeningocele and Its  Results
Sex Procedure
Augmentation
cystop lasty Complication
Other
procedure Result
F Burch Yes — — Dry
F Burch Yes* - — Dry
F Burch No - — Dry
F Burch No - — Dry
F Burch Yes* - Undiversion D ry
F Burch No - - Improved
F Burch Yes* Pyelonephritis Undiversion Dry
F Burch Yes - Undiversion Improved
F Both Yes - Undiversion D ry
F Both No - Undiversion D ry
F Both Yes 2nd AUS Failure
F Both No
reconstruction
D ry
M Young-Dees No - AUS Failure
M Young-Dees No - - Improved
M Younq-Dees No - AUS Failure
M Young-Dees No - - Improved
M Young-Dees No - Undiversion Failure
M Young-Dees No - Undiversion D ry
M Young-Dees Yes D ifficu lt AUS Failure
M Young-Dees No
catheterization
Improved
M Yound-Dees No Pyelonephritis Nephrectomy Improved
M Young-Dees No - - Dry
M Young-Dees No - AUS Failure
M Young-Dees No - - D ry
*A t the time of reconstruction.
AUS - On the waiting  list fo r a rtif ic ia l urinary sphincter.
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showed more improvement overall, with 
an acceptable result in 92%. One girl 
failed to improve and is awaiting place­
ment of an artificial sphincter. The 12 
boys who had modified Young-Dees/ 
Leadbetter bladder-neck reconstruction 
did not respond as well. The acceptable 
continence rate was only 58%. One boy 
had an augmentation cystoplasty which 
may have improved the continence rate.
Maximal urethral closing pressure 
(MUCP) was adequately documented 
both preoperatively and postoperatively 
in 14 patients. The average increase in 
MUCP was 18 cm H20  (range from 0 to 
50 cm H20). Of the 10 children showing 
a marked increase in MUCP, 8 had 
improved continence and 2 were failures. 
Conversely, in four patients with no 
improvement in MUCP, two had im­
proved continence that may be attributed 
to the effects of augmentation.
Augmentation ileocystoplasty was car­
ried out in 8 of the 24 children. Six girls 
and one boy had acceptable continence, 
but one girl was a failure. The three who 
had it done simultaneously with the
Table II -Overall Results of Outlet 
Reconstruction
Result Boys, no. (%) Girls, no. 1%)
Dry 3 (25) 9 (75)
Improved 4 (33) 2 (17)
Failure 5 (42) 1 (8)
bladder-neck reconstruction were dry. 
Five had the procedure after the initial 
operation, when bladder compliance and 
capacity failed to improve (usually after 
undiversion); three were acceptably dry 
and benefited from the procedure.
Seven of the 24 patients underwent 
undiversion at the time of bladder-neck 
reconstruction. We recognize this presents 
a problem in assessing the results of 
reconstruction alone but all were consi­
dered to have incompetent outlets 
preoperatively and the diversions were ini­
tially carried out for incontinence. These 
children had low urethral closing pressure 
on urodynamic assessment and were 
incontinent with bladder cycling. Five of 
the seven were girls and in these ure­
thropexy added little to the undiversion. 
Two of the boys had bladder-neck recon­
struction and undiversion; one was dry 
and the other failed to improve.
Complications were minor. Two 
patients suffered from urinary tract infec­
tions and one had problems with 
catheterization.
Discussion
Approximately 12% of our 200 chil­
dren with myelomeningocele who failed 
a program of clean intermittent catheteri­
zation and anticholinergic medication 
have unacceptable incontinence rates. The 
surgical approach in this group aims to
Table Ill-Resuits of Procedures
Result, no. (%)
Procedure Dry Improved Failure
Young-DeesILeadbetter 3 (25) 4 (33) 5 (42)
Burch suspension 6 (75) 2 (25) -
Combined 3 (75) “ 1 (25)
increase urethral resistance and length or 
bladder compliance and capacity through 
augmentation cystoplasty. Augmentation 
cystoplasty either alone or complement­
ing other procedures has proven to be 
clearly beneficial in patients with 
myelomeningocele.5 Acceptable results 
in girls have been achieved by bladder- 
outlet reconstruction; boys, however, 
should probably be considered for artifi­
cial sphincter placement.
Any form of outlet reconstruction 
makes artificial sphincter placement more 
complicated and because of this we await 
reports of larger series involving sphinc­
ter placement after surgery on the 
bladder-neck area. Given the ease of 
postoperative catheterization and the 
absence of complications, the results of 
these procedures are encouraging, espe­
cially in girls.
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Gastroschisis: Ultrasonographic Diagnosis, 
Perinatal Embryology,
Surgical and Obstetric Treatment and Outcomes
The embryology and onset time of gas­
troschisis are poorly understood. This 
paper reviews 22 cases of the condition 
seen at the Children's Hospital of 
Eastern Ontario between 1975 and 
1986. Sixteen cases were judged to be 
of the perinatal and 6 of the early type. 
Ultrasonography revealed the actual time 
of development in one case and the 
probable time in another. In 20 cases the 
defect was closed primarily and in 2 by 
a staged procedure (Silon pouch). 
Nineteen infants (86.4% ) survived. In all 
cases the umbilical vasculature was nor­
mal and all were right-sided. Other 
anomalies were rare and less important. 
Two clear examples of rupture of the 
umbilical ring are documented. 
Ultrasonography had been performed in 
10 infants, usually for intrauterine 
growth retardation, and gastroschisis 
was diagnosed in 4 of these. Delivery 
was by cesarean section in six. Marked 
meconium staining occurred in 16 
(73%), 7 of whom had subglottic aspira­
tion of meconium. The average birth 
weight was 2480 g. Ultrasonography is 
recommended in all cases of intrauterine 
growth retardation with careful examina­
tion of the umbilical area to establish the 
presence and time of onset of gas­
troschisis. Vaginal delivery appears to be 
the route of choice for delivery.
On connatt mal I'embryologie et quel est 
le temps d'apparition d'un gastrochisis. 
Cet article passe en revue 22 cas qui ont 
ete vus a I'Hopital pour Enfants de I'Est
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de I’Ontario entre 1975 et 1986. Seize 
cas ont ete juges de type perinatal et 6 
autres de type plus precoce. L'Schogra- 
phie a revels le moment exact ou est 
apparu le gastroschisis et le temps pro­
bable d'un deuxi&me cas. Dans 20 cas, 
la breche a ete refermee en premiere 
intention alors que dans les deux autres 
cas, ont eut recours a une operation en 
deux etapes (sac Silon). Dix-neuf enfants 
(86.4%) ont survecu. Dans tous les cas, 
le systeme vasculaire ombilical etait nor­
mal et tous etaient du cote droit. Autres 
anomalies etaient rares et moins impor- 
tantes. Deux exemples nets de rupture de 
I'anneau ombilical sont demontres. Une 
echographie avait ete faite pour 10 de ces 
enfants, habituellement pour retard de 
croissance intrauterine, et un gastroschi­
sis avait ete diagnostique dans 4 cas. Un 
accouchement par cesarienne fut prati­
que dans six cas. Une coloration mar­
quee du meconium est survenue dans 16 
cas (73%) dont 7 avaient une aspiration 
sublinguale de meconium. Le poids 
moyen de naissance etait de 2480 g. 
L'echographie est recommandee dans 
tous les cas de retard de croissance 
intra-uterine; un examen attentif de la 
region ombilicale devrait etre fait afin de 
verifier la presence et le moment d'appa­
rition d'un gastroschisis. L'accouchement 
par voie vaginale paraft souhaitable.
Both time of onset and mode of develop­
ment of gastroschisis remain an enigma. 
The availability of skilled ultrasonogra­
phy and the formulation of criteria for 
this examination will shed light on these 
two aspects. Close examination of the 
abdominal defect, the umbilical vessels 
and the herniated bowel can give more 
information on which to base a reasona­
ble embryologic theory. Early and later 
perinatal types have been described and 
several embryologic theories proposed. 
These include rupture of the amniotic 
membrane at the base of the umbilical 
cord, between 5 and 10 weeks’ gestation 
or at a later stage through an incompletely 
closed umbilical ring.1 Abnormal involu­
tion of the right umbilical vein with 
breakdown of the abdominal wall at this 
site has been suggested by deVries,2 who
supported his thesis by describing two 
cases of left-sided gastroschisis associated 
with involution of the left umbilical vein. 
Hoyme and associates3 suggested that 
occlusion of the omphalomesenteric 
artery is the primary cause, and Izant and 
associates4 proposed as causes failure of 
the somatopleural mesenchyme of the 
lateral abdominal wall to differentiate 
and absorption of the overlying ectoderm. 
Few hard data are available to support 
any of these theories.
Using ultrasonography, we demon­
strated that the development of gas­
troschisis could be timed exactly in one 
case and less exactly in another. In both, 
rupture of the umbilical ring was 
documented after birth. These cases at 
least date perinatal gastroschisis and 
strongly suggest a mechanism in this later 
group. We reviewed 22 consecutive cases 
of gastroschisis seen at the Children’s 
Hospital of Eastern Ontario, Ottawa, 
between 1975 and 1986. We discuss their 
surgical and obstetrical treatment, out­
come, findings on ultrasonography, the 
risk of meconium aspiration and proba­
ble cause of the perinatal type.
Patients and Methods
Boys and girls were equally represented 
in the study group. The average gesta­
tional age was 37 weeks and the mean 
birth weight 2480 g (including dressings). 
Eighteen of 22 infants were below the 
predicted 50th percentile.5 The indica­
tion for ultrasonography, performed in 
10 infants, was intrauterine growth 
retardation in 7. Although the umbilical 
area of the abdominal wall was not spe­
cifically examined for a defect, one was 
noted in four infants.
The earliest such diagnosis was made 
at 22 weeks’ gestation, 13 weeks before 
delivery.
Surgical Management and Results
Body heat and fluid losses were care­
fully controlled with moist, warm dress­
ings before arrival in the hospital and 
operating room. At admission, overhead 
heaters were used and dressings not
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removed until anesthesia had been 
induced and the child was ready for sur­
gery. In all cases, the abdominal opening 
was enlarged. Stretching of the abdomi­
nal wall was not always performed and 
was never vigorous. Silon pouches were 
considered necessary in two infants, both 
of whom died. Primary closure of fascia 
and skin was achieved in the remaining 
20, 1 of whom died. Herniated viscera 
were identified and described with respect
Fig. lb
FIG. 1—Ultrasonography at 35 weeks’ 
gestation, (a) Left arrow points to anterior 
abdominal wall. On its right are vessels of cord. 
Right arrow indicates eviscerated bowel, (b) 
Arrow points to eviscerated loops of bowel.
to the degree of adhesion and edema. 
Heavy matting was taken to be a mark 
of prolonged exposure to amniotic fluid. 
Lesser adhesions and easy separation of 
viscera were thought to represent a 
shorter exposure and thus a later onset.
Obstetrical Technique
We have no evidence that cesarean sec­
tion is superior to vaginal delivery. Fifteen 
infants were delivered vaginally and 13 
survived. One died of sepsis within 15 
hours of birth following prolonged 
hypothermia and the second (of 26 weeks’ 
gestation) died of pulmonary complica­
tions. These results do not support those 
of Lenke and Hatch6 who advocated 
cesarean section.
Meconium Aspiration
Meconium staining of the amniotic 
fluid and exposed viscera was seen in 16 
cases; subglottic aspiration of meconium 
occurred in 7 of them. This is a much 
higher rate than that usually seen in 
infants admitted to intensive-care units. 
In the large series reported by Matthews 
and Warshaw7 the rate was 7.4%.
Postoperative Management
Primary closure was associated with 
only minor respiratory problems, but 
respiratory paralysis appeared to be help­
ful and 15 of the 22 infants were kept 
paralysed for a variable time postopera- 
tively with no general policy as to main­
tenance of paralysis. This reflects previ­
ously reported experiences.8,9 The mean 
time of ventilatory support was 2.87 days. 
All infants were placed on total 
intravenous alimentation and nasogastric 
suction. The average time for full return 
of intestinal function was 13.4 days, 
which is less than in reported series where 
vigorous stretching was common and is 
comparable to that reported in the series 
of Canty and Collins8 where stretching 
was minimal and primary closure the 
method of choice.
FIG. 2—Forceps hold remnants of umbil­
ical membrane. Bowel has been reduced.
Ultrasonography and Embryology
Ultrasonography was performed in 10 
of our cases, for intrauterine growth 
retardation. In four of these a diagnosis 
of abdominal wall defect was made, the 
earliest at 22 weeks’ gestation. It is pos­
sible that the diagnosis was missed in the 
remaining six infants since the anterior 
abdominal wall was not specifically exa­
mined. In one patient, three scans, 
between 28 and 33 weeks’ gestation, were 
performed without evidence of gastro- 
schisis, although the umbilical area of the 
abdominal wall was visualized. Oligo­
hydramnios was noted and the fetus 
appeared small for gestational age. At 35 
weeks there was a marked increase in the 
amount of amniotic fluid and an obvious 
gastroschisis was present (Fig. 1). It 
would appear that gastroschisis developed 
between 33 and 35 weeks. At operation, 
the loops of bowel were minimally adher­
ent and there was evidence of ragged tis­
sue, suggesting rupture of the umbilical 
membrane. In a second infant, ultra­
sonography was performed at 28 weeks’ 
and at 36 weeks’ gestation because of 
intrauterine growth retardation. Gas­
troschisis was not seen at that time. At 
spontaneous vaginal delivery 4 days later, 
a large gastroschisis was present. The 
bowel was not adherent and there was a 
clear remnant of an umbilical membrane 
(Fig. 2). These two cases, at least, indi­
cate the timing of the perinatal type of 
gastroschisis and the likely probability 
that rupture of the umbilical membrane 
is the mechanism. The umbilical vascula­
ture was entirely normal on both gross 
and microscopic examination in these and 
all our other cases. This neither supports 
nor contradicts the theory of deVries. 
The value of repeated ultrasonography, 
especially between 33 and 37 weeks, is 
clear when there is retarded intrauterine 
growth, but only if the umbilical base is 
specifically examined. Without this a gas­
troschisis can easily be missed.
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Coagulopathy Induced by Aortoiliac Aneurysms
Diffuse intravascular coagulopathy (DIC) 
or consumptive coagulopathy is infre­
quently associated with aortic 
aneurysms. When the two coexist, they 
create a difficult clinical problem that 
requires optimal medical and surgical 
care. Two cases of coagulopathy 
associated with aortoiliac aneurysm are 
presented to exemplify the broad clinical 
picture that can be present. The defini­
tive treatment of DIC is removal of the 
underlying cause. The following 
recommendations are made for the 
management of patients with aortic 
aneurysms and possible coagulopathy: 
preoperatively examine the patient for 
hematomas and ecchymoses; measure 
levels of fibrinogen, platelets and fibrin 
degradation products and the prothrom­
bin and partial thromboplastin times: per­
form arteriography and check puncture 
sites for spontaneous bleeding after­
wards: at aneurysm repair ensure 
meticulous hemostasis and compensate 
ror excessive blood loss by high-speed 
autotransfusion.
II est rare que Ton rencontre I'association 
d'un syndrome de coagulation intravas- 
culaire disseminee (CID), aussi appele 
coagulopathie de consommation, et d'un 
anevrisme de I'aorte. Ensembles, ils 
creent un probleme clinique difficile d 
resoudre et exigent des soins medicaux 
et chirurgicaux de premier plan. On 
d£crit deux cas de coagulopathie asso- 
ciee a un anevrisme aorto-iliaque afin 
d'illustrer les differentes facettes du 
tableau clinique qui peuvent exister. Le 
traitement definitif de la CID exige que 
Ton fasse disparaitre la cause sous-
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jacente. Les recommandations suivantes 
sont offertes pour traiter les patients 
souffrant d'anevrisme de I'aorte et d'une 
coagulopathie possible: en preoperatoire, 
rechercher la presence d'hdmatomes et 
d'ecchymoses, mesurer le taux de fibri- 
nogene, les plaquettes et les produits de 
degradation de la fibrine, ainsi que les 
temps de prothrombine et de c6phaline; 
realiser une arteriographie et verifier au 
point de piqure la presence subsdquente 
d'un saignement spontane; au moment 
de reparer I'anevrisme, s'assurer d'une 
hemostase parfaite et compenser les per- 
tes excessives de sang par une auto­
transfusion d haute vitesse.
Diffuse intravascular coagulopathy (DIC) 
or consumptive coagulopathy is charac­
terized clinically by excessive bleeding, 
ecchymosis and petechiae and by labora­
tory evidence o f a decrease in the num­
bers of platelets and amount of fibrogen 
and an increase of fibrin degradation 
products with prolonged prothrombin 
and partial thromboplastin times. The 
disorder has often been reported after 
operative repair of lesions of the abdomi­
nal aorta,1,2 aortic dissections3 and 
peripheral aneurysms.4 Scattered  
through the literature and in most busy 
vascular practices are cases o f  severe 
coagulopathy in patients with aortoiliac 
aneurysms. The cause of the coagulopa­
thy is often questioned and also whether 
surgical excision and bypass o f the 
aneurysm will reverse the hematologic 
picture or lead to an intraoperative dis­
aster. We present two cases of coagulopa­
thies in association with aortoiliac 
aneurysms that were successfully treated 
surgically with reversal o f the coagulopa­
thies. We review the literature and con­
sider the pathogenesis and management 
of such coagulopathies.
Case Reports
Case 1
An 82-year-old farmer was referred to us 
because of a 2-year history of easy bruising 
over bony prominences and flanks and a pain­
less abdominal mass. He was first investigated 
4 months before admission for a large spon­
taneous ecchymosis of the inner part of the left 
thigh. At that time, hematologic studies rev­
ealed a hemoglobin of 66 g/L, platelet count 
of 95 x 109/L , a partial thromboplastin time 
of 43 seconds (control 30.3 seconds) and a 
fibrinogen level of 2.0 g/L (normal 2.0 to 4.0 
g/L).
His history included bilateral inguinal her­
nia repairs and a motor vehicle accident, both 
many years earlier. Both events were compli­
cated by excessive bleeding. He was taking no 
medications, denied acetylsalicylic acid con­
sumption and gave no family history of bleed­
ing disorders.
On admission, physical examination revealed 
a large, nontender pulsatile periumbilical mass. 
A large area of ecchymosis extended from the 
left groin down the inner thigh just distal to 
the knee. A small hematoma was also present 
over the right lateral thigh.
Laboratory findings on admission included 
a hemoglobin level of 107 g/L, a platelet count 
of 111 x 109/L, prothrombin time 13.6/11.6 
seconds, partial thromboplastin time 38/34 
seconds and a decreased fibrinogen level of 
0.88 g/L. Levels of fibrin degradation products 
were positive at 1 in 20 dilution and at 1 in 40 
dilution.
Abdominal ultrasonography revealed an 
infrarenal aortic aneurysm, measuring 8 cm in 
transverse diameter. Abdominal aortic angiog­
raphy was unsuccessful from both the right and 
left femoral approaches because of marked tor­
tuosity and dilatation of the iliac vessels. Both 
attempts were complicated by hematoma for­
mation at the angiography entry sites, despite 
prolonged efforts at hemostasis. The clinical 
and laboratory findings suggested that the 
patient was suffering from a chronic consump­
tive coagulopathy from his aortic aneurysm. 
There was no other identifiable cause of the 
coagulopathy after complete assessment.
The patient received intravenous cryoprecipi- 
tate 8 hours before operation but did not 
receive any heparin. At operation, an 8-cm 
infrarenal aortic aneurysm was found with 
extension into the left iliac artery. This was 
replaced without complication by a preclotted 
woven Dacron bifurcated graft. Total opera­
tive blood loss was 4000 ml as the patient bled 
easily and diffusely throughout the procedure. 
All shed blood was replaced by use of an 
autotransfuser. Aggressive replacement of 
blood products including cryoprecipitate, plate­
lets and fresh frozen plasma produced a nor­
mal coagulation state by tne end of the proce­
dure. Postoperatively, there were no bleeding
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problems and the patient’s recovery was 
uncomplicated.
Hematologic measurements in the first few 
days after operation demonstrated low plate­
let counts at 60.0 to 70.0 x 109/L  but a nor­
mal prothrombin time (9.9/11.3 seconds) and 
partial thromboplastin time (27/33 seconds). 
Fibrinogen levels rose to 47.8 g/L and fibrin 
degradation products were positive at 1 in 40 
dilution but were negative at 1 in 80. One week 
postoperatively the platelet count was 117.0 x 
109/L  and the prothrombin time and partial 
thromboplastin time remained stable at 
11.3/11.5 seconds and 31/33 seconds respec­
tively.
Fibrinogen levels were normal and fibrin 
degradation product levels were negative, 
indicating complete resolution of his 
coagulopathy.
At a 6-month follow-up visit, there were no 
clinical signs of a hematologic problem and 
hematologic values were normal.
Case 2
A 50-year-old man was transferred to our 
institution in July 1986 from a peripheral 
hospital after a 2-week investigation of persis­
tent left lower quadrant and left flank pain. 
Investigations at that time included a barium 
enema examination, retrograde pyelography 
and cystoscopy, all of which gave normal 
results. Intravenous pyelography revealed a 
shrunken right kidney and an enlarged left kid­
ney with no evidence of obstruction. The 
patient was treated intravenously with antibi­
otics for a presumptive pyelonephritis, but 
relentless left lower quadrant pain, increasing 
somnolence and a progressive rise in blood urea 
nitrogen and serum creatinine levels prompted 
ultrasonography of the abdomen. This inves­
tigation revealed a possible dissection of the 
abdominal aorta extending distally into the left 
iliac artery. The proximal extent was not seen. 
The patient was transferred to the surgical serv­
ice where, on examination, he was noted to be 
somnolent, dehydrated and afebrile. There was 
no evidence of peripheral ecchymosis or bleed­
ing. Right peripheral pulses were normal, but 
only a weak left femoral pulse was palpable 
and no distal pulses were palpable in the left 
leg. No abdominal aneurysm was detectable on 
palpation. Results of laboratory investigations 
upon admission were as follows: serum urea 
nitrogen 18.9 mmol/L urea, serum creatinine 
77.8 /xmol/L, potassium 5.7 mmol/L, pro­
thrombin time 51/16.4 seconds, partial throm­
boplastin time 88/32 seconds, hematocrit 0.39, 
leukocyte count 10.6 x 109/L , platelets 495 
x 109/L , fibrinogen 5.56 g/L, fibrin degra­
dation products positive at 1 in 40 dilution but 
negative at 1 in 80. After 1 in 1 dilution of the 
patient’s blood with a control sample, the pro­
thrombin and partial thromboplastin times cor­
rected to 11.6/10.5 seconds and 35.9/30.3 
seconds respectively, indicating a clotting- 
factor deficiency as the cause of his coagulopa­
thy. Because o f his coagulation-factor defi­
ciency of unknown etiology and progressive 
renal failure secondary to dehydration or dis­
section of the aorta, the patient underwent 
hemodialysis and received fresh frozen plasma 
and vitamin K to reverse the coagulopathy. He 
received hemodialysis and seven units of 
plasma before undergoing angiography. With 
this treatment the prothrombin and partial 
thromboplastin times corrected to 11.1/11.3
seconds and 34/33 seconds respectively. 
Angiography failed to visualize the right kid­
ney or its vasculature. A lobulated distal 
abdominal aortic aneurysm measuring 13.0 x 
9.0 cm with either intraluminal thrombus or 
dissection extending to the level of the left renal 
artery was seen. The left common iliac artery 
was occluded.
At operation a large left iliac artery 
aneurysm, with two to three litres of hematoma 
dissecting up the left paracolic gutter was 
found. This had ruptured and been contained 
for some time. The proximal aorta and renal 
arteries were normal. A 16 x 8-mm preclot­
ted bifurcated woven, double velour graft was 
used to replace the aneurysm. Blood loss was 
replaced with packed cells, and blood products 
were given to maintain a normal coagulation 
profile. The patient tolerated the procedure 
well and hematologic parameters as well as 
indices of renal function had all returned to 
normal by postoperative day 3. Subsequent 
recovery was smooth and at follow-up 6 
months later he had no signs of any hemato­
logic disorder. Twelve months after the 
aneurysm repair he underwent left 
femoropopliteal bypass for lower limb ische­
mia, without any complications.
Discussion
The pathogenesis o f coagulopathies 
induced by arterial aneurysms is not clear. 
Exposure o f subendothelial tissue in an 
aneurysm wall leads to the deposition of 
fibrin and platelets.5 Extrinsic coagula­
tion might follow release of throm­
boplastins from either the disturbed vas­
cular endothelium within the athero­
matous aneurysm or from breakdown 
products o f hemolyzed erythrocytes and 
aggregated platelets.6 Intrinsic coagula­
tion could result from exposure of suben­
dothelial surfaces and relative stasis of 
blood at the site o f the aneurysm.6 
“ Platelet consumption” within an aneu­
rysm may represent excessive incorpora­
tion of platelets into developing mural 
thrombus. Mechanical destruction as 
blood flows over the thrombus may also 
play a role.7 In fact, thrombocytopenia 
has been described as the major hemato­
logic abnormality predisposing these 
patients to excessive hemorrhage peri- 
operatively.7
Patients with arterial aneurysms have 
a dynamic balance of intravascular 
coagulation and secondary fibrinolysis on 
a continuous basis.8 This “ compen­
sated” state o f DIC may be recognized 
by laboratory evidence of consumption 
coagulopathy in the absence of clinically 
important bleeding.5 Clinically apparent 
DIC, then, appears only when the des­
tructive process overwhelms the produc­
tive ones due to an additional factor such 
as rapid aneurysm expansion or hepatic 
or renal insufficiency.8
Diffuse intravascular coagulopathy is 
characterized by two phenomena:1 (a) 
impaired hemostasis secondary to con­
sumption of platelets, clotting factors,
activation of fibrinolysis and the presence 
of fibrin degradation products, which 
inhibit platelets and the coagulation 
mechanism; (b) widespread deposition of 
fibrin thrombi in the microcirculation, 
producing some of the clinical findings 
such as renal failure.
There are many causes of DIC includ­
ing sepsis, hemorrhage, trauma, carci­
noma, amniotic fluid embolus and giant 
hemangiomas. The condition was not 
described in association with arterial dis­
ease until 1967 when Fine and associates9 
described a coagulopathy in association 
with a type I dissecting aortic aneurysm 
(Table I1-8-10-11).
Satiani and colleagues4 described two 
patients, one with an abdominal aortic 
aneurysm and the other a femoral 
aneurysm , who presented with a 
coagulopathy. These authors recom­
mended preoperative control of the bleed­
ing disorder with appropriate blood 
products, followed by surgical repair. 
Heparin therapy was considered rarely 
necessary and excessively dangerous.
Fisher and associates,8 in a prospective 
study of 76 patients with abdominal aor­
tic aneurysm, found that 40% of patients 
had alterations in levels of fibrinogen and 
fibrin degradation products, but only 4% 
o f these had clinical evidence of 
petechiae, ecchymoses or thrombocytope­
nia. They also found that fibrinogen 
levels, measured preoperatively, were not 
good indicators of underlying excessive 
fibrinolysis or DIC. An isolated finding 
of an elevated level of fibrin degradation 
products before surgery did not correlate 
with the amount o f blood lost periopera- 
tively.
Thompson and colleagues5 described 
one patient with an expanding abdomi­
nal aortic aneurysm and a coagulopathy, 
which improved with the administration 
of fresh frozen plasma and a continuous 
intravenous infusion of heparin, followed 
by surgical repair. At 3-month follow-up 
hematologic testing showed that coagu­
lation was normal. Keagy and 
associates11 reported a case of DIC, 
documented clinically and by laboratory 
data, in a patient with a stable abdomi­
nal aortic aneurysm. The coagulopathy 
resolved with heparin administration and 
subsequent aneurysmectomy.
Goto and associates6 presented three 
cases of DIC accompanying abdominal 
aortic aneurysms. Following preoperative 
administration o f heparin in an attempt 
to correct the coagulopathy, all three 
patients underwent repair. Two died of 
nonhemorrhagic complications and the 
third had a successful repair of the 
aneurysm. Postoperative follow-up 10 
weeks later revealed a normal hemato­
logic profile. These authors recommended 
giving low-dose heparin preoperatively, 
as it helped to control bleeding in two of 
their three patients.
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Skepticism exists, however, concerning 
the actual existence of a coagulopathy 
induced by arterial aneurysms. Mulcare 
and colleagues2 performed coagulation 
studies before and after operation on 32 
patients who underwent elective abdomi­
nal aortic procedures. They found no sig­
nificant abnormality in coagulation pro­
files preoperatively in 18 abdominal aortic 
aneurysms and 14 patients with aortoiliac 
occlusive disease. Postoperatively 20% 
had changes in the prothrombin and par­
tial thromboplastin times and platelet 
counts, 60% had abnormal levels of 
fibrin degradation products and plas­
minogen. They concluded that elective 
grafting of the aorta may produce a low- 
grade intravascular coagulopathy. 
However, they were unable to find evi­
dence that nonruptured abdominal aor­
tic aneurysms or aortoiliac occlusive 
disease, in themselves, promoted a 
coagulopathy. Our patients certainly pro­
vide evidence to the contrary and there 
really is little doubt as to the coexistence 
of these clinical syndromes.
Siebert and Natelson10 reported two 
patients with a chronic consumptive 
coagulopathy in conjunction with an 
abdominal aortic aneurysm and set forth 
four criteria to establish the aneurysm as 
the specific cause for a coagulopathy.
• A chronic acquired bleeding dis­
order.
• Laboratory evidence of a consump­
tive coagulopathy.
• Disappearance of the hemostatic 
defect after surgical repair.
• Maintenance of normal coagulation 
at least 3 months thereafter.
Neither of their patients met these 
criteria. One was found postoperatively 
to have an occult pancreatic carcinoma, 
which was thought to be responsible for 
the coagulopathy through the release of 
thromboplastic substances from the 
tumour. The second patient had severe 
liver disease and hypersplenism, promot­
ing the coagulopathy. The authors con­
cluded by advocating a healthy skepticism 
when arterial aneurysms and a coagulopa­
thy are found to coexist and recom­
mended another cause of the bleeding dis­
order be sought.
From our clinical experience, we con­
cur with the recommendations by Fisher 
and colleagues8 for the treatment of 
patients with aortic aneurysm and 
coagulopathies.
• Carefully examine aneurysm patients 
preoperatively for hematomas and 
ecchymoses.
• Measure levels of fibrinogen, fibrin 
degradation products and platelets, and 
prothrombin and partial thromboplastin 
times if there is any suspicion of DIC.
• Carefully monitor patients for 24 to 
36 hours after arteriography, for sponta­
neous bleeding from puncture sites.
• Expect and compensate for excessive 
blood losses with the use of a high-speed 
autotransfuser.
• Ensure m eticulous hem ostasis 
intraoperatively.
The definitive treatment of DIC in any 
case is removal of the underlying cause. 
Intravenously administered heparin has 
been recommended as this interferes with 
the clotting process and may stabilize the 
coagulopathy, but others have avoided its 
use for fear that the retarded intravascu­
lar clotting might worsen bleeding.4’8 
Thompson and colleagues,5 however, 
found that the preoperative use of hepa­
rin was a useful adjunct in controlling the 
bleeding diathesis.
Patients with a coagulopathy and aor­
tic aneurysm should be assessed to rule 
out other causes of the hematologic 
problem. Following this the aneurysm 
should be resected using systemic 
heparinization.
Summary
The two cases presented identify the 
diffuse nature  of coagulopath ies 
associated with aortic aneurysms. In the 
first case a full hematologic and clinical 
picture of diffuse in travascu la r 
coagulopathy was present that was com­
pletely reversed by resection of the 
aneurysm. In the second case, a specific- 
factor consumptive coagulopathy was 
produced by a rapid expansion of an 
unrecognized aortoiliac aneurysm. This 
review is therefore important in remind­
ing us of the coexistence of these clinical
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syndromes and that aggressive medical 
and surgical treatment can produce a 
good clinical result.
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Results of Bone Grafting of Tibial Defects 
in Uncemented Total Knee Replacements
Bony defects of the articular surface are 
frequently encountered in total knee 
replacement. As an alternative to excis­
ing more tibia and using a thicker tibial 
component, autogenous bone grafts 
have been used to fill these defects. The 
authors have analysed 43 cases in which 
bone grafts were used in conjunction 
with an uncemented tibial component. 
The follow-up was 2 to 7 years. The 
results in these cases were compared 
with those in a similar group using 
uncemented components in which bone 
grafting was not required.
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There were 15 central grafts and 28 
edge grafts. All the edge grafts and 
seven large central grafts were fixed 
with screws. If the graft size was more 
than 1 cm2, patients were not permitted 
to bear weight for 4 to 6 weeks. In the 
others, weight bearing was allowed 
immediately.
All grafts united, most within 6 
months, and substantial collapse was 
not observed. Notable sinking of the 
tibial component occurred in one late 
case, in which a rotatory subluxation 
developed due to patellar dislocation.
Collapse of the graft in a recent case, 
however, suggests that when large 
grafts are used, a heavy central stem 
should be used on the tibial component.
Des lacunes osseuses de la surface arti- 
culaire sont frequemment observees lors 
d ’une arthroplastie par remplacement 
complet du genou. Plutot que dexciser 
une partie plus importante du tibia et 
d'utiliser une composante tibiale prosthe- 
tique plus 6paisse, on a eu recours a des 
greffes osseuses autogenes pour combler 
ces lacunes. Les auteurs passent en 
revue 43 cas oil des greffes osseuses 
ont ete associees a la pose de compo- 
santes tibiales prosthetiques non cimen-
tees. Le recul varie maintenant de 2 a 7 
ans. Les resultats obtenus chez ce 
groupe sont compares a ceux d'un 
groupe similaire chez qui on a utilise des 
composantes non cimentees, mais sans 
qu'une greffe osseuse ne soit necessaire
II y eut 15 greffes centrales et 28 
greffes en bordure. Toutes les greffes en 
bordure et sept greffes centrales impor- 
tantes ont ete fixees avec des vis. Lors- 
que la surface de la greffe etait supe- 
rieure a 1 cm2, il etait interdit au patient 
d'y faire porter son poids avant 4 a 6 
semaines. Autrement, il etait permis de 
le faire immediatement.
Toutes les greffes se sont soudees, la 
plupart en moins de 6 mois, et aucun 
affaissement marque n'a ete observe. 
Dans un des derniers cas, on a note un 
tassement appreciable de la composante 
tibiale prosthetique, alors qu'une sub­
luxation due & une dislocation patellaire 
s'est produite.
NSanmoins, I'affaissement du greffon 
lors d'un cas recent, indique que quand 
une greffe importante est necessaire, on 
doit utilise une tige centrale forte pour la 
composante tibiale prosthetique.
In total knee replacement the tibial com­
ponent should sit on a flat bony surface. 
Initially, components were cemented in
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place and minor deficiencies made good 
with cement. Large defects were built up 
by using screws to hold the implant out 
to a desired length until the cement had 
cured.1 With the introduction of 
uncemented components2 bone grafting 
has been used to fill these defects. As this 
procedure has been carried out routinely 
by one of us (H.U.C.) for about 7 years, 
we believed it was time to analyse our 
experience to determine when the grafts 
united and whether collapse occurred.
FIG. 1—Sloping edge defect in medial libial 
plateau can clearly be seen.
FIG. 2—Edge defect in Fig. 1 has been 
drilled and appropriate piece of cortical can­
cellous bone has been shaped to fit defect.
FIG. 3—Graft is attached with screws.
Methods
There are two basic defects of total 
knee replacement — central and edge 
defects. Central defects occur when a 
large cyst is present, usually in rheuma­
toid arthritis, or result from previous total 
knee replacement. As these defects are 
covered by the flat base of the tibial com­
ponent, internal fixation is seldom 
required. The soft tissue is simply 
debrided and the defect packed with 
autogenous cancellous bone. Unless the 
graft is greater than 1 cm2 immediate full 
weight bearing is allowed.
Edge defects occur in long-standing 
arthritis where the edge of the tibial 
plateau is badly eroded and the bone 
usually eburnated. Multiple 2-mm drill 
holes are made in the eburnated bone to 
encourage blood vessel permeation, and 
an autogenous contoured bone graft is 
screwed into position (Figs. 1 to 4). In 
cases in which the tibial component was 
entirely of plastic, A.S.I.F. scaphoid
FIG. 4—Graft is firmly anchored to tibial 
plateau which is ready to receive tibial com­
ponent. Holes drilled for plastic pegs can be 
seen. Care must be taken that graft screws do 
not invade anchoring holes so these must be 
drilled first.
screws were used. When a porous cobalt 
chrome base plate supplemented tibial fix­
ation, either cobalt chrome or titanium 
screws were used to prevent potential cor­
rosion of the stainless steel (Fig. 5). 
Patients with grafts larger than 1 cm2 
were not allowed to bear weight for 4 to 
6 weeks in order to allow a perimplant 
bone plate to develop.
All cases of uncemented tibial compo­
nent grafting performed by the senior 
author between 1979 and 1984 were ana­
lysed and the results compared with 
equivalent procedures in which grafting 
was not required. The patients were 
reviewed every 6 months and rated using 
the Toronto knee rating system.3 At the 
same time, radiologic analysis was carried 
out by an independent observer, using 
routine x-ray films, to determine when 
graft healing or “ nonidentification” took 
place.
Findings
The 43 patients reviewed (33 women, 
10 men) ranged in age from 48 to 88 years 
(mean 68 years). The primary disease was 
osteoarthritis in 31, rheumatoid arthritis 
in 8 and avascular necrosis in 4. Eight 
patients had had total knee revision. The 
tibial components used were the ICLH 
(Protek Co., Switzerland) in 9, the Tri­
con P (Richards Surgical Company, 
Memphis, Tenn.) in 14, the Tricon P 
Revision in 2 and the Tricon M in 18.
The Tricon P and ICLH tibial compo­
nents are constructed of polyethylene and 
held in place by ridged plastic pegs. The 
Tricon M is similar but includes a porous 
metal plate for additional fixation. The 
Tricon P Revision tibial component has 
a long central metal stem.
There were 15 central grafts of which 
3 were extensive (2 being in knees that 
required revision and 1 in an old focus of
FIG. 5—Three months after grafting of severely deformed tibial plateau. Two cobalt chrome 
screws were used to hold graft in place as porous base plate of tibial component was cobalt 
chrome. Line between graft and underlying bone can still be seen.
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septic arthritis). All edge grafts were held 
in place with screws, as were several large 
central grafts (Fig. 6). Of the central 
grafts, eight were smaller than 1 cm2 and 
seven larger. They all appeared to heal, 
or at least were not recognizable by 6 
months. The 28 edge grafts took longer 
to heal, but 18 of them were larger than 
1 cm2 and had mostly healed by 6 
months. Ten smaller edge grafts had 
mostly healed by 1 year, but in many 
cases the site of union across the previ­
ously eburnated bone was visible years 
later (Fig. 7). Speed of graft incorpora-
FIG. 6—Large central defect in patient who 
required revision and in whom Tricon P revi­
sion stem was used. Two screws were used to 
stabilize graft.
tion was not influenced by the tibial com­
ponent, whether it was entirely plastic or 
metal-backed.
Sources of bones were the excised por­
tion of the knee (41) and iliac wing (2). 
There were no intraoperative problems 
but four late ones occurred. One patient 
had a lateral patellar subluxation which 
required a Hauser procedure. Two sus­
tained undisplaced patellar fractures at 3 
months and one had a supracondylar 
fracture 3 years later, treated by open 
reduction and internal fixation.
Results as rated at 2 to 7 years (mean 
3.5 years) were 59.6% excellent, 29.9% 
good, 7.4% fair and 3.1% poor. These 
percentages were similar to those in a
FIG. 7—Five years after insertion, medial 
tibial plateau edge graft can still be seen under 
ICLH knee prosthesis. Trabeculae cross scar 
line so that graft has healed, but eburnated 
bone scar is still visible.
FIG. 8—Edge defect in this medial tibial plateau was large, so Tricon M tibial stem com­
ponent was used to protect graft. Stem is wide in coronal plane to provide tilt resistance; thus 
immediate weight bearing was allowed.
group of patients receiving the Tricon P 
and M prostheses but no bone grafting 
who were rated during the same interval 
(69% excellent, 23% good, 4% fair and 
4% poor). Two patients with ICLH knee 
prostheses subsequently underwent revi­
sion, one for a sunken medial compart­
ment at 5 years as a result of rotatory sub­
luxation and one for lack of flexion. In 
both cases the grafted areas could not be 
recognized at the time of revision.
Although no problems were encoun­
tered in the series, one recent large medial 
compartment edge graft did collapse, 
leading to an angular deformity of the 
tibial component. It stabilized, but 
because of this the senior author believes 
that in cases of very large grafts the tibial 
component should be reinforced with an 
I-beam stem to give greater resistance to 
angular loads (Fig. 8).
Discussion
Knee replacement can be performed 
without bone grafting if the tibia is sim­
ply excised down to a level below the 
defect and a thick tibial component is 
used. The tibia, wedge-shaped prox- 
imally, narrows rapidly, and the bone 
softens likewise with increasing depth 
from the surface.4 A thicker narrower 
implant is thus placed in poorer quality 
bone and is more likely to sink.
All bone grafts in the series united 
without significant or visible collapse. The 
size of the central defect did not seem to 
influence healing time. Being surrounded 
by bone, the graft was no doubt rapidly 
incorporated. The smaller edge grafts 
appeared to take longer to unite than the 
larger edge grafts, perhaps because the 
latter contained more cortical bone, per­
mitting screw fixation. This is possibly a 
radiologic artifact related to the old ebur­
nated bone scar.
Collapse of a large edge graft in a 
recent case led to a re-evaluation. We now 
believe that an edge graft of more than 
1 cm2 and 5 mm deep probably should 
be protected by a central stemmed tibial 
component. This is particularly true for 
medial edge defects, as the medial tibial 
compartment tends to be more heavily 
loaded than the lateral side. The stem 
should be wide in the coronal plane to 
provide resistance to medial tilt and 
should approach the posterior cortex, 
providing resistance to anterior sinkage.
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A logical first choice 
for serious 
polymicrobial 
infections...
DalacinC
Phosphate
Sterile Solution (clindamycin phosphate)
Sustained effectiveness against:
• Bacteroides fragilis and other 
anaerobes
...common pathogens in poly­
microbial infections
• Staphylococcus aureus
...the most common organism in 
post-op wound infections
to reduce the 
threat of 
post-surgical 
complications
Dalacin C Phosphate sterile solution
(clindamycin phosphate)
Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by 
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections 
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium 
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) 
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in 
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not 
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in­
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy 
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con­
tinued only w ith close observation. Significant diarrhea occuring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowingulcera-
tion or pseudomembrane formation, should be managed with fluid, electrolyte, and protein 
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in 
persistent cases. Anticholinergics and antiperistalticagents may worsen the condition. Other causes 
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day for 5 - 10 or more days, there was a rapid ob­
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with 
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration. 
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the 
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic 
liver function tests should be performed during prolonged therapy. Blood counts should also be 
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysisare not 
effective means of removing the compound from the blood. Periodic serum levels should be deter­
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin 
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local 
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at 
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion, 
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. Tbe majority of these cases 
developed in conjuction with the use of indwelling I.V.cathetersand itisd ifficu ltto  know howmuch the 
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at 
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash.............................................................................................................................................................  1
Urticaria.......................................................................................................................................................  1
Pruritus......................................................................................................................................................... '
Fever, Leucocytosis...................................................................................................................................  1
Nausea, with or without vomiting.............................................................................................................  1
Diarrhea (See also under 'Warnings")........................................................................................................ 4
Hypotension.................................................................................................................................................  1
Hypertension................................................................................................................................................ 1
Shortness of Breath.................................................................................................................................... 1
Superinfection • ...........................................................................................................................................  4
Cardiac a r re s t" .......................................................................................................................................... 1
Bad or bitter taste in mouth........................................................................................................................ 5
• Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side 
effect of clindamycin phosphate.
* * Due to underlying myocarditis in this patient.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphat# 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysis and liverand kidney function tests. Some of these tests were abnormal initially and returned* 
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became 
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal 
systems. Transient elevations of serum transaminases have occured in some patients, but other litter ^  
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No specific 
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five djsyy- 
have been given without adverse effects.
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DOSAGE AND ADMINISTRATION
Adults 4  <*■
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses. .
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more tharl 
600 mg into a single site are not recommended. , _
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to 
I.V. administration to a dilution of 300 mg in 50 m l of diluent (6mg/mL) or more, and infused in not less
thanlOminutes. Administrationofmorethan1200mginasingle1 hourinfusionisnotrecommende^.
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, eAh J 
infused over 20 minutes or longer.
Severe Infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over 
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip or 
in 3 or 4 equal doses each infused over 20 minutes or longer may be given. *  *•
Dilution and infusion rates:
Dose Diluent Time
300 mg 50 mL 10 min.
600 mg 100 mL 20 min. f .  V*
900 mg 150 mL 30 min.
1200 ma 200 mL 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum Rapid Maintenance
clindamycin levels infusion rate infusion rate
Above 4 mcg/mL 10mg/m in.for30min. 0.75 mg/min. M  —
Above5mcg/mL 15mg/m in.for30min. 1.00 mg/min.
Above 6 mcg/mL 20m g/m in.for30m in. 1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2 ,3  or 4 equal doses. *  <
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer.
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body 
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.)
Dilution and Compatibility: «  j
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 mL of the following commonly userfin- 
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours: A 4
Sodium chloride injection
Dextrose 5% in water p  ^
Dextrose 5% in.saline
Dextrose 5% in Ringer s Solution ^
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride 
Dextrose 2'/2% in Lactated Ringer s Solution (Hartmann’s Solution) ^
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is 
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution:
Clindamycin phosphate equivalentto clindamycin base 150 mg
Benzyl alcohol 5 mg >
Disodium edetate 0.5 mg
Water for injection q.s. f  "
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH 
range of 5.5 to 7.0. 4
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request. CE 137710
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Heparin-Induced Thrombosis (White Clot Syndrome) 
Secondary to Prophylactic Subcutaneous Administration
of Heparin
As a reminder that thrombocytopenia 
may occur even with very small doses of 
heparin, the author describes the case of 
a 76-year-old man who was admitted for 
elective hip surgery and received "mini­
dose" heparin prophylactically. Profound 
thrombocytopenia developed, followed 
by deep vein thrombosis and then 
arterial occlusion to the lower limb. Ini­
tially, the importance of the low platelet 
count was not recognized and a continu­
ous infusion of heparin (35 000 units/d) 
was given. It was discontinued when the 
limb became cold, pulseless, paralysed 
and anesthetic, and an emergency aorto- 
gram demonstrated occlusion of the 
femoral artery. Removal of the thrombus, 
closed fasciotomies, infusion of 
Rheomacrodex in dextrose and adminis­
tration of warfarin resulted in the 
patient's recovery of sensation and 
movement in the limb.
Afin de rappeler que la thrombocytopenie 
peut venir compliquer un traitement 
d'heparine a tres faible dose, les auteurs 
decrivent le cas d'un homme de 76 ans 
qui fut hospitalise pour une chirurgie non 
urgente de la hanche et qui recut a titre 
preventif une "mini dose" d'heparine.
Une thrombocytopenie profonde est 
apparue qui fut suivie d'une thrombose 
veineuse profonde, puis d'une occlusion 
arterielle du membre inferieur. Au debut, 
I'importance du faible compte plaquet 
taire ne fut pas reconnue et une perfu 
sion continue d'heparine (35 000 U/dl 
fut administree. Elle fut interrompue 
quand le membre devint froid, exempt de 
pouls, paralyse et insensible; une aorto- 
graphie d'urgence demontra I'occlusion 
de I'artere femorale. L'enlevement du 
thrombus, la realisation de fasciotomies 
fermees, la perfusion de Rheomacrodex
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dans un solute glucose et I'administra- 
tion de warfarine permirent au patient de 
recouvrer les sensations et le mouve- 
ment du membre.
The administration of heparin has, in a 
small number of patients, promoted 
major venous or arterial occlusion that 
threatened life or limb (white clot syn­
drome). The episodes were apparently the 
result o f an immune-mediated platelet 
aggregation disorder. The following 
report describes the case o f a patient who 
suffered profound thrombocytopenia 
during the prophylactic subcutaneous 
administration o f heparin, then had 
major deep vein thrombosis and a limb- 
threatening arterial occlusion.
Case Report
A 76-year-old man with severe osteoarthri­
tis was admitted to the Dr. Everett Chalmers 
Hospital, Fredericton on Feb. 5, 1986 for an 
elective right total hip replacement. There was 
no clinical evidence of past or present phlebi­
tis, deep vein thrombosis or pulmonary 
embolism. The hemoglobin level and platelet 
count were normal. He had never received 
heparin. Because he was thought to be at risk 
for deep vein thrombosis postoperatively, a 
prophylactic regimen of heparin subcutane­
ously was planned.
The day after admission, a routine hip 
replacement was performed under epidural 
anesthesia. Heparin, 5000 units every 8 hours 
subcutaneously, was started 8 hours after the 
operation. For the next 11 days, his recovery 
progressed except for a persistently elevated 
temperature reaching as high as 38°C. Routine 
blood tests showed an expected fall in the 
hemoglobin levels but the platelet counts were 
normal. Eleven days after operation his right 
lower limb became markedly swollen with a 
12-cm increase in circumference of the thigh 
and a 3.8-cm increase of the calf. A venogram 
revealed extensive deep vein thrombosis in the 
calf and thigh and possibly thrombosis of the 
iliac veins. The platelet count had now fallen 
to 29 x 109/L  (Fig. 1), but the importance of 
this was not appreciated. The subcutaneous 
administration of heparin was discontinued, 
and with a 5000-unit bolus a continuous infu­
sion of 35 000 units/d was started. A lung scan 
4 days later showed three areas of pulmonary 
infarction. Three days after this his right limb
suddenly became cold, pulseless, paralysed and 
anesthetic. Doppler ultrasonography failed to 
detect blood flow in the limb. The platelet 
count was 19 x 109/L. An emergency arteri­
ogram showed occlusion of the right common 
femoral artery extending to the distal one-third 
of the superficial femoral artery. A diagnosis 
of heparin-induced thrombosis was made and 
the drug infusion discontinued.
During emergency surgical exploration, the 
right common femoral artery was found to be 
plugged with pale thrombus, which was 
moulded to the contours of the artery and did 
not appear embolic in origin. It is noteworthy 
that the patient’s blood appeared to be ade­
quately anticoagulated, since there was no evi­
dence of propagation thrombus distal to the 
occlusion. The thrombus was removed. A 
second discrete thrombus was removed from 
the distal one-third of the superficial femoral 
artery by a Fogarty balloon catheter. Circula­
tion was restored and closed fasciotomies were 
performed on the muscle compartments of the 
calf. Heparin was discontinued. An infusion 
of Rheomacrodex 40 in dextrose 5% (Dextran 
40) (1 L/24 h) was started immediately 
postoperatively and acetylsalicylic acid, 325 mg 
twice daily, prescribed. On the following day 
sodium warfarin was administered and 
anticoagulation established over several days. 
The patient regained sensation and movement 
of the limb. No further complications occurred 
and he was discharged 3 weeks later. Warfa­
rin was continued for 3 months.
Discussion
The rate o f benign thrombocytopenia 
secondary to heparin administration has
HG. 1—Patient’s platelet counts during 
administration of mini-dose and full-dose 
heparin.
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been variously reported as being between 
0% and 26%, with bovine heparin more 
often being incriminated than its porcine 
counterpart.1 In the majority of cases, 
the fall in platelet count is less than 
33%2 and is innocent and transient. The 
white clot syndrome occurs only in 0.6% 
of patients receiving heparin,3 and, in 
these, the fall in the platelet count is more 
profound (probably below an arbitrary 
figure of 100 x 109/L). The condition 
appears to be due to an antigen-antibody 
complex reaction leading to massive plate­
let aggregation, although, paradoxically, 
patients receiving full doses of heparin 
may appear fully anticoagulated. The 
onset is usually between 6 and 12 days 
after starting heparin therapy, or sooner 
if there has been prior exposure to the 
drug. The patients suffer either new onset 
of occlusion of large vessel veins or arter­
ies or have exacerbations of pre-existing 
thrombosis.
Whether venous thromboembolic dis­
ease should be included in the syndrome 
has been questioned4 on the grounds that 
deep vein thrombosis is common in 
hospitalized patients. Our patient was cer­
tainly at risk postoperatively, and the pro­
found thrombocytopenia (29 x  109/L) 
that existed at the time the symptoms
appeared does not necessarily imply a 
causal relation. The venous system was 
not surgically explored since the throm­
bosis had been established for 7 days and 
exploration was considered of question­
able benefit.
In many of the reported cases the aorta 
has been the site of platelet aggregation. 
It is possible that the arterial platelet clot 
in this patient was embolic from the 
aorta, although clinically this did not 
seem to be so.
It is noteworthy that very low heparin 
dosage may create this syndrome. “ Mini­
dose” heparin given prophylactically5 
and even the tiny dose required to main­
tain an arterial line have been incrimi­
nated. The clinical syndrome may be 
recognized by measuring platelet counts 
regularly. Seriously ill patients have a var­
iety of possible causes for throm­
bocytopenia, but platelet aggregation 
studies should prove diagnostic. Rapid 
conversion from heparin to warfarin ther­
apy in less than 6 days offers a measure 
of protection. If the platelet count falls 
below an arbitrary level of 100 x 109/L , 
withdrawal of heparin is appropriate. 
Dextran and acetylsalicylic acid, as plate­
let inhibitors, may be indicated. Prota­
mine sulfate has no effect on the immune
reaction. Arterial embolectomy has been 
successful, especially since, in fully 
anticoagulated patients, extensive propa­
gation thrombosis is absent. For this rea­
son, there is also the intriguing possibil­
ity of a successful venous thrombectomy, 
although this has not been described.
Awareness of the high death rate 
(29%), amputation rate (21%)‘ and that 
even tiny doses of heparin may promote 
major platelet aggregation, should reduce 
the occurrence of this catastrophe.
I thank Drs. Dalton Dickinson and Doro­
thy McDade for their assistance, Mrs. Lynn 
Keeley-LeBlanc who typed the manuscript and 
Glen Martin, Education Division, Dr. Everett 
Chalmers Hospital, who prepared the illus­
tration.
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Efficacy of Incorporating Cyclosporine Into Liposomes 
to Reduce Its Nephrotoxicity
A preparation of cyclosporine (CsA) 
in liposomes was tested in the rat to 
evaluate its effectiveness in reducing CsA 
nephrotoxicity.
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The drug was injected intravenously in 
unilaterally nephrectomized Lewis rats at 
a daily dose of 25 mg/kg for 14 days, 
either in a cremophore solution (eight 
rats) or in a preparation of liposomes 
(eight rats). Another group of four 
animals received the cremophore solution 
alone.
Overall, rats treated with the CsA- 
liposome preparation had reduced toxic­
ity, exhibiting better survival rates and 
less weight loss than those treated with 
the CsA-cremophore. Incorporating CsA 
into liposomes induced a statistically sig­
nificant (p < 0.05) reduction in the 
otherwise progressive increase of serum 
creatinine during week 2 of the experi­
ment. Following administration of CsA- 
liposome preparation, epithelial cells of 
the proximal renal tubules appeared mor­
phologically normal, without evidence of 
vacuolization, which is characteristic of
CsA nephrotoxicity and was seen in the 
CsA-cremophore group.
Although the exact mechanism is not 
clearly understood, it is likely that the 
tissue distribution of CsA, when incorpo­
rated into liposomes, is modified in 
favour of the reticuloendothelial cells, 
thereby sparing highly sensitive, but non­
target organs such as the kidneys.
Une preparation de cyclosporine- 
liposomes (CsA) a ete testee chez le rat 
afin d'evaluer son efficacite sur la reduc­
tion de la nephrotoxicite liee a la CsA.
La CsA a ete injectge par voie intra- 
veineuse chez les rats Lewis, ayant subis 
une nephrectomie unilateral, a la dose 
de 25 mg/kg par jour pour 14 jours con- 
secutifs, soit en solution dans du cremo­
phore (huit rats), soit incorporee dans 
des liposomes (huit rats). Un autre
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groupe d 'anim aux a recu le crem ophore 
seul (quatre rats).
Com parativem ent aux rats traites a la 
C sA -crem ophore, ceux ayant recu la 
preparation de C sA -liposom e ont montre 
une toxicite system ique reduite, de par 
une survie amelioree et une perte pon­
derate m oindre. L'incorporation de CsA 
dans des liposom es a entraine une eleva­
tion significativem ent (p <  0 .0 5 ) moins 
importante de la creatinine serique dans 
la deuxiem e semaine de I'experim enta- 
tion. De plus, apres adm inistration d une 
preparation liposomale de C sA , les cel­
lules epitheliales des tubules renaux 
proxim aux furent depourvues de lesions 
vacuolaires caracteristiques de la 
nephrotoxicite a la C sA , telles qu 'obser- 
vees dans le groupe traite a la C s A - 
crem ophore.
Bien que le mecanism e exact ne soit 
pas clair, il est vraisem blable que la dis­
tribution tissulaire de la C sA , apres incor 
poration dans des liposom es, soit 
modifiee en faveur des cellules reticulo- 
endotheliales, epargnant ainsi des 
organes sensibles mais non vises, 
com m e les reins.
Nephrotoxicity is one of the most com­
mon complications of cyclosporine (CsA) 
therapy in organ transp lan tation .1 
Modifying the cellular distribution of 
CsA by the use of an appropriate carrier 
could reduce this toxicity.
The use of “lysosomotropic” drugs has 
effectively reduced undesirable toxic side 
effects of a wide variety of drugs, at the 
same time maintaining or even enhanc­
ing their therapeutic effectiveness.2,3 
Among these, macromolecular com­
plexes, such as the Adriamycin-DNA
complex, have reduced free drug-induced 
cardiac4,5 and renal toxicity6,7 without 
loss of immunosuppressive activity in 
experimental renal allografts.8,9 Such 
drug linkages are limited and other 
lysosomotropic carriers searched for have 
included liposomes.10,11
Because of the highly hydrophobic 
property of CsA, the drug can be easily 
entrapped in the lipid layer of liposomes. 
We therefore decided to evaluate the 
efficacy of a CsA-liposome preparation 
in reducing drug-induced nephrotoxicity 
in a rat model.
Materials and Methods
Male Lewis rats (Charles River Breed­
ing Laboratories Inc., Wilmington, 
Mass.), weighing between 300 and 450 g, 
were used. A left nephrectomy was per­
formed on day 0 under ether anesthesia.
Cyclosporine-liposome preparations 
were obtained by evaporation of a chlo­
roform solution of phosphatidylcholine, 
cholesterol and CsA, in the respective 
weight proportions of 5 to 1 to 2.5, fol­
lowed by suspension in a tromethamihe- 
sodium chloride buffer, sonicadon and
FIG. 3—Serum creatinine concentrations in 
rats after intravenous administration of CsA 
in cremophore- and liposome-treated groups.
centrifugation. The preparations were 
tested, by high pressure liquid chromatog­
raphy, for CsA concentration and percen­
tage incorporation of CsA.
Drugs were injected intravenously 
through the tail vein under light ether 
anesthesia. Three groups of animals were 
studied. Group 1 (eight rats) received a 
CsA-cremophore preparation (Sandoz 
Canada Inc., Dorval, PQ) at a daily dose 
of 25 mg/kg for 14 days. Group 2 (eight 
rats) was treated with the CsA-liposome 
preparation using the same CsA dosage. 
Group 3 (four rats) received the cremo­
phore solution alone in an amount 
equivalent to that in the first group.
Blood samples were taken before CsA 
or cremophore administration and three 
times a week for blood chemistry analy­
sis. Autopsies were performed on day 14 
after sacrifice of the animal or earlier if 
the rat died before the end of the experi­
ment. Kidneys were processed for 
microscopic and ultrastructural exami­
nation.
The data were subjected to statistical 
analysis using a multiple regression test. 
A p value of < 0.05 was considered sig­
nificant.
Results
Group 1 rats had a higher death rate. 
Two of the eight rats of this group died 
within 14 days, whereas all animals in 
group 2 survived (Fig. 1).
Weight loss was significantly (p < 
0.03) less pronounced during the second 
week of the experiment in group 2 com­
pared with group 1 (Fig. 2), suggesting an 
overall reduced toxicity. Furthermore, 
incorporation of CsA into liposomes
FIG. 1—Survival rate of rats after 
intravenous administration of cyclosporine 
(CsA) in cremophore- and liposome-treated 
groups.
FIG. 2—Weight loss of rats after 
intravenous administration of CsA in 
cremophore- and liposome-treated groups.
FIG. 4—Kidney of rat treated with CsA-cremophore and killed on day 14. Most proximal 
tubular epithelial cells show clear vacuoles of various sizes within their cytoplasm (hemaloxylin- 
phloxine-saffron stain, original magnification X 400).
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induced a statistically significant (p < 
0.05) reduction in the progressive increase 
of serum creatinine levels (Fig. 3).
Cyclosporine trough plasma levels were 
not affected by the vehicle used (18.2 ± 
6.1 X 103 ng/ml in group 1 and 18.5 ± 
12.5 x 103 ng/ml in group 2).
Microscopic examination of the kid­
neys in group 1 rats revealed clear vacu­
oles in the cytoplasm of numerous renal 
proximal tubular cells (Fig. 4), as 
described by Mihatsch and colleagues.12 
In contrast, a marked reduction of these 
toxic lesions was noted when CsA was 
incorporated into liposomes (Fig. 5).
Group 3 rats, receiving the cremophore 
solution alone, showed normal weight 
gain (Fig. 6) and no significant modifi­
cation of renal function (Fig. 7). The 
vacuolization process noted in group 1 
was not detected in group 3 animals, but 
ultrastructural studies revealed crystalloid 
structures similar to those described by 
Verani.13
Discussion
If the use of CsA as a potent 
immunosuppressive agent in organ trans­
plantation is to be continued, every effort
FIG. 6—Weight of rats after intravenous 
administration of cremophore solution.
should be made to reduce its nephrotox­
icity, one of its most harmful side effects.
Liposomes, which are biodegradable 
and nontoxic lipid vesicles, appear to be 
promising as drug carriers to reduce 
undesirable toxic side effects while main­
taining or even enhancing the therapeu­
tic efficacy of the drugs. Water-soluble 
as well as lipid-soluble drugs can be 
trapped in liposomes, in the internal aque­
ous space and in the lipid layer respec­
tively.10’11
Incorporating drugs such as CsA into 
liposomes allows the formation of slow- 
release derivatives. Furthermore, by 
potentially altering the normal distribu­
tion and binding of CsA in blood and tis­
sues, one may expect to increase uptake 
by target cells (particularly when they 
involve the reticuloendothelial system), 
thereby sparing sensitive but non-target 
organs such as the kidneys.
Our results clearly show the overall 
reduced toxicity of CsA after it is incor­
porated into liposomes (Figs. 1 and 2). 
Also improved are the functional (Fig. 3) 
and morphologic (Fig. 5) outcomes of 
CsA nephrotoxicity. Cyclosporine plasma 
levels do not appear to be affected by 
incorporation into liposomes and are thus
FIG. 7—Serum creatinine concentrations in 
rats after intravenous administration of cremo­
phore solution.
not associated with the reduced toxicity 
although any relationship between these 
two factors remains unclear. Since cremo­
phore by itself does not increase serum 
creatinine levels, the reduction of CsA 
nephrotoxicity after encapsulation of the 
drug into liposomes should be attributa­
ble to those carriers, which presumably 
modify CsA tissue distribution, keeping 
it away from the kidney.
Reduced renal toxicity of CsA- 
liposomes in a rat model has also been 
demonstrated by Hsieh and associates,14 
using the glomerular filtration rate by inu- 
lin clearance as an index of nephrotoxic­
ity, but morphologic studies were not per­
formed.
This beneficial effect of a CsA- 
liposome preparation warrants further 
attention, particularly if immunosuppres­
sion is not affected, as shown by Aziz 
and colleagues15 and Hsieh’s group.14 
Preliminary experiments done in our 
laboratory, using a CsA-liposome prepa­
ration in renal allografts, did not show 
any deleterious effect on the immunosup­
pressive activity obtained with CsA- 
cremophore, at the dose of 2 mg/kg for 
14 days. Further investigation needs to be 
done to determine the optimal liposome 
preparation, since the tissue distribution 
and pharmacokinetics of drugs can be 
modified by altering their lipid composi­
tion, size and charge.
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Pseudocalculus of the Common Bile Duct
Common-bile-duct growths are rarely 
identified unless they cause chronic 
biliary obstruction. This case report 
describes a 71-year-old woman who had 
jaundice and epigastric pain. A 
cholecysto-colonic fistula was demon­
strated by endoscopic retrograde cholan­
giopancreatography. The patient also had 
multiple filling defects in the common 
bile duct. The fistula was closed and 
stones were removed. A postoperative 
cholangiogram showed two calculi. One 
was removed with a basket through the 
T-tube tract, but the second, which did 
not appear completely free of the 
common-duct wall, could not be 
removed by the basket method. Subse­
quently at laparotomy this was found to 
be a benign pedunculated polyp, com­
posed of collagenous and vascular tissue 
and with no surface epithelium. Sur­
geons should bear in mind the possibility 
of a common-bile-duct growth in cases 
of extrahepatic biliary obstruction.
Les tumeurs du choledoque sont rare- 
ment identifies a moins qu'elles causent 
une obstruction biliaire chronique. On 
decrit le cas d'une femme de 71 ans 
souffrant d'ictere et de douleur epigastri-
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que. Une fistule cholecystocolique fut 
mise en evidence par cholangiopancrea- 
tographie endoscopique retrograde. La 
patiente presentait de multiples lacunes 
radiologiques dans le choledoque. La fis­
tule fut fermee et des calculs retires. Un 
cholangiogramme pratique en postopera- 
toire revela deux calculs. Un calcul put 
etre enleve par un panier passe dans un 
tube en T; I'autre qui ne paraissait pas 
completement detache de la paroi du 
choledoque, ne put etre retire par la 
methode du panier. Subsequemment, a 
la laparotomie ^n dentifia un polype 
pedicule benin, compose de tissus colla 
gene et vasculaire, sans surface epithe- 
liale. Le chirurgien devrait garder a 
I'esprit la possibility d'une tumeur du 
choledoque dans les cas d'obstruction 
biliaire extrahepatique.
Benign epithelial tumours o f the extra- 
hepatic biliary system are rare. A review 
by Chu1 in 1950 demonstrated that only 
30 o f 55 presented cases withstood 
vigorous application of clinical and histo­
logic criteria. In no case was a correct 
preoperative diagnosis made. By 1970, 76 
cases had been demonstrated.2 The etiol­
ogy o f these lesions has not become any 
clearer since Chu’s retrospective study; 
however, the importance of identifying 
these tumours and distinguishing benign 
from malignant lesions has become 
increasingly clear.
This report illustrates the difficulty in 
obtaining a correct preoperative diagno­
sis when a pedunculated polyp mimicked 
a retained common-duct calculus at T- 
tube cholangiography and endoscopic 
retrograde cholangiopancreatography 
(ERCP).
Case Report
A 71-year-old woman with a 5-year history 
of biliary colic was admitted to St. Boniface 
General Hospital, Winnipeg, with jaundice and 
epigastric pain. Endoscopic retrograde cholan­
giopancreatography revealed a cholecysto- 
colonic fistula and choledocholithiasis (Fig. 1). 
Severe heart disease, requiring placement of a 
pacemaker, and the patient’s refusal precluded
surgery. She was readmitted 13 months later 
with a clinical diagnosis of cholangitis; she was 
jaundiced, had epigastric pain and was febrile. 
Endoscopic retrograde cholangiopancreatog­
raphy demonstrated multiple common-bile- 
duct calculi and the persistent cholecysto- 
colonic fistula. The patient now consented to 
surgery, and cholecystectomy, choledocholi- 
thotomy, closure of the cholecysto-colonic 
fistula and choledochoscopy were carried out. 
The patient’s common bile duct and hepatic 
ducts were found to  be patu lous. 
Choledochoscopy revealed debris throughout 
the extrahepatic biliary system, but no other 
calculi were evident. A no. 6 Baker’s dilator 
passed with ease into the duodenum. A no. 18 
French T tube was placed in the common bile 
duct for drainage.
On postoperative day 10, a T-tube cholan­
giogram demonstrated two filling defects in the 
distal common bile duct, diagnosed as calculi 
(Fig. 2). The patient was referred to the Depart­
ment of Radiology for stone extraction through 
the T-tube tract. One stone was easily removed 
with the Medi-Tech biliary stone basket (Medi- 
Tech Ltd., Watertown, Mass.), but removal 
of the second was unsuccessful. One week later 
a second attempt at removal was unsuccessful, 
so a drainage tube was placed in the tract. The 
second attempt induced a gram-negative 
(Escherichia coli) bacteremia that was treated 
successfully with antibiotics. When the patient 
returned to the hospital 4 weeks later for stone
FIG. 1—Cholecysto-colonic fistula and mul­
tiple calculi in common bile duct.
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extraction, the drainage tube had pulled out 
and the tract could not be dilated.
At a repeat laparotomy 3 months later, 
choledochotomy revealed a common-duct 
lesion, which was excised. A postoperative 
cholangiogram was clear and the T tube was 
removed 6 weeks after surgery. The patient’s 
recovery was uncomplicated.
The excised lesion was a polypoid structure 
composed of a reparative pattern of col­
lagenous and vascular tissue elements totally 
devoid of surface epithelium (Fig. 3). This 
polyp arose from an area of the common-duct 
mucosa where mucosal distortion was 
observed. There was no evidence of malignant 
disease in the margins of mucosal epithelium. 
The polypoid growth did not show the more 
active growth pattern of an invasive fibroma­
tosis that can occasionally be seen in this area. 
Thirty-one months after surgery, the patient 
remains asymptomatic.
FIG. 2—Two filling defects in common bile 
duct. More proximal defect was benign pedun­
culated polyp.
Discussion
The most frequently reported benign 
tumours of the extrahepatic bile ducts are 
adenomas and papillomas, and the most 
frequently reported associated symptoms 
are jaundice and pain.2’3 The common 
bile duct was the site of 90% of benign 
extrahepatic biliary tumours' but was the 
site of only 35% of extrahepatic carci­
nomas.3
Our patient had a long history of 
cholelithiasis and choledocholithiasis. The 
presumed cause of the cholecysto-colonic 
fistula was a calculus. It is tempting to 
relate the lesion found in the common bile 
duct to the patient’s long-standing chole­
docholithiasis. Others have attempted to 
link choledocholithiasis and common- 
duct growths.4’5 In this case, the pathol­
ogy report supported the idea that 
prolonged irritation of the mucosal sur­
face resulted in a collagenous tissue 
growth. In retrospect, the possibility that 
the second filling defect in the common 
bile duct was a polyp should perhaps have 
occurred to us during the first attempt at 
basket removal. The polyp continually 
popped out of the basket as it was being 
closed, quite unlike routine stone 
removal. An additional possibility for dis­
tinguishing calculi from polyps is sug­
gested in Fig. 2. The most distal defect 
is seen to float free surrounded by con­
trast medium. A cholesterol calculus was 
removed during the first basket extrac­
tion. The remaining defect, although 
quite mobile during extraction attempts, 5 
is not seen to be completely free of the 
common-duct wall and was in fact 
attached by a pedicle.
The clinical importance of benign 
common-duct growths relates to their 
potential for causing recurrent cholangi­
tis and intermittent obstruction. They 
may also act as a nidus for recurrent cal­
culus formation in the biliary system.
An alternative method for managing an 
elderly patient such as ours might include 
endoscopic retrograde sphincterotomy 
with the placement of a biliary 
endoprosthesis. This mode of treatment, 
however, would leave the nature of the 
lesion unknown. In 1957, Duncan and 
Wilson,6 in a report of benign tumours 
of the common bile duct, suggested that 
newer radiopaque imaging techniques 
would make diagnosis of duct lesions 
much easier. The case presented here 
shows, however, that despite these newer 
techniques, we must consider the possi­
bility of unusual pathologic findings in 
cases of extrahepatic biliary obstruction.
We gratefully acknowledge the assistance of 
Drs. G.P. Sharma, M. Hamonic and A. Mol- 
gat in preparing this report.
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Fig. 3a
FIG. 3—(a) Lesion removed from common dud was polypoid reparative growth of collagenous tissue protruding from common-duct 
mucosa (hematoxylin and eosin, original magnification x 50). (b) Junction between common-duct mucosa and reparative growth of collagen. 
Poly poid lesion is denuded of surface epithelium (hematoxylin and eosin, original magnification X 150). (c) Stroma of lesion is composed entirely 
of collagenous and vascular component devoid of any malignant features and inflammatory elements (hematoxylin and eosin, original magnifi­
cation x 150).
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Healing of Extra-articular Angulated Apex Volar 
Fractures of the Distal Radius
Healed extra-articular angulated apex 
volar fractures of the distal radius are a 
relatively common orthopedic finding.
The functional end-results of treatment 
of this injury are controversial.
Twenty-nine patients with 34 fractures 
were reviewed by subjective and objec­
tive assessment, as well as radiologic 
examination. Some had unsatisfactory 
results. These poor results were 
associated with older age, poor anatomi­
cal reduction and. in some, the presence 
of a midcarpal instability pattern.
Les fractures extra-articulaires consoli- 
dees de la partie distale du radius qui 
presentent une angulation sont obser- 
vees relativement frequemment en ortho- 
pedie. Les resultats fonctionnels du trai- 
tement de cette blessure sont 
discutables.
Vingt-neuf patients presentant 34 frac­
tures ont fait I'objet devaluations sub- 
jectives et objectives, ainsi que d'exa- 
mens radiologiques. Certains montraient 
des resultats insatisfaisants. Les mauvais 
resultats etaient relies au grand age, a 
une mauvaise reduction anatomique et, 
dans certains cas, a la presence d'un ter­
rain mesocarpien instable.
Although a common orthopedic injury, 
the fractured distal radius continues to 
generate controversy with regard to treat­
ment and its functional end-results. Since 
1814, when Abraham Colles1 first 
described the fracture named after him, 
numerous studies have attempted to ana-
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lyse the functional end results of fracture 
management. Colies’ initial paper1 
assured that whatever the form of treat­
ment “ ...one consolation only remains, 
that the limb at some remote period will 
again enjoy perfect freedom in all its 
motions, and be completely exempt from 
pain’’. Despite this assurance, a number 
of authors have taken issue with Colles’ 
original statement. Gartland and 
Werley2 reported unsatisfactory results 
that correlated with the loss of the nor­
mal volar tilt of the distal radius. Bacorn 
and Kurtzke3 reviewed over 2000 
patients with distal radial fractures and 
identified a subset of patients who did 
poorly. They reported that the degree of 
dysfunction in patients with poor results 
was directly related to the amount of 
residual deformity. Scheck4 agreed, not­
ing that a poor anatomical result led to 
greater disability. Others have disputed 
these findings. Smaill5 reported satisfac­
tory results with less-than-adequate ana­
tomical reduction. As recently as 1983, 
Rubinovich and Rennie6 took the posi­
tion that Colles was correct in his origi­
nal assessment that at some time func­
tional end-results of treatment would be 
satisfactory despite less-than-adequate 
reduction. Therefore, the controversy 
continues. Is anatomical reduction impor­
tant in determining the end-result of treat­
ment of distal radial fractures? In an 
attempt to resolve this controversy, an 
analysis of the results of healed extra- 
articular angulated apex volar fractures 
of the distal radius was undertaken.
The purpose of this paper is to find out 
if there exists a group of patients with 
poor end-results after a healed extra- 
articular apex volar fracture of the distal 
radius. If so, we intended to identify the 
etiologic factors involved and draw up 
guidelines that could serve as prognostic 
indicators for the final result of 
treatment.
Patients and Methods
One-hundred patients were treated at 
Victoria Hospital, London, Ont. between
1977 and 1982 for healed extra-articular 
angulated apex volar fractures of the dis­
tal radius. Twenty-nine (10 men, 19 
women) agreed to return for a clinical and 
radiologic follow-up examination. 
Patients who had been treated in any 
fashion other than casting, with or 
without reduction, were excluded.
Clinical examination, performed on all 
patients by one of the authors (A.M.), 
consisted of both subjective assessment 
and objective testing. Subjective assess­
ment included a questionnaire that made 
special reference to the presence of pain, 
feelings of weakness and functional limi­
tation.
Based on the subjective questionnaire, 
the 29 patients (34 wrists) were assigned 
to one of four groups. Group 1 consisted 
of the contralateral, normal wrists of 24 
of our patients and served as a control 
group. These 24 wrists were asympto­
matic and had not sustained any previ­
ous injury. Group 2 included seven wrists 
with healed extra-articular angulated apex 
volar fractures of the distal radius. These 
wrists were asymptomatic and had no 
functional limitation. Group 3 comprised 
11 wrists associated with mild to moder­
ate symptoms including an occasional 
ache or pain but still allowing the patient 
to perform normal daily activities. 
Finally, in group 4 were 16 wrists that 
produced symptoms at rest. The patient 
had to modify work activities because of 
functional limitation, pain or weakness in 
the affected extremity.
Objective testing consisted of grip 
strength measurements with a Jamar 
dynomometer (Asimow Engineering Co., 
Los Angeles, Calif.) at all five levels and 
pinch strength assessed with a Bunnell 
pinch meter to assess key and tip pinch 
strength in both hands on each patient. 
Range of motion was recorded in both 
wrists in palmar and dorsiflexion and 
radial and ulnar deviation was recorded 
with a standard goniometer.
Radiologic examination of both wrists 
in all patients consisted of standard 
anteroposterior and lateral films, as well 
as stress films in radial and ulnar devia-
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tion and in palmar and dorsiflexion. A 
clenched-fist posteroanterior view was 
also obtained.
F ind ings
The 29 patients ranged in age from 19 
to 84 years at the time of follow-up (mean 
59.2 years). The mean ages of patients in 
groups 2 and 3 were 47 and 57 years
FIG. 1—Mean age greatest in those with 
poorest subjective results.
Group
FIG. 2—Mean range of motion was less and 
side-to-side difference greater in more sympto­
matic patients. Dotted bars = palmar flexion, 
hatched bars = dorsiflexion
20  n
1 2  3 4
Group
FIG. 3—Mean grip strength, as measured at 
level 2 on Jamar dynomometer.
FIG. 4—Mean key pinch strength is 
diminished in more symptomatic patients.
respectively. Patients in group 4 had the 
highest mean age (65.6 years) (Fig. 1). 
Fourteen wrists were dominant. Follow­
up averaged 30.7 months (range from 17 
to 134 months).
The mean range of motion decreased 
from group 2 to group 4 (Fig. 2). Grip 
and pinch strength were reduced in all 
fractured wrists when compared to the 
contralateral normal wrists (Figs. 3 and 
4). Patients in group 4 had the greatest 
reduction in grip and pinch strength.
Three radiologic parameters were 
associated with the poor end-results: 
ulnar variance, radial angle and volar tilt. 
The greatest aberrations from normal 
occurred in group 4 wrists. No difference 
was noted in the scapholunate angle and 
there was no evidence of scapholunate 
dissociation in any of the patients.
Mean ulnar length, as seen on the 
posteroanterior view, was -0 .6  mm. In 
the group 4 patients the mean side-to-side 
difference in ulnar length was + 3.05 mm
FIG. 5—Radial fracture. Note angulation 
apex volar at lunocapitate articulation. Lunate 
is volar-flexed with respect to radius.
T a b le  I— U ln a r L e n g th
G ro u p
M e a n  s id e - to -s id e  
d if fe re n c e ,  m m
1 N o rm a l
2 +  0 .5 0
3 + 0 .6 4
4 +  3 .0 5
T a b le  I I— R a d ia l A n g le
G ro u p
M e a n  re d u c t io n  f ro m  
n o rm a l,  °
1 N o rm a l
2 1 .5
3 4 .7
4 7 .5
T a b le  I l l - V o la r  T i l t
G ro u p M e a n  lo s s  o f  v o la r  t i l t ,  °
1 N o rm a l
2 8 .5 0
3 1 2 .9 0
4 1 8 .3 0
FIG. 6—Healed radial fracture. Lunate is 
volar-flexed with respect to distal radius. Note 
angulation apex dorsal at lunocapitate articu­
lation.
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(Table I). Shortening and radial deviation 
results in a diminished radial angle. The 
largest mean reduction in the radial angle 
of 7.5° occurred again in group 4 wrists 
(Table II).
The normal attitude of the distal 
radius, as seen on the lateral view, is 
approximately 10° of volar angulation.7 
The group 4 patients exhibited the largest 
mean loss of volar tilt of 18° when com­
pared with the normal wrists (Table III).
Interestingly, 9 of 16 patients in group 
4 demonstrated increased angulation at 
the midcarpal articulation (Figs. 4 and 5).
Discussion
The fact that the majority of patients 
sustaining distal radial fractures have 
good results is not disputed. However, 
this review demonstrated that a group of 
patients with poor subjective and objec­
tive results does exist.
As in previous studies,2"4 anatomical 
reduction seems to be the key factor in
determining the final result. Ulnar vari­
ance, radial angle and loss of volar tilt 
are all a good measure of the adequacy 
of reduction. Taleisnik and Watson8 
reported 13 cases of malunited fractures 
of the distal radius with associated mid- 
carpal instability and suggested that this 
resulted from the loss of normal palmar 
tilt of the distal radius that disrupts 
normal radiocarpal mechanics. Whether 
this instability is a result of compensatory 
realignment or of ligamentous disruption 
is unknown but requires further study 
because midcarpal instability may be a 
factor in patients with poor end-results.
Conclusions
A group of patients exists in which 
poor subjective and functional results 
occur after treatment of extra-articular 
apex volar fractures of the distal radius. 
The adequacy of reduction seems to be 
the most important factor in assuring 
good results.
References
1. COLLES A: On the fracture of the carpal extremity of the 
radius. Edinb Med Surg J  1814; 10: 182-186
2. G artland JJ JR, WERLEY CW: Evaluation of healed 
Colles’ fractures. J Bone Joint Surg [Am] 1951; 33: 
895-907
3. BACORN RW, Kurtzke JF: Colles’ fracture; a study of 
2,000 cases from the New York State Workmen’s Com­
pensation Board. J  Bone Joint Surg [Am] 1953; 35: 
643-658
4. SCHECK M: Long-term follow-up of treatment of com­
minuted fractures of the distal end of the radius by trans­
fixation with Kirschner wires and cast. J  Bone Joint Surg 
[Am] 1962; 44: 337-351
5. SMAILL GB: Long-term follow-up of Colles’ fracture. J  
Bone Joint Surg [Br] 1965; 47: 80-85
6. RUBINOVICH RM, RENNIE WR: Colles’ fracture: end 
results in relation to radiologic parameters. Can J  Surg 
1983; 26: 361-363
7. FRIBERG S, LUNDSTROM B: Radiographic measurements 
of the radio-carpal joint in normal adults. Acta Radiol 
[Diagn] (Stockh) 1976; 17: 249-256
8. Taleisnik J, WATSON HK: Midcarpal instability caused 
by malunited fractures of the distal radius. J  Hand Surg 
[Am] 1984; 9: 350-357
BOOKS RECEIVED
This list is an acknowledgement of 
books received. It does not preclude 
review at a later date.
Benign Strictures of Bile Ducts. Edward I 
Galperin, Nikolai F. Kuzovlev and Suren 
R. Karagiulian. 345 pp. Must. International 
Universities Press, Inc., Madison, Conn., 
1987. $60.00 (US). ISBN 0-8236-0494-2.
Clinical Endocrinology of Calcium 
Metabolism. Edited by T. John Martin and 
Lawrence G. Raisz. 424 pp. Must. Marcel 
Dekker, Inc., New York, 1987. $115.00 
(US). ISBN 0-8247-7689-5.
Color Atlas of Head and Neck Surgery. Face, 
Skull and Neck. Jatin P. Shah. 256 pp. 
Must. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1987. $221.50. ISBN 0-8089-1882-6.
Coronary Angioplasty. Bernhard Meier. 279 
pp. Must. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1987. $73.50. ISBN 0-8089-1892-5.
Endoscopic Laser Surgery Handbook. Edited 
by Stanley M. Shapshay. 520 pp. Must. 
Marcel Dekker, Inc., New York, 1987. 
$125.00 (US). ISBN 0-8247-7711-5.
External Fixation: Joint Deformities and Bone 
Fractures. Mstislav V. Volkov and Oganes 
V. Oganesyan. 366 pp. Must. International 
Universities Press, Inc., Madison, Conn., 
1987. $60.00 (US). ISBN 0-8936-1795-5.
La gonarthrose. Redige par F. Bonnel, Ch. 
Mansat et J.H. Jaeger. 329 pp. Must. Mas­
son, Paris, 1987. Prix non mentionne. 
ISBN 2-225-81150-4.
Handbook of Thoraco-abdominal Nerve 
Block. Jordan Katz and Hans Renck. 196 
pp. Must. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1987. $102.95. ISBN 0-8089-2972-9.
Liver Transplantation. 2nd ed. Edited by Sir 
Roy Caine. 571 pp. Must. Grune & Strat­
ton, Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1987. Price not 
stated. ISBN 0-8089-1858-3.
Microscopy and Microsurgery of the Larynx 
and Laryngopharynx. Vanik S. Pogosov 
and Vasilii F. Antoniv. 180 pp. Must. Inter­
national Universities Press, Inc., Madison, 
Conn., 1987. $37.50 (US). ISBN 0-8236- 
3363-2.
Surgical Pathology of Diffuse Infiltrative Lung 
Disease. Andrew Flint and Thomas V 
Colby. 234 pp. Must. Grune & Stratton, 
Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1987. $73.50. 
ISBN 0-8089-1867-2.
Total Knee Revision Arthroplasty. Edited by 
W. Norman Scott. 223 pp. Must. Grune & 
Stratton, Inc., Orlando, Fla.; Academic 
Press Canada, Don Mills, Ont., 1987. 
$88.25. ISBN 0-8089-1864-8.
Transplantation Reviews. Volume 1. Edited by 
Peter J. Morris and Nicholas L. Tilney. 248 
pp. Must. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1987. $73.50. ISBN 0-8089-1884-2.
hydrocortisone -  zinc sulfate 
Available in ointment and suppositories
Anusol-HC
GEE)
PARKE-DAVIS
Scarborough, Ontario M1L 2N3
Product monograph available upon request.
VOLUME 31, NO. 1, J A N U A R Y  1988 /  T H E  C A N A D I A N  J O U R N A L  O F  S U R G E R Y 41
The Blue Badge of Professionalism M *
GRADUATE
POSTGRADUATE
y  academic programs developed by the 
Council set a high standard. Your recog- 
131 nition and support, when you see the 
#  I APMR lapel pin worn by a highly 
f j  j  motivated professional representative, 
W r are important to the achievement of the 
w  Council’s objectives.
As a professional, you know that the 
essence of professionalism is a recog­
nized high standard of qualification. 
The Council for APMR was established 
to develop and m aintain professional 
standards for pharmaceutical represen­
tatives to serve you more effectively. The
i f
K *\
A
A A
k
*
x 4.
A .
BASIC COURSE
Representatives who have completed their own companies’ 
training program are eligible to enter the basic course, a de­
manding one year academic program based on recognized 
texts in anatomy, biology, physiology, microbiology, phar­
macology and immunology. Successfully passing the an­
nual examination, held in university settings across Canada, 
achieves accreditation and the right to wear the blue and 
silver lapel pin. Well over 50% o f industry representatives 
have successfully achieved this distinction. Outstanding 
academic achievement in the course is recognized by the 
award o f gold, silver and bronze medals.
POSTGRADUATE COURSES
After completion o f  the BASIC COURSE, representatives are
entitled to enter one o f the specialized one year postgraduate 
courses. These represent a major part o f  the Council’s 
expanded activities. They now number eight including:
■ Drugs Affecting Cardiovascular and Renal Functions
■ Infectious Disease and Its Therapy
■ Drugs Affecting the Respiratory System
■ Drugs Affecting the Gastrointestinal System
■ Drug Therapy o f Inflammation
■ Endocrinology
■ Neurology: Diseases and Treatments
■ Psychiatry: Diseases and Treatments
Those successfully completing the annual examination are 
entitled to wear a blue and gold lapel pin. About 75% o f 
accredited APMRs have gone on to complete one or more 
postgraduate courses. Outstanding academic achievement 
in each course is recognized by the award o f a gold medal.
A
■ h
V
f
*  *
* •
lr y<
The Council for the 
Accreditation of Pharmaceutical Manufacturers Representatives of Canada
3466 Ashby Street, Saint Laurent, Quebec H4R 2C1 Telephone: (5141333-8362
The next time you see 
an APMR, take a 
moment to ask 
about our
program.
h
*
y ’
y
i  ■
The  purpose of the Council is to assist pharmaceutical manufacturers to establish anil maintain high standards ot knowledge for their representatives in medical, pharmacologic and scientific subjects
>  i 
+
4 -
A 4
4 /
V
►
y
4 ^
*. 4
*
v r
r
►
R.B. Bo u r n e , m d , f r c s c ; H . B it a r , m d ; P .R . A n d r e a e , b s c ; L .M . M a r t i n , m b , b s ; 
J.B . F i n l a y , p h  d ; F . M a r q u is , m d , f r c sc
In-Vivo Comparison of Four Absorbable Sutures: 
Vicryl, Dexon Plus, Maxon and PDS
Absorbable sutures are initially equal or 
superior to nonabsorbable sutures in 
terms of tensile strength but are 
absorbed at variable rates by the action 
of hydrolysis. This study demonstrated 
that the in-vivo half-life tensile strength 
of the braided absorbable sutures poly- 
glycolic acid (Dexon Plus) and polyglactin 
910 (Vicryl) is 2 weeks, whereas those 
of the monofilament absorbable sutures 
polyglyconate (Maxon) and polydioxa- 
none (PDS) are 3 and 6 weeks respec­
tively. The addition of a single hitch or 
six knots reduced the in-vitro tensile 
strength by 30% to 35%. Polyglyconate 
(Maxon) suture demonstrated the best 
in-vitro knot security.
Au debut, les sutures resorbables sont 
egales ou superieures aux sutures non 
resorbables en matiere de force de ten­
sion, mais elles sont absorbees par voie 
d'hydrolyse a des vitesses qui varient. 
Cette etude d^montre que la demi-vie 
in vivo de la force de tension des sutures 
resorbables tressees faites d'acide 
polyglycolique (Dexon Plus) et de poly­
glactin 910 (Vicryl) est de 2 semaines, 
alors que celles des sutures resorbables 
faites de monofilament de polyglyconate 
(Maxon) et de polydioxanone (PDS) sont 
respectivement de 3 et 6 semaines. 
L'addition d'un seul ou de six noeuds 
reduit la force de tension in vitro de 
30%  a 35%. Les sutures de polyglyco­
nate (Maxon) montrent in vitro la secu­
rity la plus grande sur le plan des 
noeuds.
The strength of a healing wound is impor­
tant to the practising surgeon, as it may 
mean the difference between the success
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or failure of a given procedure. The rate 
of healing is related not only to the struc­
ture involved but also to local and general 
factors.1 In a clean incised wound, the 
fundamental purpose of suture placement 
is to oppose the wound edges until heal­
ing has progressed sufficiently that nor­
mal tensile forces can be withstood. Rela­
tively vascular tissues such as skin, 
subcutaneous tissue and muscle heal rela­
tively quickly compared with ligaments 
and tendons. The use of inappropriate 
suture material might lead to dehiscence 
of an abdominal incision, wound break­
down of a repaired rotator cuff tear or 
patellar subluxation following a total 
knee replacement.
Historically, nonabsorbable sutures 
have played an important role in the 
development of surgical procedures. 
Local reaction to many of these sutures 
prompted the development of absorbable 
sutures,2"8 which disintegrate at variable 
rates by the action of hydrolysis. Braided, 
absorbable sutures such as polyglycolic 
acid (Dexon Plus; Davis & Geek, Willow- 
dale, Ont.) and polyglactin 910 (Vicryl; 
Ethicon Ltd., Peterborough, Ont.) have 
become the standard.2,4,912 Their rapid 
hydrolysis has led to the development of 
monofilament absorbable sutures such as 
polyglyconate (Maxon; Davis & Geek) 
and polydioxanone (PDS; Ethicon),13,14 
which provide a smaller surface area for 
hydrolysis and hence retain their tensile 
strength longer.
Our objectives were to compare the in- 
vitro and in-vivo tensile strengths of four 
of the most commonly used absorbable 
sutures (Vicryl, Dexon Plus, Maxon and 
PDS). Although tensile strength is an 
important determinant in the success or 
failure of a given suture, it was recognized 
that stress raisers (i.e., hitches) and knot 
security were other important factors.15 
We, therefore, decided to study these fac­
tors as well.
Materials and Methods
In- Vitro Tensile Strength
Dry, unused sutures.—Tensile testing
was performed on four 0-gauge nonab­
sorbable sutures (polypropylene [Prolene; 
Ethicon], silk and two polyesters [Ethi- 
bond; Ethicon, and Ti-Cron; Davis & 
Geek]) and the four 0-gauge absorbable 
sutures chosen, by looping the sutures 
around capstans and applying tension 
with an MTS no. 858 Bionix test system 
(MTS, Minneapolis, Minn.) (Fig. 1). A 
crosshead speed of 1 mm/s to the point 
of suture breakage was used. Each test 
suture was 20 cm long, but the actual 
length between the capstans around which 
the sutures were wrapped twice was 5 cm. 
Ten sutures were tested in each subgroup 
to obtain a standard deviation for each 
suture’s tensile strength. Tensile strength 
was recorded in newtons.
Absorbable sutures in normal saline fo r  
24 hours.—The four absorbable sutures 
were immersed in a normal saline solu­
tion for 24 hours at room temperature. 
They were then subjected to the same ten­
sile strength testing as demonstrated in 
Fig. 1.
Absorbable sutures with knots.—The
FIG. 1—Capstan method of tensile testing 
on MTS no. 858 Bionix testing machine. Each 
20-cm suture had 5-cm test length between two 
capstans.
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four absorbable sutures were divided into 
four subgroups of 10 sutures. A single 
hitch was placed at the midpoint of each 
suture and the tensile testing repeated. 
This process was repeated both for dry 
and wet sutures.
To assess knot security, the absorba­
ble sutures were transected then joined 
with four, five and six square knots. Each 
group consisted of 10 sutures. The tests 
were performed with the sutures both dry 
and wet. Tensile testing was performed 
as before with the knot at the midpoint 
between the capstans.
In- Vivo Tensile Strength
We used five female, adult, New 
Zealand, white rabbits weighing a mean 
of 2 kg each. Four suture bundles, each 
containing 10, 20-cm lengths of one of the 
four suture types, were placed in the dor­
sal subcutaneous space of each rabbit. At 
weeks 1, 2, 3,4 and 6, the dorsal incisions 
were reopened and the suture bundles 
removed. The sutures were placed in nor­
mal saline while in transit from the animal 
operating room to the orthopedic research 
laboratory. Tensile testing as demon­
strated in Fig. 1 was performed on the 
sutures within 2 hours of harvesting.
Results
In-Vitro Tensile Strength
Dry, unused sutures.—Tensile testing 
of dry, unused sutures revealed that the 
strongest was Maxon (106 N) followed by 
Vicryl, Dexon Plus and PDS. Nonabsorb­
able sutures were not superior to absorb­
able sutures. Silk and Prolene had only 
about 50% of the tensile strength of 
absorbable sutures (Fig. 2). The mono­
filament absorbable sutures (Maxon and 
PDS) and the Prolene demonstrated 
considerable elongation before rupture 
(Fig. 3).
Absorbable sutures after 24 hours in
FIG. 3—Demonstration of stiffness and ulti­
mate tensile strength of sutures tested (cross- 
head speed I mm/s). Absorbable sutures: ▲ 
= Vicryl, ▼ = Dexon Plus, +  = Maxon, 
■  = PDS. Nonabsorbable sutures: □  = Ethi- 
bond, Ti-Cron, •  = silk, x = Prolene.
saline.—Soaking in normal saline for 24 
hours reduced the tensile strength of each 
absorbable suture by 4% to 13% (Fig. 4).
Absorbable sutures with knots.—The 
placement of a single hitch at the mid­
point of an absorbable suture reduced the 
tensile strength of each suture, whether 
dry or wet, by 30% to 35%. Interestingly, 
this reduction in tensile strength was simi­
lar to that of the various sutures with six 
knots (Fig. 5).
Polyglactin 910 (Vicryl) and poly- 
glycolic acid (Dexon) demonstrated poor 
knot security when tested dry. Knot hold­
ing power was enhanced when they were 
wet (Fig. 5). Polyglyconate (Maxon) 
sutures demonstrated superiority over the 
other sutures tested in terms of knot secu­
rity. Testing sutures with four or five 
knots was associated with a large standard
deviation owing to occasional knot 
insecurity. The use of six knots gave the 
most consistent results.
In-Vivo Testing
Figure 6 demonstrates the tensile 
strength of the four absorbable sutures 
studied in vivo from weeks 1 to 6. The 
braided absorbable sutures, Dexon Plus 
and Vicryl, had lost approximately one- 
half of their tensile strength by 2 weeks 
and had virtually no tensile strength by 
4 weeks.
The monofilament absorbable sutures 
Maxon and PDS demonstrated longer 
half-lives in terms of tensile strength. 
Whereas Maxon started out with greater 
tensile strength, by 3 weeks it was much 
inferior to PDS. This trend continued. By
HG- 2—Tensile strength of dry unused absorbable and nonabsorbable sutures (crosshead 
speed 1 mm/s). T = Vicryl, 2 = Dexon Plus, 3 = Maxon, 4 = PDS, 5 = Prolene, 6 = silk, 
7 = Ethibond, 8 = Ti-Cron.
FIG. 4—Tensile strength of absorbable sutures before (dotted bars) and after (hatched bars) 
soaking in normal saline for 24 hours (crosshead speed 1 mm/s).
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6 weeks, Maxon had virtually no tensile 
strength whereas PDS retained about 
50% of its tensile strength (Fig. 6).
Discussion
The purpose of any suture material is 
to oppose wound edges until the wound 
is strong enough to withstand the tensile 
forces to which that structure is normally 
subjected. It is well known that various 
tissues heal at different rates, depending 
upon such factors as local blood supply 
and the structure involved. Braided, 
nonabsorbable sutures such as polyglac- 
tin 910 (Vicryl) and polyglycolic acid 
(Dexon Plus) should be used only when 
sufficient healing can be expected within 
2 weeks (i.e., for subcutaneous tissue and 
subcuticular skin closure). When wound 
healing will likely take more than 2 weeks, 
a nonabsorbable suture or one of the 
monofilament absorbable sutures (Maxon
or PDS) should be chosen. Maxon is 
appropriate when approximately 3 weeks’ 
healing is required, whereas PDS seems 
more appropriate for cases requiring up 
to 6 weeks for wound healing (e.g., rota­
tor cuff repairs).
In the in-vivo tests, we measured only 
the tensile strength of intact absorbable 
sutures. We did not test the knot charac­
teristics of these sutures. Hitches and 
knots have a marked effect on the tensile 
strength of sutures and the in-vivo 
influence on these would be of interest. 
In-vitro, polyglyconate (Maxon) seemed 
to have enhanced knot characteristics.
From the findings of this study, we 
believe that a number of statements can 
be made.
• Unused, absorbable sutures are equal 
or superior to nonabsorbable sutures in 
terms of tensile strength.
• Tensile strength of absorbable 
sutures will be reduced by 4% to 13%
FIG. 5—Effect of single hitch and six knots on suture tensile strength in vitro (crosshead 
speed 1 mm/s).
V I C R Y L  D E XON MA X O N P D S
FIG. 6—Tensile strength of Vicryl, Dexon Plus, Maxon and PDS sutures in vivo after I 
to 6 weeks’ implantation.
with 24 hours of soaking in normal saline.
• The addition of one hitch or six 
knots will reduce the tensile strength of 
absorbable sutures by 30% to 35%.
• The most consistent knot security 
was achieved when six square knots were 
used to tie the braided or monofilament 
absorbable sutures.
• Polyglyconate (Maxon) sutures 
demonstrated the best in-vitro knot 
security.
• The half-life, in terms of tensile 
strength, of the absorbable sutures 
studied was 2 weeks with polyglycolic acid 
(Dexon Plus) and polyglactin 910 (Vicryl), 
3 weeks with polyglyconate (Maxon) and 
6 weeks with polydioxanone (PDS).
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Giant-Cell Tumour of the Sacrum in a Child
Giant-cell tumours rarely are seen in chil­
dren before epiphyseal fusion occurs and 
such tumours in the spine are uncom­
mon. The authors report the case of a 
giant-cell tumour of the sacrum that 
developed in a 12-year-old girl before 
epiphyseal fusion. Embolization with acti­
vated microfibrillar collagen relieved her 
symptoms and was carried out twice 
before progression of the tumour neces­
sitated radiotherapy. Giant-cell tumours 
of the spine are particularly difficult to 
manage since the accepted treatment for 
such tumours at other sites is wide 
resection, excisional curettage or surgical 
curettage with chemical cautery. 
However, embolization alone or com­
bined with other methods of treatment is 
valuable, particularly in non-resectable 
giant-cell tumours of the spine.
II est rare qu'on observe une tumeur a 
cellules geantes chez I'enfant avant que 
ne survienne la fusion des epiphyses et il 
est egalement rare qu'une telle tumeur 
soit localisee au niveau de la colonne 
vertebrate. Les auteurs d6crivent une 
tumeur a cellules geantes qui est appa- 
rue au niveau du sacrum chez une fillette 
de 12 ans, avant la fusion des epiphy­
ses. L'embolisation a I'aide de collagene 
microfibrillaire active a permis, h deux 
reprises, de soulager les symptdmes 
avant que la tumeur ne progresse au 
point de necessiter de la radiotherapie.
Les tumeurs a cellules geantes de la 
colonne sont particulierement difficiles a 
traiter puisque les tumeurs de ce type 
exigent habituellement une resection 
large, un curetage excisionnel ou un 
curetage chirurgical avec cauterisation
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chimique. IMeanmoins, l'embolisation 
seule ou associee a d'autres methodes 
de traitement est utile, particulierement 
dans le cas de tumeurs a cellules gean­
tes de la colonne, non resecables.
Giant-cell tumours occurring before 
epiphyseal fusion takes place are rare. 
They occur uncommonly in the spine and 
in this site are difficult to treat. We report 
a case of a child who had a giant-cell 
tumour in the sacrum prior to epiphyseal 
fusion.
Case Report
A 12-year-old girl had a 9-month history of 
bilateral lower extremity and lower back pain 
originally treated as sciatica with analgesics. 
X-ray films at the time of admission to another 
hospital showed extensive destruction of the 
sacrum by an expansile lesion (Fig. 1). 
Retrospective analysis of films obtained 4 
months earlier showed loss of the anterior spi­
nal line. A computed tomogram at the time of 
admission showed a large sacral and pelvic 
mass with cortical expansion and destruction. 
In the belief that this was an intrapelvic 
tumour, a laparotomy was performed. Biop­
sies taken from the large cystic mass were not 
diagnostic. The patient was transferred to our 
hospital in July 1986, at which time she had 
a 4-week history of urinary incontinence and 
decreased sensation in the plantar aspect of the 
right foot. She had lost 5.5 kg and had secon­
dary amenorrhea. Objectively there was mild 
weakness of quadriceps and hamstring mus­
cles bilaterally with absence of right ankle and 
knee reflexes. Urinary tract infection was 
present, the urinary bladder was grossly dis­
tended and hypotonic with a large residual 
volume.
Biopsy through a posterior approach was 
again not diagnostic. On Aug. 4, 1986 a third 
operative biopsy was obtained under general 
anesthesia. The material was decalcified, 
embedded in paraffin and processed for rou­
tine histologic examination. The features of this 
lesion were typically those described by Mirra 
and colleagues1 and correspond to those con­
sidered by Jaffe2 as a low-grade lesion. Other 
tumours of bone and soft tissues that could 
have been confused with the present one histo­
logically were considered in the differential 
diagnosis but were easily ruled out, and giant­
cell tumour of bone was confirmed (Fig. 2). 
Biochemical and hematologic test results indi­
cated no abnormalities with the exception of 
normochromic normocytic anemia. Bone scan­
ning did not reveal any other lesions.
FIG. 1—Computed tomogram of pelvis through sacroiliac joints at time of initial presen­
tation shows large sacral tumour causing cortical expansion and destruction. There is 
inhomogeneity of soft-tissue component, likely due to tumour necrosis and cyst change.
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On Aug. 11, 1986, abdominal aortography 
and selective internal iliac angiography were 
performed under general anesthesia. Emboli­
zation of branches of both the internal iliac 
arteries and the median sacral artery was per­
formed using activated microfibrillar collagen 
(Avitene; Alcon Canada Inc., Mississauga, 
Ont.). A small amount of tumour blush 
remained after the procedure. The patient did 
not complain of pain or fever after emboliza­
tion. Subjectively there was improvement in the 
lower extremity weakness and better bladder 
control with decreased residual volumes.
The girl did well until October 1986 when 
she experienced increased discomfort in her left 
leg after a fall. Palpation of the sacrum elicited 
pain. Computed tomography showed a slight 
increase in the size of the mass and some 
peripheral calcification, particularly anteriorly. 
Angiography showed a return of some of the 
tumour vascularity, and embolization using 
Avitene was repeated into selected internal iliac 
and median sacral branches.
Repeat computed tomography 2 months 
later showed no increase in the intrapelvic por­
tion of the tumour, but there was an increase 
in size posteriorly with further loss of bone. 
On Dec. 29, 1986, before the girl received radi­
otherapy, bilateral oophoropexy was carried 
out to preserve ovarian function. With a cobalt 
unit, three-field radiation was applied to cover 
the sacrum from L5 to the tip of the coccyx 
and to include both sacroiliac joints. A total 
dose of 4000 rad (40 Gy) was given between 
Jan. 5, 1987 and Feb. 10, 1987. After this, the 
bulging mass over the sacrum decreased in size 
and urinary incontinence improved.
At follow-up in April 1987 the patient was 
active, pain free and continent of urine. 
However, straight-leg raising was limited to 35° 
and there was bilateral wasting of leg muscles. 
Computed tomography showed regression of 
the posterior bulge with increased calcification 
within the remaining tumour mass (Fig. 3).
In July 1987, 1 year after initial treatment, 
further calcification was seen in the tumour, 
and the only remaining neurologic deficit was 
mild residual urinary incontinence.
Discussion
Giant-cell tumour in children before 
epiphyseal fusion is uncommon. Picci and 
associates3 reviewed the literature and 
found a rate of 1.7% (20 lesions in 1162 
cases). They added six new cases from 
their experience o f 326 tumours. Eftek- 
hari and colleagues4 reported two further 
cases of giant-cell tumour in children, 
making the reported number 28. Giant­
cell tumour is uncommon in the spine, 
being seen in only 3.2% o f giant-cell 
tumours.5 Recently Dahlin6 reported 33 
cases in the sacrum from his experience 
o f 407 cases. Smith and colleagues7 
reported 13 giant-cell tumours of the 
sacrum in 200 cases, and they stated that 
this is the most common location after the 
long bones. They also found it to be the 
most common benign tumour of the 
sacrum in their series.
Tumours of the sacrum are difficult to 
manage. The accepted treatment for 
giant-cell tumour is surgical curettage 
with chemical cautery, or excisional curet­
tage or wide resection. Lower recurrence 
rates are found in those who have under­
gone a wide resection.8 Surgical therapy 
can be carried out in the vertebrae, and 
Sung and associates9 reported total exci­
sion of the sacrum with placement of a 
large homograft in one patient. This 
patient also received radiotherapy and 
had residual sphincter disturbance, gait 
abnormality and amenhorrea after the 
procedure. Smith’s group7 used radi­
otherapy or partial excision with radi­
otherapy in their patients with nonresec- 
table tumours o f the sacrum. They
reported a recurrence in 7 of their 13 
patients with five deaths due to the dis­
ease or complication of the treatment.
Chuang and associates10 reported the 
use of intra-arterial embolization with 
Gelfoam and spring coils in eight patients 
with giant-cell tumour and two with com­
bined giant-cell tumour and aneurysmal 
bone cyst o f the pelvis, both of which 
were unresectable. These had been 
assessed as nonresponding tumours at 
least 6 weeks after radiotherapy or 
chemotherapy. Pain was relieved in seven 
patients and calcification increased, sig-
FIG. 2—Histologic features of biopsy specimen obtained on Aug. 4, 1986 (hematoxylin 
and eosin, original magnification x 250). Low-grade neoplastic giant-cell tumour. Figure shows 
mononuclear stromal cells with diffuse and homogeneous sprinkling of giant cells. There is no 
histologic or cytologic feature indicative of aggressive growth.
FIG. 3—Computed tomogram through pelvis at level of sacroiliac joints 8 months after 
presentation shows increase in size of sacral mass anteriorly that had been noted in December 
1986. However, there has been regression of posterior extension of tumour. There is also increase 
in calcification within tumour.
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nifying healing, in five patients. Four of 
these five patients had giant-cell tumours 
without aneurysmal bone cyst. Eftekhari 
and colleagues4 reported on two girls 
aged 12 and 15 years. The 12-year-old girl 
had a giant-cell tumour of the L4 ver­
tebral body, previously reported by Chu- 
ang and colleagues.10 She underwent 
decompressive laminectomy as well as 
chemotherapy with methotrexate and 
Adriamycin, followed by 5000 rad (50 
Gy) of radiotherapy. Failure to control 
the tumour prompted arterial emboliza­
tion of the lumbar arteries at L4 and L5 
with Gelfoam and spring coils, with les­
sening of the pain, regression of the mass 
and rim calcification. Embolization of the 
right superior gluteal artery was repeated 
2 years later with Ivalon when the mass 
appeared to be slightly larger. Six months 
after this she had full range of activity 
with no pain and no neurologic deficit. 
The second patient had an aneurysmal 
bone cyst with giant-cell components in 
the sacrum that recurred after resection. 
Over 9 months she received cisplatinum 
therapy intra-arterially then embolization 
with Ivalon, Gelfoam and spring coils in 
three sessions to occlude the branches of 
the internal iliac and middle sacral arter­
ies as well as the fourth lumbar arteries. 
Additional cisplatinum was given intra­
arterially on four occasions. Follow-up at 
9 months after the first cisplatinum infu­
sion showed increased calcification of the 
mass and apart from minimally decreased 
strength of the right hamstrings, no neu­
rologic deficit was present. Feldman and 
associates11 reported the use of intra­
arterial embolization preoperatively to 
control hemorrhage in a patient with mul­
tiple giant-cell tumours.
Radiotherapy for giant-cell tumours 
has been related to increased malignant 
transformation. Giant-cell tumours are 
also relatively radioresistant.10 Sarcoma 
can complicate these tumours in approx­
imately 10% of cases. A recurrence rate 
of approximately 50% follows irradi­
ation.10
We used activated microfibrillar colla­
gen as the embolization material in our 
patient. It is a nonpermanent occlusion 
material, being resorbed after approxi­
mately 1 month. We thought that with 
complete occlusion radiologically, 
tumour necrosis would take place, but 
because of the absorbable nature of the 
material, repeat embolization would be 
possible if necessary. There was initial 
relief of symptoms and some increased 
calcification within the tumour mass after 
embolization. Unfortunately the tumour 
progressed posteriorly and it was decided 
to offer radiotherapy to control this 
symptomatic extension. There appears to 
have been further healing following the 
radiotherapy and the patient was doing
well 8 months after the first embolization.
Symptoms from giant-cell tumour 
growth may be relieved by embolization, 
which can be combined with other 
methods of therapy. This may be impor­
tant in the treatment of nonresectable 
giant-cell tumours of the spine.
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Retroperitoneal Perforation of the Rectum 
During Barium Enema Examination
Colorectal perforation during barium 
enema examination is rare. The authors 
report the case of an 84-year-old woman 
in whom retroperitoneal perforation of 
the rectum occurred during barium 
enema examination. Potential mechan­
isms of injury include trauma, overinfla­
tion of the balloon, recent instrumenta­
tion and associated disease of the rectal
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mucosa. When the colon has been well 
prepared before examination, and air 
alone, not barium, has been insufflated 
into the retroperitoneum, then such 
injuries may be managed successfully 
without operation, as in this case.
II est rare qu'on assiste a une perforation 
du colon ou du rectum au cours d'un 
lavement baryte. C'est ce que decrivent 
les auteurs, cas survenu chez une femme 
de 84 ans qui subit une perforation retro- 
peritoneale pendant cet examen. Divers 
mecanismes peuvent etre impliques dont 
un traumatisme. un gonflement exagere 
du ballonnet. un examen recent a I'aide 
d'instruments ou une maladie sous- 
jacente de la muqueuse rectale. Quand le 
colon a ete bien prepare pour I’examen 
et que de Fair seulement (nom du 
baryum) a ete insuffle dans I'espace 
retroperitoneal, comme ce fut le cas ici.
de tels lesions peuvent alors etre traites 
avec succes sans intervention chirur- 
gicale.
The occurrence of perforation of the 
colon or rectum complicating barium 
enema examination is extremely low.1'2 
Perforation of the rectum may be free 
into the abdominal cavity or retro- 
peritoneum. We describe the case of an 
elderly woman who suffered retroperi­
toneal perforation of the rectum during 
barium enema examination. The patient 
was successfully managed without oper­
ation.
Case Report
An 84-year-old woman with moderately 
severe ischemic and valvular heart disease 
underwent air-contrast barium enema for 
vague complaints of abdominal pain. After 
evacuation of the barium column and during
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the insufflation of air, the patient experienced 
angina, which was relieved by sublingual 
administration of nitroglycerin. The radiolo­
gist noted the presence of air retroperitoneally 
on fluoroscopy so the examination was termi­
nated. No other abnormality was noted.
When we assessed her condition approxi­
mately 6 hours later in the emergency depart­
ment she had few symptoms. She had minor 
retrosternal discomfort and noted that her 
voice was higher pitched than normal. There 
was widespread subcutaneous emphysema, 
involving her entire trunk, neck and head. 
There was emphysema of her eyelids and ini­
tially she could not open her eyes fully. The 
patient was afebrile and not tachycardic. Her 
abdomen was soft and not tender. Bowel 
sounds were normal. No blood was noted on 
rectal examination. Other findings on physi­
cal examination were normal. Her leukocyte 
count was 11.4 x 109/L .
Rigid sigmoidoscopy with minimal insuffla­
tion of air showed a small (less than 1 cm) 
anterior laceration or puncture of the rectum 
at about 6 cm from the anal verge. The colon 
was empty of stool and there was little barium. 
The mucosa was normal. Diffuse retroperi­
toneal air, pneumomediastinum and sub­
cutaneous emphysema were evident on plain 
abdominal and chest x-ray films (Fig. 1); no 
free intraperitoneal air could be identified. No 
other abnormality was noted on the barium 
enema films.
We decided to manage the patient nonoper- 
atively for several reasons: there were no clin­
ical signs of peritonitis several hours after the 
injury, nor were there radiologic indications 
of air or barium within the abdominal cavity; 
the colon had been well cleansed of stool before 
radiologic examination and it appeared that air 
only, and not barium, had been insufflated into 
the retroperitoneum; the operative risk related 
to the patient’s cardiac disease was considered 
greater than the risk of infection when the 
patient’s condition was closely monitored. The 
patient was admitted to hospital and assessed 
frequently by clinical examination. She was 
given nothing by mouth initially and received
cefoxitin intravenously for 1 week. The sub­
cutaneous emphysema resolved completely 
over 2 to 3 days and the patient was well at 
follow-up 1 month later.
Discussion
Most perforations related to barium 
enema examination occur in the rectum 
above the peritoneal reflection. Four 
mechanisms of injury have been sug­
gested: (a) trauma from the enema tip; (b) 
overinflation of the balloon; (c) recent 
colonic instrum entation, especially 
associated with biopsy; (d) the presence 
of rectal mucosal disease such as cancer, 
diverticulosis or inflammatory bowel dis­
ease. The cause of the perforation in our 
patient is not certain, but traumatic inser­
tion of the enema tip and inadvertent 
overinflation with air are the most likely 
causes.
Approaches to the management of rec­
tal trauma in general have been influenced 
by wartime experience.3 The treatment 
o f high-velocity injuries includes 
laparotomy with closure of the perfora­
tion, complete diversion of the fecal 
stream by colostomy, distal rectal 
washout, presacral drainage and the use 
of broad-spectrum antibiotics. In general, 
similar principles apply to civilian 
injuries.4'5
Colorectal perforation during barium 
enema differs in several ways from other 
such trauma. Perforation may occur 
retroperitoneally, intraperitoneally and 
even into the portal circulation.1 Injury 
to rectal mucosa only and the introduc­
tion of barium into the rectal wall may 
result in the formation of an intramural 
barium granuloma.1,2 Barium within the 
abdominal cavity undergoes progressive 
aggregation, partial or complete phagocy­
Fig. la Fig. lb
FIG. 1—Plain abdominal (a) and chest (b) x-ray films, taken several hours after perfora­
tion, demonstrate extensive subcutaneous emphysema and air in soft tissues. Right kidney is 
clearly outlined with air, and pleura is dissected off right hemidiaphragm.
tosis and fibroblastic encapsulation with 
extensive adhesion formation.6 In addi­
tion, barium acts as an adjuvant; that is, 
in combination with bacteria it acceler­
ates the inflammatory response and the 
septic course of peritonitis.7 Feces, bile 
and blood behave in a similar fashion. 
However, unlike these substances, barium 
rapidly disperses and forms tenacious 
adhesions to peritoneal and retroperi­
toneal surfaces. In view of these proper­
ties an aggressive operative approach to 
intraperitoneal perforation with barium 
spillage has been advocated, including 
copious saline irrigations and complete 
debridement of all the barium, with 
presacral drainage and a diverting 
colostomy.8,9 Retroperitoneal barium 
instillation requires similar aggressive 
debridement.10
Retroperitoneal emphysema in the 
absence of a barium leak may follow a 
more benign course and may not require 
surgical intervention.2'10'11 In contrast to 
unprepared bowel, prior mechanical 
cleansing of the colon and rectum usually 
greatly diminishes the bacterial inoculum. 
The majority of perforations related to 
barium enema are believed to be small, 
and the leakage of air probably stops 
spontaneously upon relief of the increased 
intraluminal pressure.10 In the absence 
of symptoms the retroperitoneal air 
generally disperses within 2 weeks.10
The use of air-contrast examinations of 
the colon in place of single-contrast bar­
ium studies may result in colorectal per­
forations with air insufflation alone. As 
exemplified by our patient, nonoperative 
management of such injuries may be 
appropriate. Frequent clinical assessment 
must be made and surgical intervention 
carried out in the event of any deteriora­
tion in the patient’s condition.
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Expected Contamination of the 
Orthopedic Surgeon’s Conjunctiva
Likely contamination of a surgeon's con­
junctiva by patients' body fluids is sur­
prisingly frequent. Blood and fat are the 
most common agents but cellular implan­
tation may occur. Possible contamination 
was documented in 37 of 60 orthopedic 
procedures. Power tools, hammering and 
the use of rongeurs are the main culprits 
in producing a forced spray most likely 
to cause contamination. Reduction of the 
hip at the time of replacement 
arthroplasty is often associated with 
propulsion of blood. Not a single case of 
possible contamination resulted from the 
pumping action of a severed vessel.
Since orthopedic surgeons work in a 
high-risk environment, safety glasses are 
recommended to prevent contraction of 
viral diseases such as hepatitis B and 
acquired immune deficiency syndrome by 
way of the conjunctiva. The glasses will 
also protect the surgeon from bacterial 
and cellular conjunctival contamination, 
in addition to preventing physical 
damage secondary to propelled bone and 
cement.
La contamination probable de ia conjonc- 
tive d'un chirurgien par les liquides orga- 
niques de ses patients est etonnamment 
frequente. Le sang et les tissus adipeux 
sont les plus souvent impliques mais des 
implantations cellulaires peuvent surve- 
nir. Sur 60 interventions orthopediques, 
une contamination possible a ete verifiee 
dans 37 cas. L'utilisation d'outils electri- 
ques, de marteaux et de rugines, tous 
capables de provoquer des eclaboussures 
de tissus, est la principale cause de con­
tamination. Lors d'une arthroplastie de la 
hanche, la reduction chirurgicale est sou­
vent accompagnee d'un jet de sang. 
Aucun cas de contamination possible n'a 
ete relie au sectionnement d'un vaisseau. 
Puisque le chirurgien orthopedique tra-
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vaille dans un environnement a risque, le 
port de verres de securite est recom- 
mande afin de prevenir I'acquisition via 
la conjonctive d’une maladie virale telle 
que (’hepatite B ou le syndrome d'immu- 
nodeficience acquise. Les verres servent 
aussi de barriere contre les contamina­
tions conjonctivales bacteriennes et cel­
lulaires en plus de prevenir les lesions 
physiques consecutives a la projection 
d'os ou de ciment.
It is well recognized that hepatitis may be 
contracted by minute amounts of con­
taminated blood entering the body 
through a break in the skin, needle prick 
or through mucosal surfaces including the 
conjunctiva.1-4 Multiple other infections 
occurring after conjunctival contamina­
tion have been documented,5-7 including 
a fatal case of rabies contracted by a 
veterinary surgeon from blood splashed 
into his eyes while performing an 
autopsy.8
This study was undertaken to define the 
rate of likely macroscopic contamination 
of the conjunctiva by orthopedic surgeons 
during their work.
Method
In a prospective study of 60 cases, high- 
impact polycarbonate glasses (as used by 
squash players) were worn by all mem­
bers of the surgical team for every ortho­
pedic procedure, excluding arthroscopy. 
Contamination was recorded as present 
or absent by observing macroscopic blood 
or fat droplets on the lenses at the con­
clusion of each procedure. Initially, the 
quantity of contamination was assessed 
by estimating the size and number of 
spots, but this proved impractical and was 
abandoned. The perceived cause of the 
spray was recorded as was the composi­
tion of the contaminant.
Results
Thirty-seven of 60 consecutive cases 
were associated with contamination of the 
protective glasses. With two or more sur­
geons frequently present, there were 125 
exposures in 60 procedures. In the 37
cases both surgeon and assistant were 
contaminated during the same procedure 
for a total of 59 contaminations. Power 
tools, hammers and rongeurs were the 
cause of forced spray in 35 cases; they 
were not used in the other 2. No power 
tool, hammer or rongeur was used in 
16 of 23 “ clean” cases. In one case of 
chondroma contamination, tissue was 
propelled from a curette. Fat droplets 
often appeared on the lenses in total knee 
replacement and bunion excisions, related 
to the use of an oscillating saw; blood 
droplets were most often associated with 
the use of a hammer or rongeur. Partic­
ulate matter was identified on glasses 
after the use of a rotary burr.
All total joint procedures were 
associated with lens contamination.
In 29 operations a tourniquet was used;
14 were associated with contamination,
15 were not.
Discussion
Conjunctival contamination is related 
to orthopedic instruments that spray body 
fluids at high speed. No case was recorded 
secondary to the relatively slow single 
spurt from a severed blood vessel.
After conjunctival contamination, the 
droplet or cell would be washed away by 
tears and carried down the nasolacrimal 
ducts to areas in the upper nasal passages 
where microorganisms might establish an 
infection.8 The amount of contamina­
tion may be exceedingly minute; 1.0 ml 
of plasma from a person infected with 
hepatitis B proved infectious at a 10-7 
dilution in a chimpanzee.9 The surgeon 
should be aware that hepatitis B virus 
retains its infectivity even when the 
droplet has dried and after a prolonged 
period on a suitable environmental sur­
face.9 Rabies,3 Newcastle disease,6 Cox- 
sackie B viral infection,5 and hepatitis 
B1-4 are a few examples of diseases 
acquired via the conjunctiva. No case of 
acquired immune deficiency syndrome 
contracted in this manner has yet been 
reported.
Orthopedic surgeons work in a high- 
risk environment and must protect them­
selves against conjunctival contamination
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and the subsequent possibility of hepati­
tis B infection or AIDS.
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Total Replacement of the Transverse Aortic Arch 
With the Gott Aneurysm Shunt
A  new method of temporary external 
shunting for total replacement of the aor­
tic arch is described. Its greatest advan­
tage is that systemic heparinization is 
not required. In a 46-year-old man total 
body perfusion was achieved with two 
9-mm Gott aneurysm shunts inserted 
between the ascending aorta and both 
femoral arteries. Blood supply to the 
brain was maintained with the cut halves 
of a 7-mm Gott shunt connected as side 
branches to one of the 9-mm shunts, 
allowing cannulation of both carotid 
arteries. The total cardiac output, meas­
ured at 4.7 L/min by the thermodilution 
technique through a Swan-Ganz 
catheter, was propelled through these 
preheparinized multibranch shunts. A 
flowmeter adapted on one of the 9-mm 
Gott shunts demonstrated a shunt flow 
of 2000 ml/min and it was deduced that 
the other 2700 ml of the total cardiac 
output was delivered by the other shunt. 
During the 29 minutes of cross­
clamping, there was no change in the
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filling pressure of either the right heart 
(central venous pressure 5 cm H20) or 
the left heart (pulmonary wedge pressure 
8 mm Hg). Aortic continuity was re­
established with the interposition of a 
34-mm tubular woven Dacron prosthe­
sis, on which two 10-mm woven Dacron 
side branches were anastomosed to the 
innominate and left common carotid 
arteries. The patient had no neurologic 
deficit and had normal physiologic func­
tion of all other organs.
Les auteurs decrivent une nouvelle 
methode de derivation temporaire 
externe destinee au remplacement total 
de la crosse aortique. Son avantage 
majeur est I'exclusion complete de toute 
heparinisation systemique. Toute la per­
fusion du corps humain est assuree a 
coeur battant par I'intermediaire de deux 
shunts de Gott no 9 introduits proximale- 
ment au niveau de I'aorte ascendante et 
distalement dans chacune des deux arte- 
res femorales. Pour preserver ('irrigation 
du cerveau. les deux moities d'un shunt 
de Gott no 7 etaient jointes lateralement 
sur un des shunts de Gott no 9 et canu- 
lees distalement dans chacune des deux 
arteres carotides primitives. La totalite 
du debit cardiaque, mesure a 4.7 L/min 
par la methode de thermodilution avec 
un catheter de Swan-Ganz, fut ainsi 
derivee a travers ce systeme de tubes
pre-heparinises. Un debit-metre electro- 
magnetique dispose sur I'un des shunts 
de Gott no 9, enregistra un debit de 
shunt de 2000 ml/min, permettant de 
deduire que le reste du debit cardiaque. 
soit 2700 ml/min etait absorbe par le 
deuxieme shunt de Gott no. 9. Durant 
les 29 minutes qu'a dure le clampage 
aortique, la pression veineuse centrale 
est restee a 5 cm de H20  et la pression 
pulmonaire bloquee est demeuree a 8 
mm Hg, demontrant toute absence de 
surcharge cardiaque droite et gauche. La 
reconstruction de la crosse aortique a 
ete realisee a I'aide d'une prothese de 
Dacron tubulaire tissee de 34 mm inter- 
posee, sur laquelle avaient ete prealable- 
ment anastomosees deux branches late­
ra ls  de Dacron tisse de 10 mm, 
destinees respectivement au tronc inno­
mine et a la carotide primitive gauche. Le 
patient se reveilla des la fin de ('interven­
tion chirurgicale sans aucune sequelle 
neurologique et I'analyse de certains 
parametres vitaux permet la conclusion 
que la physiologie normale de tous les 
autres organes a aussi ete preservee.
Extracorporeal circulation combined with 
hypothermic total circulatory arrest1-3 
has been widely adopted over the past 10 
years as a method of physiologic support 
during resection of aneurysms of the 
transverse aortic arch. However, because
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hypothermia and systemic heparinization 
are needed, coagulopathy and hemor­
rhagic complications are still frequent.4 
Moreover, it remains to be demonstrated 
that this method assures optimal long­
term protection of the brain without any 
further deterioration of the nerve cells.
In order to reproduce as closely as pos­
sible the physiologic conditions, we have 
perfected a new method of organ preser­
vation. Perfusion of the body is assured
FIG. 1—Preoperative aortogram shows 
aneurysm of transverse aortic arch, involving 
origin of innominate and left common carotid 
arteries. Left vertebral artery originates 
separately from aortic arch and, like left sub­
clavian artery, is not involved in aneurysm.
FIG. 2—Diagram of new temporary exter­
nal shunting procedure proposed for total 
replacement of aortic arch. Two 9-mm Gott 
aneurysm shunts are inserted from ascending 
aorta to both femoral arteries through 10-mm 
woven Dacron prostheses previously 
anastomosed as side branch to each femoral 
artery. Circulation to brain is maintained with 
two halves of 7-mm Gott aneurysm shunt con­
nected proximally to one of two 9-mm Gott 
aneurysm shunts and inserted distally into 
innominate and left common carotid arteries.
by propelling the total blood volume 
through a sutureless temporary external 
bypass by a normally perfused beating 
heart under normothermic conditions. 
Systemic heparinization is not used. This 
sophisticated shunting device was con­
structed from the 9-mm Gott aneurysm 
shunt (Sherwood Medical Industries, St. 
Louis, Mo.) that we have already used in 
the resection of 175 descending thoracic 
aortic aneurysms and confirmed as a safe 
shunting procedure.5
Case Report
A 46-year-old man was seen at another 
hospital for progressive dyspnea of 6 months’ 
duration that had become severe. A chest x- 
ray film disclosed an anterior mediastinal mass 
believed to be a tumour. At exploration 
through a median sternotomy a thoracic 
aneurysm was found and the patient was 
referred to our institution for surgical 
treatment.
There was no history of trauma. A serologic 
test for syphilis gave positive results. Aortog­
raphy (Fig. 1) revealed an irregular thoracic 
aneurysm 8 cm in dimension limited to the 
transverse aortic arch and involving the origin 
of both innominate and left carotid arteries. 
The ascending aorta was slightly enlarged but 
not aneurysmal. The left vertebral artery com­
ing directly off the aortic arch and the left sub­
clavian artery were not included in the 
aneurysm. A thoracic scanogram obtained with 
perfusion excluded any dissecting process and 
confirmed left tracheobronchial compression 
by the aneurysm.
Technique o f  External Shunting
The lesion was approached through a 
median sternotomy, and the incision was 
extended along the right sternocleidomastoid 
muscle border. The innominate vein was under 
excessive tension and had to be ligated for bet­
ter exposure. The external shunt was con­
structed with two 9-mm Gott shunts and the 
two halves of a 7-mm Gott shunt (Fig. 2). Each 
groin was exposed and a 10-mm woven Dacron 
graft was anastomosed as a side branch on each 
femoral artery. This allowed retrograde per­
fusion of the upper body and also conserved dis­
tal perfusion of both lower limbs.
The right anterolateral side of the ascend­
ing aorta was cannulated with one of the 9-mm 
Gott shunts, through a double pursestring 
suture. The distal tip of the shunt was 
introduced into the 10-mm Dacron graft previ­
ously anastomosed to the right femoral artery. 
An electromagnetic flowmeter was adapted on 
the shunt as previously described.6 The other 
9-mm Gott shunt was inserted in the same man­
ner from the left anterolateral side of the 
ascending aorta to the 10-mm woven Dacron 
graft previously anastomosed to the left 
femoral artery. A stainless-steel connector with 
two side branches was interposed between the 
two cut halves of this 9-mm shunt.
As described before,7 the two side branches 
of the connector allowed branching of the two 
cut halves of a 7-mm Gott aneurysm shunt and 
the cannulation of each distal tapered end of 
this shunt into the right and the left carotid 
arteries in that order. Then the origin of the
right subclavian artery, the right carotid artery 
and the left carotid artery were occluded with 
clamps and all the circulation to the brain was 
supplied by the two halves of the 7-mm Gott 
shunt connected to the 9-mm Gott shunt previ­
ously introduced into the ascending aorta. The 
patient’s head had been covered previously 
with ice-bags and no electroencephalography 
was used.
Surgical Technique
First the ascending aorta was cross-clamped 
4 cm below the aortic arch aneurysm, then the 
distal aorta was occluded proximal to the left 
subclavian artery. A clamp was also applied 
separately on the left vertebral artery. The 
aneurysm was opened longitudinally and found 
to be full of old clots and fibrin. The aorta was 
transected at both anastomotic ends to make 
sure that the posterior aortic adventitia was 
included in the suture line.
A 34-mm woven Dacron graft, on which two 
separate 10-mm woven side branches had previ­
ously been anastomosed, was used to re­
establish aortic continuity. The distal anasto­
mosis was performed first, preserving the take­
off of the left vertebral artery. The proximal 
anastomosis was then completed and air bub­
bles evacuated thoroughly through the 10-mm 
side branches by first releasing the clamp on 
the distal aorta. The ascending aortic clamp 
was then removed and the two 9-mm Gott 
shunts were occluded with clamps in order to 
preserve a selective perfusion of the brain 
through the two 7-mm Gott shunts. The 
innominate and left common carotid arteries 
were reimplanted on the newly constructed aor­
tic arch with an end-to-end anastomosis on 
each 10-mm Dacron side branch. Cannulas 
were removed from both vessels, assuring nor­
mal cerebral perfusion with a pulsatile flow. 
The proximal tip of each 9-mm Gott shunt was 
removed from the ascending aorta and 
hemostasis was secured by tying down the two 
pursestring sutures. Cannulas were removed 
from both femoral arteries which were closed 
by leaving a piece of the Dacron branches so 
that an angioplasty could be done.
Adjunct to the surgical technique.—As for 
every surgical procedure involving the thoracic 
aorta6 we have used autotransfusion for two 
major reasons.
• If any signs of left-heart overload appear, 
selective conservation of the blood in the 
autotransfusion reservoir will decrease the 
preload and help to control the proximal hyper­
tension immediately. This blood can then be 
given back to the patient before removing the 
aortic clamps in order to readjust the blood 
volume.
• If blood loss is extensive, the blood pres­
sure can be stabilized by rapid reinfusion.
H emodynamic Data (Table I)
The cardiac output was measured preoper- 
atively at 4.7 L/min by the thermodilution 
technique through a Swan-Ganz catheter. The 
period of cross-clamping lasted 29 minutes. 
During this time the heart had to propel its total 
output throughout this multibranch tubing. 
The right carotid artery was perfused through 
the shunt for 44 minutes and the left carotid 
artery for 64 minutes.
The cardiac output (4.7 L/min), the cardiac 
index (2.3 L/min«m"2), the central venous
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pressure (5 cm H20 ) and the pulmonary 
wedge pressure (7 mm Hg) did not vary dur­
ing aortic cross-clamping and the proximal aor­
tic pressure did not increase to more than 140 
mm Hg and averaged 120 mm Hg, while a drip 
of both nitroglycerin and nitroprusside were 
infused at a rate of 25 microdrip/min. Con­
tinuous electrocardiographic monitoring dis­
closed a normal sinus rhythm throughout the 
aortic reconstruction. The patient’s urine out­
put during the 29 minutes of aortic occlusion 
was 80 ml. The total perioperative blood losses 
were 2000 ml of which 1000 ml were saved by 
autotransfusion and the other 1000 ml were 
replaced with banked blood.
Postoperative Course
On arrival in the intensive-care unit, the 
patient was awake and had normal neurologic 
function of both upper and lower limbs. No 
vasoactive drugs were required. Hemodynamic 
measurements showed a cardiac output of 7.3 
L/min, a cardiac index at 3.6 L/min»m'2, a 
central venous pressure at 5 cm H20  and a 
pulmonary wedge pressure of 8 mm Hg. Nor­
mal heart and pulmonary function allowed 
extubation of the patient on the morning after 
operation. Total chest-tube drainage was 150 
ml, and the drains were removed 24 hours after 
the operation. Blood urea nitrogen and serum 
creatinine levels did not vary from normal 
preoperative levels, indicating no renal dys­
function. An aortogram obtained on postoper­
ative day 7 (Fig. 3) disclosed a normal aortic 
arch and patent side branches going to the 
innominate and left carotid arteries. It showed 
also that the left vertebral artery was preserved. 
The patient went home on postoperative day 
10. He resumed work 3 months after the oper­
ation. When seen at the outpatient clinic 9 
months after the surgical repair, he was asymp­
tomatic and enjoying a normal life.
Comments
To our knowledge, this is the first 
report of this technique of external shunt­
ing with two Gott aneurysm shunts for 
replacement of an aortic arch aneurysm. 
It represents a tremendous physiologic 
improvement of a similar technique that 
we described in 1979.7 Our experience 
with the Gott aneurysm shunt is quite 
extensive and conclusive: 175 descending 
thoracic aortic aneurysms were resected 
w ithout causing paraplegia. This 
encouraged us to apply the same princi­
ple of shunting to more complex proce­
dures.
We found by measuring hemodynamic 
data6 that as much as 4000 ml/min of 
blood can be delivered through a 9-mm 
Gott shunt. By using two such shunts we 
were convinced that the total cardiac out­
put could be absorbed through the tub­
ing without any fear of heart overload 
and acute left ventricular distension. An 
electromagnetic flowmeter adapted on 
one of the 9-mm Gott shunts recorded a 
flow of 2000 ml/min. As the total cardiac 
output was measured at 4.7 L/min, the 
other 9-mm shunt likely delivered the 
extra 2700 ml/min ejected by the heart. 
This is probably close to the reality, con­
sidering that neither the central venous 
pressure nor the pulmonary wedge pres­
sure changed during the period of aortic 
cross-clamping. From hemodynamic data 
detailed in Table I, it is also obvious that 
optimal left heart decompression was 
achieved. A hemodynamic tracking pro­
file determined with both the left ventric­
ular stroke-work index and the pulmo­
FIG. 3—Postoperative aortogram showing 
surgical correction of aortic arch aneurysm 
with 34-mm woven Dacron prosthesis on which 
two side branches (10-mm woven Dacron 
prosthesis) have been anastomosed to re­
establish continuity of innominate artery and 
left common carotid artery.
T a b le  1 - M e a n  C a rd ia c  H e m o d y n a m ic  D a ta
M e a s u r e m e n t B e fo re
A o r t ic  c ro s s -c la m p in g  
D u rin g A f t e r
A r t e r ia l  p re s s u re , m m  H g 1 2 0 1 4 0 1 2 0
H e a r t  r a t e ,  b e a ts /m in 6 2 6 2 6 2
C a r d ia c  o u tp u t ,  L /m in 5 .1 4 . 7 4 . 6
C a r d ia c  in d e x , L /m in  m  2 2 .5 2 .3 2 .2
S t r o k e  v o lu m e , m l 8 3 7 5 7 3
L e f t  v e n tr ic u la r  s t r o k e - w o r k  in d e x ,  
g -m /m 2 - b e a r ’ 3 4 3 1 3 0
S y s t e m ic  v a s c u la r  r e s is ta n c e , d y n e s /s -c r t r 6 9 7 9 1 0 8 0 1 1 0 6
P u lm o n a r y  v a s c u la r  r e s is ta n c e , d y n e s /s - c n r 5 1 2 4 1 3 7 1 4 0
P u lm o n a r y  c a p il la r y  w e d g e  p re s s u re , m m  H g 7 7 7
C e n t r a l  v e n o u s  p re s s u re , c m  H 20 5 5 5
nary capillary wedge pressure shows that 
normal ventricular function was pre­
served throughout the aortic cross­
clamping. The absence of neurologic 
deficit and the preservation of the nor­
mal renal function are also obvious signs 
of optimal organ protection. The absence 
of metabolic acidosis during aortic cross­
clamping is also evidence of optimal tis­
sue perfusion.
Conclusions
The experience of only one case of a 
new technique should be interpreted with 
much caution. However, the hemo­
dynamic data obtained in our patient 
proved that this shunting procedure was 
safe and perfectly tolerated by the heart, 
which continued to work with normal fill­
ing pressures during aortic cross­
clamping. In such cases, when there is 
enough length of healthy ascending aorta 
to allow safe proximal cannulation, this 
method of aortic shunting is an impor­
tant adjunct for the surgeon faced with 
repairing an aortic arch aneurysm. One 
of the main advantages is the preserva­
tion of normal cardiovascular physiology 
without disturbing the coagulation 
process because systemic heparinization 
is not needed. However, use of this proce­
dure demands that the surgeon be 
familiar with the techniques of aortic can­
nulation.
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Tuberculous Enteritis and Peritonitis
In Turkey, diseases associated with 
Mycobacterium tuberculosis are com­
mon. Intestinal tuberculosis has generally 
been a complication of pulmonary tuber­
culosis, but recently there has been an 
increase in the frequency of intestinal 
tuberculosis without the pulmonary form.
The authors present their experience 
over 8 years in 41 patients (aged 15 to 
56 years) who underwent surgery for 
tuberculous enteritis (14), peritonitis 
(13), a combination of the two (5), geni­
tal tuberculosis and peritonitis (5) and 
tuberculous mesenteric lymphadenitis 
(4). Of these, 29 had no associated pul­
monary tuberculosis. Eighteen of the 41 
patients had complications of their dis­
ease —  bowel obstruction in 13, intesti­
nal perforation in 2, intestinal bleeding in 
2 and enterocutaneous fistula in 1. The 
diagnosis was established at operation 
and by the appearance of caseating 
granuloma on histologic examination and 
isolation of the causative organism.
Twenty-four patients required emer­
gency surgery; 2 who had bowel perfo­
ration died. Operative procedures 
included laparotomy with biopsy (17), 
resection of intestine (10), division of 
adhesions (7), evacuation of mesenteric 
abscesses (4) and bypass (3). There 
were seven (17% ) operative deaths.
The authors recommend that noninva- 
sive procedures be used for the diagnosis of 
intestinal tuberculosis, but if these fail, 
surgery is indicated.
En Turquie, les maladies causees par 
Mycobacterium tuberculosis sont fre- 
quentes. La tuberculose intestinale est 
generalement une complication de la 
tuberculose pulmonaire mais. recem- 
ment, on a assiste a une augmentation
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de la frequence de la tuberculose intesti­
nale en I'absence de forme pulmonaire.
Les auteurs decrivent 8 annees d'expe- 
riences au cours desquelles 41 patients 
(ages de 15 a 56 ans) ont ete operes 
pour entente (14) ou peritonite (13) 
tuberculeuse, ou ('association des deux 
(5), une tuberculose genitale avec perito­
nite (5) ou une lymphadenite mesenteri- 
que tuberculeuse (4). De ce nombre, 29 
n'avaient pas de tuberculose pulmonaire. 
Dix-huit des 41 patients ont presente 
des complications de leur maladie; obs­
truction intestinale (13), perforation 
intestinale (2), hemorragie intestinale (2) 
et fistule enterocutanee (1). Le diagnos­
tic a ete etabli a I'operation, a ('observa­
tion d'un granulome caseeux a I'examen 
histologique et a ('isolation de I'orga- 
nisme causal.
Vingt-quatre patients ont du subir une 
intervention d'urgence; 2 malades victi- 
mes d'une perforation intestinale sont 
decedes. Parmi les interventions prati- 
quees, on compte, des laparotomies 
avec biopsies (17), la resection intesti­
nale (10), la division de I’adhesion (7), 
l evacuation d'abces mesenteriques (4) 
et des derivations (3). II y eut 7 deces 
peroperatoires (1 7 % ).
Dans les cas de tuberculose intesti­
nale, les auteurs recommandent une 
intervention diagnostique non sanglante; 
en cas d'echec, la chirurgie est indiquee.
Diseases due to Mycobacterium sp are 
common in Turkey. New cases are usually 
seen in patients living under poor condi­
tions. In the past, abdominal tuberculo­
sis caused by ingestion of milk contami­
nated by Mycobacterium bovis frequently 
complicated extensive pulmonary tuber­
culosis. But recently the rate of primary 
intestinal tuberculosis, in the absence of 
recognizable pulmonary disease, has 
increased.
Mycobacterium tuberculosis and M. 
bovis are not the only mycobacteria 
associated with abdominal tuberculosis. 
Because of a declining rate of tuberculo­
sis and greater awareness and recognition 
of mycobacteriosis, atypical varieties are 
now more frequently seen. In contrast to
tuberculosis, the other mycobacteria are 
not transmitted from person to person 
but infection is acquired from the 
environment by mechanisms that are not 
yet understood.1
In some patients, an imprecise preoper­
ative diagnosis can result in tuberculosis 
being an unexpected finding at surgery. 
In this retrospective study we relate our 
experience with the clinical and surgical 
features of abdominal tuberculosis.
Patients and Methods
We reviewed the charts of 41 consecu­
tive patients who underwent laparotomy 
for tuberculous enteritis and peritonitis at 
Qukurova University Hospital in Adana, 
Turkey, between 1979 and 1986. Their 
ages ranged from 15 to 56 years, with 27 
patients being between 20 and 35 years 
old. As in most reported series, women 
were affected more often than men — 1.7 
to 1 in our series.
The diagnosis of tuberculosis was 
accepted with one or all of the following; 
demonstration of acid-fast bacilli, either 
by stain of the biopsy or ascitic fluid; 
determination of Mycobacterium sp in 
culture and differentiation tests; confir­
mation of caseating granuloma on 
biopsy.
Findings
Of the 41 patients, 14 had tuberculous 
peritonitis, 13 intestinal tuberculosis, 5 
tuberculous enteritis and peritonitis, 5 
genital tuberculosis and peritonitis and 4 
had only tuberculous mesenteric lym­
phadenitis. In the last group, one patient 
had been operated on for small-bowel 
volvulus due to mesenteric lymphadeni­
tis, and at laparotomy for abdominal 
trauma in the other three mesenteric lym­
phadenitis was an incidental finding.
In 24 of the 41 cases the organisms were 
demonstrated by culture and differentia­
tion tests. Mycobacterium tuberculosis 
was isolated from 11 patients, M. bovis 
from 5 and atypical mycobacteria from 8.
Active pulmonary tuberculosis was 
seen in five patients, six had a history of 
the disease and one had cervical lym-
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phadenitis. The other 29 patients had no 
associated pulmonary tuberculosis. The 
tuberculin skin test (PPD) was positive in 
only 22 of the 41 patients.
The early symptoms were generally 
nonspecific, consisting of abdominal 
pain, nausea, vomiting and periods of 
alternating diarrhea and constipation. 
Two of the five patients who had genital 
tuberculosis with peritonitis had been
FIG. 1—Irregular distribution of barium and 
destruction of mucosal pattern in some areas 
in patient with intestinal tuberculosis.
FIG. 2—Patchy mucosal changes and small 
aphthoid ulcers in transverse colon of patient 
with intestinal tuberculosis.
infertile for 3 and 7 years respectively, 
amenorrhea being the clinical symptom 
in one. Mediterranean lymphoma was the 
likely preoperative diagnosis in the two 
patients with malabsorption syndrome 
and weight loss. Low-grade fever, palpa­
ble abdominal mass and abdominal dis­
tension were the most common findings 
in patients with chronic symptoms. Of the 
24 with tuberculous peritonitis, 10 
patients manifested peritoneal irritability 
and 7 had clinically determined painless 
ascites.
In 13 patients who had intestinal 
obstruction, x-ray films of the abdomen 
revealed gas-fluid levels. Pneu­
moperitoneum was detected in one 
patient who had a perforated cecum. A 
barium study of the small intestine 
showed mucosal defects and irregular dis­
tribution of barium (Fig. 1). These signs 
suggested intestinal tuberculosis in five 
cases. Barium enema study showed fill­
ing defects in the cecum, colonic strictures 
and small aphthoid ulcers of the trans­
verse colon (Fig. 2). Ultrasonography rev­
ealed enlarged mesenteric lymph nodes, 
thickening of the bowel wall, intensely 
echogenic areas in mesentery and ascites 
in 14 cases. Computed tomography in 
seven patients indicated high-density 
ascites, irregular masses in the omentum, 
low-density masses and lymph nodes in 
various areas, but a definitive diagnosis 
of abdominal tuberculosis could not be 
made on these findings alone.
Results of routine laboratory investiga­
T a b l e  1— P r e o p e r a t i v e  D i a g n o s is  
I n d i c a t io n  f o r  L a p a r o t o m y
o r
D ia g n o s is / in d ic a t io n
N o .  o f  
p a t i e n t s
I n t e s t i n a l  o b s t r u c t i o n 1 3
A b d o m in a l  m a s s 8
A c u t e  a b d o m e n 7
I n c id e n t a l  f in d in g  a t  o p e r a t i o n 4
B o w e l  p e r f o r a t i o n 2
G a s t r o i n t e s t i n a l  b le e d in g 2
C a r c i n o m a  o f  t h e  c o lo n 2
M e d i t e r r a n e a n  l y m p h o m a 2
S p o n t a n e o u s  e n t e r o c u t a n e o u s 1
f is t u la
tions were usually within the normal 
range. In 7 of the 24 patients with tuber­
culous peritonitis, the protein content of 
ascitic fluid ranged from 2.8 to 6.1 g/L. 
The moderate number of lymphocytes in 
the fluid was suggestive of tuberculosis, 
but the fluid was positive for acid-fast 
bacilli by stained smear in only two 
patients. The normal values for ADA of 
peritoneal and pleural fluids in our hospi­
tal were accepted as 15 IU/L to 25 IU/L. 
In all our cases the ADA levels in ascitic 
fluid were greater than 58 IU/L (mean 
102 IU/L).
The problem most frequently requiring 
surgery was intestinal obstruction (13 
patients); 9 of these were found to have 
tuberculous peritonitis and 4 intestinal 
tuberculosis (Table I). Intestinal tubercu­
losis was located in the ileocecal region 
in nine patients, small intestine in five, 
transverse colon in one and sigmoid colon 
in one. Two patients had diffuse colonic 
and ileal involvement.
The surgical procedures are set forth in 
Table II.
The most consistent histopathologic 
changes were the presence of granuloma­
tous inflammation including Langhans’ 
giant cells, epithelioid cells and lympho­
cyte infiltration with central caseation. 
The tubercle formation was not promi­
nent in some patients, although diffuse 
lymphocyte infiltrations were frequent 
(Fig. 3).
There were seven operative deaths 
(17.0%) in our series, two of which 
occurred after emergency surgery for 
bowel perforation. Four deaths were due 
to advanced abdominal tuberculosis with 
intestinal obstruction and one resulted 
from tuberculous peritonitis with hepatic 
involvement.
All patients received antituberculous 
chemotherapy as follows: isoniazid (300 
mg/d) for 12 months, rifampicin (600 
mg/kg) for 9 months, morphazinamide 
(30 mg/kg daily) for 2 months and strep­
tomycin (1 g intramuscularly) to a 
total dose of 45 g. Prednisone was 
administered to patients with the adhesive 
form of tuberculous peritonitis.
T a b l e  I I - - T y p e s  o f  O p e r a t i o n
O p e r a t i v e  p r o c e d u r e
N o .  o f P e r i t o n i t i s E n t e r i t i s
E n t e r i t i s  + 
p e r i t o n i t i s
M e s e n t e r i c
l y m p h a d e n it is
O p e r a t i v e
d e a t h s
p a t i e n t s (n  -  1 9 ) (n  =  1 3 ) (n  -  5 ) In  -  4 ) In  =  7 )
B i o p s y  o n l y 1 7 11 2 1 3 2
L y s i s  o f  a d h e s io n s 7 7 — _ _ _
E v a c u a t i o n  o f  m e s e n t e r i c 4 1 — 2 1 1
a b s c e s s e s  
I n t e s t i n a l  r e s e c t io n
R i g h t  h e m i c o l e c t o m y 4 - 4 — _ 1
R i g h t  h e m i c o l e c t o m y  + 1 - 1 — — _
t e r m i n a l  i le u m  r e s e c t i o n
S u b t o t a l  c o l e c t o m y 3 — 2 1 _ 1
S m a l l  i n t e s t i n a l  r e s e c t i o n 2 — 2 _ __ 1
B y p a s s
l l e o t r a n s v e r s e  c o l o s t o m y 2 — 1 1 — —
G a s t r o j e j u n o s t o m y 1 — 1 - - 1
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Discussion
Although intestinal tuberculosis was 
sometimes secondary to pulmonary dis­
ease, enteritis was frequently the primary 
focus of the disease in most reported 
cases.2-4 Tuberculous peritonitis may 
result from rupture of the mesenteric 
lymph nodes, secondary to disease in fal­
lopian tubes and intestine. Among our 24 
patients with tuberculous peritonitis we 
located the primary focus as mesenteric 
lymph nodes in 7, enteritis in 5 and geni­
tal tuberculosis in 5. In the other seven 
patients primary focus was not clinically 
evident.
The mycobacteria were all identified 
from culture and biochemical tests as 
described by Runyon.5 Despite the
absence of atypical mycobacteria in some 
reported series,3,6 we isolated them in 
eight patients. Changing patterns of 
extrapulmonary tuberculosis are evident, 
including an insidious clinical presenta­
tion, negative findings of tuberculin skin 
tests, the absence of pulmonary tubercu­
losis and a rarity of caseation granu­
lomas.7 These changes we believe are due 
to the increasing proportion of atypical 
mycobacteria in this disorder.
In many reported series, the association 
between alcoholism and tuberculosis is as 
high as 60%.8 We did not find this in 
any of our patients, possibly because in 
Turkey tuberculosis is endemic and poor 
hygiene is a more important causative fac­
tor than alcoholism. The symptoms we 
observed and noted in other reports2,9
were insidious in the group of chronic 
cases.
In tuberculous peritonitis, the entire 
peritoneal surface is usually covered with 
tubercles, varying in size from 1 to 2 mm. 
We observed also a spider’s web appear­
ance with pseudomembranes on the 
peritoneum. In patients with ascites, the 
soapy, slippery impression of the fluid 
was probably due to the high concentra­
tion of protein and lymphocytes.
Tuberculous peritonitis may present as 
a protein and lymphocyte-rich ascites or 
as severe fibrotic adhesions.10 In our 
experience extensive dissection may be 
hazardous and should be avoided when 
there are fibrotic adhesions. It should be 
noted that the primary treatment is 
antituberculous chemotherapy and that 
recurrent ileus subsides spontaneously.
In some patients, histologic findings of 
intestinal tuberculosis were similar to 
those of Crohn’s disease. The identifica­
tion of Mycobacterium sp is the most 
accurate method of diagnosing tubercu­
losis.4,6 Crohn’s disease appears to occur 
much less frequently in Turkey than in 
Western countries. In the same period 
there were only three surgically verified 
cases of Crohn’s disease compared with 
18 of intestinal tuberculosis. Colonic 
tuberculosis may manifest features of 
other inflammatory bowel disease and has 
been misdiagnosed as ulcerative coli­
tis .11,12 Amebic colitis, another endemic 
disease in our country, was the disease 
most commonly considered in the 
differential diagnosis of tuberculosis.
Radiologic investigations are of limited 
value in diagnosing abdominal tubercu­
losis and the ability of a gastrointestinal 
series to detect the disease has been 
reported elsewhere.13-15 The colonic 
aphthoid small ulcers commonly seen in 
Crohn’s disease have been demonstrated 
radiologically by C arr-Locke and 
Finlay13 in a patient with colonic tuber­
culosis. In our two cases of diffuse 
colonic tuberculosis, there were aphthoid 
ulcers in the transverse colon which led 
us to conclude that these ulcers are also 
frequently seen in this disease.
The complications of abdominal tuber­
culosis that we encountered were bowel 
obstruction (31.7%), intestinal perfora­
tion (4.9%), intestinal bleeding (4.9%), 
enterocutaneous fistula (2.4%) and small- 
bowel volvulus due to mesenteric lym­
phadenitis (2.4%). Ulcer perforation 
occurred in 7% to 15% of all patients 
who had intestinal tuberculosis.2 
Gilinsky and colleagues16 recently 
reported their experience with eight cases 
of perforated tuberculous bowel. They 
advocated simple closure of the perfora­
tion rather than resection or bypass. We 
recommend that noninvasive procedures 
be used in the initial investigation of sus­
pected cases but surgical intervention may
Fig. 3b
FIG. 3—(a) Omentum shows mass of tuberculous granulomas (hematoxylin and eosin, origi­
nal magnification x 25). (b) Areas of tubercles surrounded by lymphocytes and Langhans’ giant 
cells. Caseation was not feature (hematoxylin and eosin, original magnification x 40).
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be necessary when the diagnosis is in 
doubt.
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Effect of Various Low-Dose Concentrations of Verapamil 
Cardioplegia on Small-Amplitude Electrical Activity 
During Cardioplegic Arrest
The effect of verapamil cardioplegia on 
atrioventricular conduction was exa­
mined in 19 dogs. During 90 minutes of 
ischemic arrest, five dogs received multi­
dose potassium cardioplegia, containing 
1.2 mg/L of verapamil (group 1), five 
received potassium cardioplegia contain­
ing 600 /xg/L of verapamil (group 2) and 
nine animals received cardioplegia con­
taining 300 fig/L of verapamil (group 3). 
Atrioventricular conduction was meas­
ured in all groups before bypass, after 
90 minutes of ischemia and after 45 
minutes of reperfusion. Specially 
designed plunge electrodes were used to 
monitor the electrical status of the heart 
during arrest in group 3 and, in addition, 
left ventricular function and concentra­
tion of high-energy phosphates were 
determined before and after ischemic 
arrest. Conduction was prolonged in four
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group 1 dogs and in two group 2. Atrio­
ventricular conduction was measured in 
six group 3 dogs; five had prolonged 
conduction and one experienced second- 
degree heart block. Small-amplitude elec­
trical potentials were recorded from the 
myocardium in two of nine dogs in group 
3. Persistent electrical activity was 
associated with continued use of high- 
energy phosphates and resulted in 
decreased left ventricular function after 
90 minutes of ischemic arrest. Our data 
indicate that small doses of verapamil 
will delay atrioventricular conduction and 
will not prevent small-amplitude electrical 
activity.
On a etudie chez 19 chiens les effets 
d'une cardioplegie au verapamil sur la 
conduction auriculo-ventriculaire. Durant 
un arret ischemique de 90 minutes, cinq 
chiens furent soumis a une cardioplegie 
provoquee par de multiples doses de 
potassium renfermant 1,2 mg/L de vera­
pamil (le groupe 1) cinq autres recurent 
du potassium additionne de 600 jtg/L de 
verapamil (le groupe 2) et neuf animaux 
furent mis en cardioplegie avec 300 /tg/L 
de verapamil (le groupe 3). Dans tous 
les groupes. la conduction auriculo-ventri­
culaire fut mesuree avant derivation, 
apres 90 minutes d'ischemie et apres 45 
minutes de reperfusion. Des electrodes
implantees, specialement concues pour 
ces mesures, furent utilisees pour monito- 
rer la conductivity electrique du coeur 
durant I'arret chez le groupe 3; de plus, 
la fonction ventriculaire gauche et la con­
centration des phosphates a haut niveau 
energetique ont ete determinee avant et 
apres I'arret ischemique. La conduction a 
ete prolongee chez 4 chiens du groupe 1 
et deux du groupe 2. La conduction 
auriculo-ventriculaire du groupe 3 a ete 
mesuree chez six chiens; cinq montraient 
une prolongation de la conduction et un 
a subi un bloc auriculo-ventriculaire au 
second degre. Des potentiels electriques 
de faible amplitude furent enregistres du 
myocarde de deux des neuf chiens du 
groupe 3. Une activite electrique persis- 
tante etait associee a ('utilisation continue 
des phosphates a haut niveau energeti­
que et causait une baisse de la fonction 
ventriculaire gauche apres 90 minutes 
d'arret ischemique. Ces resultats indi- 
quent que de petites doses de verapamil 
retardent la conduction auriculo- 
ventriculaire et ne protegent pas contre 
une activite electrique de faible 
amplitude.
Ischemic injury frequently occurs after 
prolonged aortic occlusion despite strict 
adherence to current methods of 
myocardial preservation. The mechanism
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of this injury is still unclear, although 
recent investigations in our laboratory 
indicate that potassium cardioplegia may 
not maintain complete electrical arrest 
and persistent small-amplitude electrical 
potentials may be recorded from the 
myocardium at 10°C.' These observa­
tions prompted us to investigate the 
effects of verapamil cardioplegia on 
myocardial preservation. Standeven and 
colleagues2 suggested that verapamil 
cardioplegia may augment the myocardial 
protection afforded by potassium cardi­
oplegia by providing more complete elec­
trical arrest. In a previous study,3 we 
found that high-dose verapamil cardiople­
gia abolished electrical activity from the 
myocardium and provided excellent 
myocardial protection during prolonged 
aortic occlusion but resulted in a 25% 
incidence of complete heart block. We, 
therefore, designed the present study to 
determine whether low doses of verapamil 
could augment the myocardial protection 
afforded by potassium cardioplegia and 
maintain complete electrical arrest 
without an unacceptable rate of atrioven­
tricular dissociation.
Material and Methods
We studied 19 adult mongrel dogs, 
weighing between 22 and 26 kg. Atrioven­
tricular conduction was measured in five 
animals that received 10 ml/kg body 
weight of potassium crystalloid cardiople­
gia (Table I) containing 1.2 mg/L of ver­
apamil (group 1). This concentration of 
verapamil was half the dose that had been 
used in earlier experiments3 and had 
resulted in a 25% incidence of complete 
heart block. The cardioplegia was infused 
into the ascending aorta after application 
of the aortic cross-clamp, with subsequent 
infusions at 30-minute intervals during 
the 90-minute period of arrest. Similar 
conduction measurements were made in 
five animals receiving potassium crystal­
loid cardioplegia containing 600 ng/L of 
verapamil (group 2) and nine animals 
receiving potassium crystalloid cardiople­
gia containing 300 /ig/L of verapamil 
(group 3). Because of the substantial 
reduction in verapamil concentration in 
group 3 dogs, we decided not only to 
measure atrioventricular conduction but 
to determine the effects of this concen­
tration of verapamil on myocardial 
preservation and the presence of persis­
Table 1—Composition of Potassium Crystalloid 
Cardioplegia
Ringer's lactate, ml 800
Dextran 40 in 10°C dextrose, ml 180
Potassium, mmol/L 20
Heparin, U/L 2000
Toronto insulin, U/L 4
Solu-Cortef, mg/L 40
Sodium bicarbonate, mmol/L 25
pH 7.7
tent electrical activity in the myocardium.
Transmural myocardial temperature 
and electrical activity were continuously 
monitored with specially designed plunge 
electrodes over the left anterior descend­
ing coronary distribution during arrest. 
The technical aspects related to the meas­
urement of transmural temperature and 
small-amplitude electrical potentials from 
the myocardium during cardioplegic 
arrest have been described in detail previ­
ously.1
Left ventricular function was also 
assessed before bypass, after 90 minutes 
of ischemia and after 45 minutes of reper­
fusion, and transmural biopsies were 
obtained for analysis of high-energy phos­
phates before bypass and at 15 and 45 
minutes after ischemic arrest.
Surgical Preparation
The dogs were sedated with 1 ml of 
Innovar and anesthesia was induced and 
maintained with sodium pentobarbital (5 
mg/kg). Pancuronium bromide (0.1 
mg/kg) was administered intravenously 
after intubation, and ventilation was 
provided with a pressure-regulated ven­
tilator.
The chest was opened through a 
median sternotomy and the heart sus­
pended in a pericardial cradle. The left 
femoral artery was cannulated with a no. 
14 French USCI arterial cannula (C.R. 
Bard Inc., Billerica, Mass.) while both 
cavae were cannulated with no. 34 French 
USCI cannulas. A no. 8 French USCI 
catheter was positioned in the right 
femoral artery for continuous monitor­
ing of blood pressure and a no. 7 French 
Swan-Ganz thermodilution catheter was 
positioned in the pulmonary artery to 
determine cardiac output. A no. 5 French 
transducer catheter (frequency response 
0 to 24 kHz) was introduced through the 
apex of the left ventricle to measure left 
ventricular end-diastolic pressure and the 
rate of rise of left ventricular pressure 
(dP/dt). Cardiopulmonary bypass was 
established with a Medtronic impellar 
pump (model 1835-OOU; Medtronic Inc., 
Circulatory Systems Division, Roseville, 
Miss.) driven by a Medtronic circulatory 
assist console (model 1810) that would 
deliver nonpulsatile flow at a rate of 2.5 
L/min • n r2. The azygous vein and both 
cavae were snared and the ventricles were 
vented during arrest.
At a rectal temperature of 26°C, the 
aorta was cross-clamped and 10 ml/kg of 
crystalloid potassium cardioplegia, con­
taining varying concentrations of ver­
apamil, was administered to induce the 
arrest and at 30-minute intervals during 
the 90 minutes of ischemia. Topical iced 
saline was placed in the pericardial well 
and over the anterior surface of the heart 
to maintain myocardial temperature 
within the range of 8° to 10°C.
Measurement o f  
Atrioventricular Conduction
Atrioventricular conduction was meas­
ured after sternotomy, after 90 minutes 
of ischemic arrest and after 45 minutes 
of reperfusion. By manipulation during 
reperfusion, the rectal temperature 45 
minutes after ischemic arrest was brought 
to an identical reading with that measured 
initially. The atrium was paced with a 
Cordis Chronocor model 156B pace­
maker (Cordis Corp., Miami, Fla.) at a 
rate of 150 beats/min and the electro­
cardiogram was recorded on a Gould- 
Brush 260 amplifier (Gould Inc., Oxnard, 
Calif.) and recorder. Measurements of 
atrioventricular conduction were deter­
mined from strip-chart recordings that 
displayed the atrial pacemaker potential 
and the R-wave of the electrocardiogram.
Determination o f  
Left Ventricular Function
Cardiac index, left ventricular stroke- 
work index and the rate of rise of left ven­
tricular pressure (dP/dt) were measured 
after sternotomy, after 90 minutes of 
ischemia and after 45 minutes reperfusion 
in group 3. Measurements were deter­
mined at a heart rate of 150 beats/min 
and at a left ventricular end-diastolic pres­
sure of 10 mm Hg. Heart rate was in­
creased to 150 beats/min in dogs with 
lower heart rates by temporary atrial pac­
ing. The left ventricular end-diastolic 
pressure was manipulated to 10 mm Hg 
by withdrawing or infusing volume from 
the oxygenator. Left ventricular function 
was calculated from standard formulas 
described previously.4
High-Energy Phosphate Levels
Full-thickness transmural left ventric­
ular biopsies were obtained from group 
3 dogs for determination of high-energy 
phosphate levels. The specimens were 
removed from the left ventricle overlying 
the left anterior descending coronary dis­
tribution after sternotomy and at 15 and 
45 minutes of reperfusion. The techniques 
for obtaining, preserving and analysing 
these specimens have been outlined 
previously5.
Statistical Analysis
Results have been reported as the arith­
metic mean with standard error and the 
unpaired Student’s t-test was used for 
statistical comparisons.
Results
Group 1
Group 1 dogs received 876 ± 27 /rg of 
verapamil during cardiac arrest (4.9 ± 0.2
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/xg/g of heart muscle). Atrioventricular 
conduction was prolonged in four of the 
five animals, but there was no incidence 
of complete heart block. The small num­
ber of animals in this initial group 
precluded statistical analysis, but the 
results suggested that this concentration 
of verapamil prolonged conduction.
Group 2
In the five dogs in group 2 that received 
potassium crystalloid cardioplegia, con­
taining verapamil 600 jtg/L, a total of 410 
± 7 ng of verapamil was administered 
during the period of arrest (2.9 ± 0.6 
/rg/g of heart muscle). Atrioventricular 
conduction was prolonged in two dogs.
Group 3
The nine group 3 animals received 209 
± 3.4 fig of verapamil (1.4 ± 0.01 ;rg/g 
of heart muscle) during the arrest. Atri­
oventricular conduction was measured in 
six of the nine animals; it was delayed in 
five. The increase in atrioventricular con­
duction ranged from 8 to 64 ms (mean 28 
ms, p <  0.04). One animal in this group 
had prolonged 2:1 heart block.
Small-amplitude electrical potentials 
from  the myocardium.—The administra­
tion of verapamil-potassium cardioplegia 
induced complete electrical arrest in all 
dogs, but two had small-amplitude elec­
trical activity within 10 to 15 minutes after 
the initial infusion of cardioplegia. Elec­
trical activity was abolished by reinfusion 
of cardioplegia at 30 minutes, but again 
became apparent before reinfusion at 60 
minutes. Plunge-electrode activity was 
present when there was no visual mechan­
ical activity and when the electrocardio­
gram was isoelectric. The remaining seven 
animals in this group maintained com­
plete electrical arrest throughout the 
entire period of ischemia.
Left ventricular function .—The dogs 
were subdivided into two groups based on 
the presence of small-amplitude electrical 
activity. The hemodynamic data for these 
groups are summarized in Table II and 
expressed as a mean increase or decrease 
in each measurement after 90 minutes of 
ischemia and 45 minutes of reperfusion. 
Cardiac index increased by 1.3 ± 7 
ml/min«kg_1 in those animals without 
electrical activity and by 23 ± 14
m l/m in-kg_l in those with electrical 
activity (p < 0.05). Left ventricular 
stroke-work index was reduced by 0.07 ± 
0.06 g-m/beat*kg 1 in the nonfibrillators 
and by 0.15 ± 0.2 g-m/beat-kg_1 in the 
fibrillators (p < 0.5). The rate of rise of 
left ventricular pressure (dP/dtmax) was 
reduced by 39 ± 64 mm Hg/s in the 
animals without electrical activity and by 
60 ± 34 mm Hg/s in those with electri­
cal activity (p < 0.4). Peripheral vascu­
lar resistance decreased by 400
dynes/s-cnr5 in the nonfibrillators and 
by 2002 dynes/s«cnr5 in those with elec­
trical activity (p < 0.06).
High-energy phosphates.—There was 
no significant change in the concentration 
of adenosine triphosphate (/tmol/g dry 
weight of cardiac muscle) in any of the 
animals after 15 minutes of reperfusion. 
However, ATP decreased by 0.05 ± 0.6 
nm/g  in the nonfibrillators and by 4.5 ± 
0.5 /tm/g in those animals with electrical 
activity after 45 minutes of reperfusion 
(p < 0.09).
Discussion
Calcium channel blockers have been 
used clinically to augment the myocardial 
protection provided by potassium car­
dioplegia.6,7 This group of drugs is 
thought to reduce the cellular influx of 
calcium during ischemic arrest and to pre­
vent post-ischemic calcium-ion influx, 
thereby reducing reperfusion injury.8,9 
Standeven and colleagues2 demonstrated 
that adding a calcium channel blocker to 
potassium cardioplegia improved 
myocardial preservation; they suggested 
that calcium-channel-blocker cardiople­
gia may protect the myocardium by 
providing more-complete electrical arrest. 
This concept has been supported by 
recent investigations in our laboratory,3 
showing that the addition of high-dose 
verapamil to potassium crystalloid cardi­
oplegia prevents small-amplitude electri­
cal activity during extended periods of 
aortic occlusion. Unfortunately, we 
found that the increased protection 
afforded the high-dose verapamil was 
associated with a 25% rate of complete 
heart block, which persisted for 1 to 2 
hours after the arrest. The clinical use of 
calcium-channel-blocker cardioplegia has 
also been associated with a high frequency 
of atrioventricular conduction abnormal­
ities. When Guffin and associates10 
added verapamil to potassium crystalloid 
cardioplegia they found that 78% of 
patients experienced varying degrees of 
heart block; 33% of their patients 
required atrioventricular sequential pac­
ing. A similar experience was reported by 
Hicks and colleagues6 after the use of 
verapamil cardioplegia; 70% of their 
patients experienced conduction abnor­
malities and 6% required pacing in the 
intensive-care unit. Clark and associates7 
employed nifedipine cardioplegia and 
noted that the heart frequently failed to 
beat spontaneously after release of the 
aortic cross-clamp and that much longer 
periods of reperfusion were necessary 
before atrioventricular conduction re­
turned to normal. Thus, both experi­
mental and clinical studies indicate that 
conduction abnormalities are a common 
complication of calcium-channel-blocker 
cardioplegia.
Conduction abnormalities associated 
with the use of calcium channel 
antagonists appear to be related not only 
to the concentration of the drug used in 
cardioplegia but also to the total dose 
administered during the period of cardiac 
arrest. Keefe and Kates11 and Hulthen 
and colleagues12 investigated the effects 
of verapamil on cardiac membranes. 
They demonstrated that verapamil has a 
high affinity for binding sites in cardiac 
membranes that results in the gradual 
accumulation of the drug within muscle 
cells; this explains why conduction abnor­
malities may persist long after infusion of 
calcium-channel-blocker cardioplegia. 
The concentration of verapamil in the 
cardioplegic solution is also a factor 
although there appears to be considera­
ble individual variability. Although 
Yamamoto and colleagues13 suggest that 
the optimum concentration of verapamil 
in cardioplegia is approximately 500 ng/L 
and that higher doses frequently cause 
varying degrees of heart block, Guffin 
and colleagues10 have shown that much 
smaller doses (375 /ig/L) are also 
associated with a high rate of complete 
heart block. These observations indicate 
that multidose verapamil cardioplegia 
may result in the gradual accumulation 
and binding of the drug with cellular 
membranes, resulting in the prolongation 
of atrioventricular conduction or heart 
block following cardioplegic arrest.
In an earlier study,3 we demonstrated 
that potassium cardioplegia containing 5 
mg/L verapamil provided excellent 
myocardial preservation and prevented 
small-amplitude electrical activity during 
ischemic arrest but resulted in a 25% inci­
dence of persistent atrioventricular dis­
sociation. The concentration of verapamil
Table 11-Mean Change in Ventricular Function After 90 Minutes of 
Ischemia and 45 Minutes of Reperfusion
Measurement Nonfibrillators Fibrillators p value*
Cardiac index, + 1.3 ± 7t +23 ± 14 <0.05
ml/min-kg 1
Left ventricular stroke- -0.07 ± 0.06 -0.15 ± 0.2 <0.5
work index, g-m/beat-kg 1
dP/dtmax, mm Hg/s -39  ± 64 -60  ± 34 < 0.4
Peripheral vascular -400 ± 362 -2002 ± 779 < 0.06
resistance, dynes/s-cm-5 
'Unpaired Student's /test. 
tSEM = standard error of mean.
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used in these experiments3 was extrapo­
lated from previous canine experimental 
investigations14’15 that had demonstrated 
no conduction abnormalities with the 
intravenous infusion of similar concentra­
tions of verapamil. The disparity between 
our observations and these experimental 
results14-15 is presumably related to the 
fact that we infused verapamil directly 
into the coronary circulation, which may 
have resulted in excessively high concen­
trations of the drug in the myocardium. 
We, therefore, designed the present study 
to determine an optimum dose of ver­
apamil that would prevent small- 
amplitude electrical activity during 
ischemic arrest without provoking 
untoward effects on atrioventricular con­
duction. The concentration of verapamil 
used in our earliest experiments3 was 
reduced by 50% in group 1. These five 
dogs received a total dose of verapamil 
that ranged from 780 to 984 ng. Atrioven­
tricular conduction was generally 
prolonged but there was no instance of 
complete heart block. In group 2, the 
dogs received a lower total dose of ver­
apamil ranging from 390 to 450 fig. Atri­
oventricular conduction was prolonged 
but in only two of the five animals. In 
group 3 nine dogs received a total dose 
of verapamil ranging from only 192 to 
219 ng. Atrioventricular conduction was 
measured in six of the nine animals and 
despite the marked decrease in the con­
centration of verapamil, conduction was 
prolonged in five dogs and one 
experienced prolonged second-degree 
heart block. The effect of verapamil 
cardioplegia on atrioventricular conduc­
tion was, therefore, not always predic­
table.
We decided to monitor the electrical 
status of the heart during cardioplegic 
arrest in group 3 animals and to assess the 
effects of this very small concentration of 
verapamil on myocardial preservation, 
because we felt that any further reduction 
in the concentration of verapamil would 
be unlikely to prevent small-amplitude 
electrical activity. Persistent electrical 
potentials were recorded from the 
myocardium at 10°C in two of nine 
animals in group 3, indicating that low- 
dose verapamil indeed will not prevent 
small-amplitude electrical activity. In con­
trast, high-dose verapamil (5 mg/L of 
crystalloid cardioplegia) studied in our 
earlier experiments,3 using an identical 
surgical preparation, completely 
abolished small-amplitude potentials 
from the myocardium. The data reported 
in this study complement those of a previ­
ous report by Ferguson and colleagues16 
who used nifedipine cardioplegia during 
40 minutes of ischemic arrest. They added 
200 g.g of nifedipine to each litre of 
potassium crystalloid cardioplegia and 
monitored electrical activity from the 
myocardium with specially designed
plunge electrodes. Nifedipine reduced but 
did not abolish the incidence of small- 
amplitude electrical activity; small- 
amplitude electrical potentials were fre­
quently recorded from the myocardium 
before the reinfusion of cardioplegia at 
regular intervals during the period of 
cardiac arrest.
Assessment of myocardial preservation 
after 90 minutes of ischemia and 45 
minutes of reperfusion in group 3 indi­
cated that preservation was only optimal 
when the heart was completely electrically 
arrested. Persistent electrical activity was 
associated with substantially greater 
reduction of ATP after 45 minutes of 
reperfusion. The rate of rise of left ven­
tricular pressure (dP/dtmax) was lower 
after ischemic arrest in animals with elec­
trical activity, although the results were 
not statistically significant. Cardiac index 
and left ventricular stroke-work index 
rose in both the fibrillators and nonfibril- 
lators, the increase in both these indices 
being greater in the fibrillators. These 
observations might be explained by the 
fact that peripheral vascular resistance 
was much lower in the nonfibrillators. 
The difference in peripheral vascular 
resistance, however, between these two 
groups is not readily apparent and was 
not related to the total dose of verapamil 
administered during the arrest or the core 
temperature during the measurements.
Our data indicate that low-dose ver­
apamil cardioplegia will not prevent 
small-amplitude electrical activity and 
that even very small concentrations of 
verapamil are frequently associated with 
conduction abnormalities. Furthermore, 
the effects of verapamil on atrioventric­
ular conduction are not directly related 
to the concentration of the drug, because 
the delay in conduction in group 3 dogs 
receiving a very small dose of verapamil 
was similar to that in the first two groups 
of animals receiving higher concentra­
tions.
Our data suggest that clinical applica­
tion of calcium-channel-blocker cardio­
plegia may be limited since cardioplegia 
must be safe and nontoxic to the 
myocardium and the total volume of 
cardioplegia administered during the elec­
tive arrest should not be a critical factor. 
The clinical use of cardioplegia frequently 
results in the administration of large 
volumes of cardioplegic solution to ensure 
optimum myocardial cooling, particularly 
in patients with critical coronary artery 
stenosis and in those patients with 
myocardial hypertrophy. These data and 
previous observations in our laboratory3 
indicate that excellent myocardial preser­
vation may be provided with crystalloid 
solutions as long as a complete electrical 
arrest is maintained during the period of 
anoxia. Our observations suggest that 
attention should be focused on the 
development of techniques to monitor the
electrical status of the heart during cardi­
oplegic arrest rather than continuing to 
modify contemporary cardioplegic solu­
tions. Continuous monitoring of the elec­
trical status of the heart would provide 
the surgeon with a method of gauging the 
volume and frequency of cardioplegic 
administration necessary to provide a 
complete electrical arrest and to ensure 
optimal myocardial preservation during 
prolonged aortic occlusion.
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Elderly Long-Stay Surgical Patients
This paper examines long hospital stays 
(more than 30 days) among 196 surgical 
patients over 65 years of age in two 
acute-care hospitals. Patients in the long- 
stay group — 54 (28%) of the 196 — 
were not demographically different from 
the others but showed a significantly (p 
< 0.05) higher rate of cognitive impair­
ment, dependence before admission and 
admission through the emergency 
department. Although these patients 
more often required catheterization and 
were nursed in bed or in "gerichairs", 
many were suitable for discharge to the 
community if appropriate accommodation 
could have been found.
Cet article se penche sur les sejours hos- 
pitaliers prolonges (de plus de 30 jours) 
parmi 196 patients chirurgicaux de plus 
de 35 ans qui ont ete admis dans deux 
centres hospitaliers pour soins de courte 
duree. Les patients dont I'hospitalisation 
fut prolongee, 54 (28%) des 196, ne 
presentaient pas de caracteristiques dif- 
ferentes des autres, mais ils montraient 
un taux significativement plus eleve (p <  
0.05) de deficit cognitif, d'etat de 
dependance avant leur hospitalisation et 
d'admission par le service d’urgence.
Bien que ces malades eurent plus sou- 
vent besoin d'un catheter et furent trai- 
tes au lit ou dans une chaise pour vieil- 
lard, plusieurs auraient pu r£integre la 
communaute si des services appropries 
avaient pu y etre trouves.
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Elderly patients (those over 65 years of 
age) who must be hospitalized for longer 
than 30 days pose a particular problem 
to the health-care system in terms of both 
appropriate treatment and hospital costs. 
Yet long hospital stay as a measure of the 
outcome o f surgery in the elderly has 
received comparatively little attention. 
Most reports deal mainly with death 
rate;1 where length of stay is mentioned, 
long hospital stay as an outcome is gener­
ally not reported.2
This paper examines long hospital stays 
among elderly surgical patients and 
focuses on the risks associated with 
prolonged hospitalization and the type of 
care that such patients require.
Methods
In this paper, surgical patients were 
defined as those admitted or transferred 
to a surgical unit. Long-stay patients were 
those hospitalized for 30 days or more on 
the day o f the interview.
The study was conducted as two cross- 
sectional surveys, in April 1983 and April 
1984 respectively, in St. John’s, Nfld. The 
two hospitals studied serve as tertiary care 
centres for 590 000 persons. In 1981, 
approximately 8.5% of the population 
was aged 65 years or older.3
The data collection protocol included 
a standardized review o f the health-care 
record. Data on demographic variables, 
residence at admission and discharge, 
type of admission, diagnosis, type of 
procedure, complications and in-hospital 
transfers were recorded. Next, a struc­
tured interview with the patient was car­
ried out. Information comprised observer 
assessment, test data and self-reported 
information. The interview gave informa­
tion on health attitudes and beliefs, on 
functional capacity in the activities of 
daily living (e.g., eating, bathing, meal 
preparation),4’5 on cognitive impairment6 
and on the presence o f urinary catheters, 
use o f restraints, tube-feeding and 
“ gerichairs” and other variables related 
to patient care. In addition, the patient’s 
primary nurse was interviewed, at which 
time a standardized nursing assessment 
was completed and corroboration of the
patient’s history sought. The protocol was 
pretested on 10 patients.
The significance of differences in 
means was assessed using the two-tailed 
/-test. The x2 test was used in the analy­
sis o f proportions.
Results
Data collection forms were completed 
on 196 elderly surgical patients. Of these, 
67% came to hospital from their own 
homes, 20% from a relative’s home and 
the remaining 13% from a nursing home. 
The age distribution was similar to that 
of the Newfoundland population, with 
61% being between 65 and 74 years, 28% 
between 75 and 84 years and 11% 85 
years or older.4
Of those living in the community, 38% 
were dependent in at least one essential 
activity of daily living. Almost 40% of 
this group were living with a spouse, 33% 
with a child and the remainder with 
another relative or friend.
Over 67% of the patients were either 
on general surgery or orthopedic services, 
the remainder being divided between neu­
rosurgery, urology, ophthalmology and 
otolaryngology. In 60% a serious 
preoperative medical risk was identified; 
a further 15% suffered from dementia. 
Only 25% of patients had no identifia­
ble risk factor.
Of the 196 patients, 54 (28%) had 
hospital stays longer than 30 days (range 
from 31 to 365 days). Two-thirds of them 
had stays in excess of 60 days.
There were few demographic differ­
ences between the long-stay and short- 
stay patients (Table I). Both groups 
showed a small preponderance of women. 
Long-stay patients were less likely to be 
married than short-stay patients. The 
majority of both groups came from their 
own homes. Although the average ages 
did not differ substantially, it is interest­
ing that the long-stay group had propor­
tionately twice as many very elderly (85 
years or more) patients as the short-stay 
group.
Long-stay patients were significantly (p 
<  0.05) more often dependent in some
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essential activity of daily living4 than 
short-stay patients (62% versus 26% 
respectively).
The length of stay was associated with 
the type of procedure performed (Fig. 1). 
In particular, those who underwent 
orthopedic procedures were more likely 
to experience long stays, as was the case 
in 43% of elderly orthopedic patients.
The presence of cognitive impairment 
also posed a significant risk of long hospi­
tal stay (Table II). Moderate to severe 
cognitive impairment was present in 59% 
of long-stay patients compared with only 
25% (14 of 57) of short-stay patients.
The mode of admission to hospital also 
shows significant differences between the 
two groups (Fig. 2), emergency admission 
being associated with prolonged hospitali­
zation.
Excluding dementia, preoperative med­
ical risks did not favour either of the two 
groups. In spite of factors that included 
a history of myocardial infarction, 
peripheral vascular disease, untreated 
hypertension, congestive heart failure, 
anemia, chronic obstructive lung disease, 
diabetes mellitus, stroke, pneumonia and 
urinary tract infection, there were fewer 
preoperative medical risks in the long-stay 
group. Although there was no difference 
in the rate of major postoperative com­
plications (two patients), long-stay 
patients did have a higher frequency of 
minor complications, particularly anemia 
and uncontrolled diabetes mellitus. Such 
complications occurred in 46% of long-
stay patients, compared with 30% of 
short-stay patients. In both groups, the 
most common complication was a tran­
sient postoperative anemia. Decubitus 
ulcers were present in 5% of long-stay 
patients.
Table III compares selected characteris­
tics of the care received by both patient 
groups. When interviewed, most long- 
stay patients were in bed with the rails up 
and 30% (compared with 11% of the 
short-stay patients) were either in 
“ gerichairs” or had them at the bedside. 
Although a higher rate of urinary 
catheterization might be expected in those 
most recently operated on, only 11% of 
short-stay patients compared with 39% of 
the long-stay group had urinary catheters 
in place. Slightly more long-stay patients 
were restrained or were being tube fed, 
but the differences were not significant. 
The proportion of long-stay patients who 
were in bed or were catheterized suggests 
a higher level of dependence in this group, 
but it is interesting to note that, by nurs­
ing assessment, 37% of these were consi­
dered ready to be discharged with little 
or no assistance from the community, if 
there was a place for them to go.
Discussion
Several studies on the outcome of 
hospital admissions of the elderly have 
included surgical patients, but prolonged 
hospitalization as an outcome has not
been examined,7-10 although Lamont and 
colleagues10 did report that 11.5% of 
surgical patients and 40% of orthopedic 
patients were discharged to nursing 
homes, an outcome associated with 
prolonged hospita lization  in the 
elderly.11-15
Murphy13 found that 16% of 325 sur­
gical and orthopedic  beds were 
“ blocked” by long-stay patients. This 
estimate is similar to the 14.2% noted in 
a Toronto study16 of medical and surgi­
cal beds, but is somewhat higher than esti­
mates of 4.8% in another British study12 
and 10% in a New York report cited by 
Glass and associates.17 The proportion 
of bed-days affected is, of course, higher; 
McArdle and colleagues11 reported that 
33% of bed-days in an acute medical serv­
ice were occupied by patients not need­
ing acute care. Similarly, Robbins and 
Donaldson15 found that 28% of bed- 
days used by elderly patients with hip 
fractures were spent awaiting discharge.
The definition of “ long stay” is con­
troversial. Although some prospective 
studies have not used a pre-set limit, argu­
ing that “ social stay” can occur at any 
time,15,17 most set a criterion, ranging 
from 28 days12 to 6 months,18 depending 
on the particular administrative setting. 
While these definitions are necessarily 
arbitrary, our clinical experience accords 
with the impressions of McAlpine19 and 
Rubin and Davies12 in selecting the 
30-day cutoff. Of note, in the prospec­
tive series of Robbins and Donaldson,15 
is that most patients had completed active 
treatment by 30 days.
The estimate of the proportion of beds 
occupied by long-stay patients is higher
FIG. 1—Proportion of long-stay patients by 
type of surgical procedure. Abd/urol = 
abdominal/urologic, CVT = cardiovascu- 
lar/thoracic, EENT = opthalmologic/ears, 
nose, throat. While bars = short stay, hatched 
bars = long stay.
Table 1-Demographic Characteristics of 196 Long-Stay and Short-Stay Patients
________________________________  Long stay, no. (%)_________________ Short stay, no. (%)
Sex
Male 24 (44) 67 (47)
Female 30 (56) 75 (53)
Residence*
Own home 33 (61) 96 (70)
With relative 15 (28) 23 (17)
Nursing home 6 (11) 19 (141
Marital status!
Single 5 (9) 14 (10)
Married 25 (47) 72 (51)
Widowedldivorced 23 (43) 56 (39)
Age, yr
65 -  74 29 (54) 91 (64)
75 -  84 17 (31) 38 (27)
>  85 8 (15) 13 (9)
Average age 75 ± 7.4 73 ± 6.5
(± SD), yr
’ Data not available for 4 short-stay patients. 
tData not available for 1 long-stay patient.
________ Table II—Cognitive Impairment in Long-Stay and Short-Stay Elderly Patients*
_____________ Cognitive impairment, no. (%)
Length of stay Severe Moderate None
Long 19 (41.3) 8 (17.4) 19 (41.3)
Short_________________________ 5 (8.8)__________________ 9 (15.8)______________ 43 (75.4)
*103 patients. Only in the second year were short-stay patients interviewed. Data are missing on 
10 patients (8 long stay, 2 short stay) with whom an interview could not be completed, p <  0.05.
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than has been reported previously in 
studies using a 30-day criterion. The result 
seems a reliable estimate for the popula­
tion, as it did not vary much in the 2 years 
studied. In both years, the proportion of 
patients with stay in excess o f 60 and 90 
days did not vary. These findings may 
reflect local practices and be attributable 
to the lack of an established geriatric serv­
ice at the time of the study or to the rela­
tively undeveloped system of home-care 
services in the community.
Many factors contribute to long hospi­
tal stays,16 but some groups are reported 
to  be consistently at risk — those with 
cognitive impairment,U,I6_18’20,21 unrelia­
ble community support,11"13’17,18 problem 
behaviour,14,18 those who are more than 
75 years old12’13'17 and women.12’13’18 
In contrast to  these reports we found 
that the long-stay patients were not more 
often female, widowed or very elderly. 
None the less, the twofold higher fre­
quency of dependence in the community 
before admission suggests that the long- 
stay patients in this study share essential 
features with others described previ­
ously.12,13’18 The finding of a higher 
proportion with cognitive impairment 
also supports this view.11,16-18’20’21 
Other risks, such as emergency adm is­
sion, are controversial.12,13’18’22 In this 
study we found that 72% of long-stay 
patients were admitted through the emer­
gency department. It is interesting that 
while limited mobility before admission 
is a risk factor for long stay ,12,13,18 
M urphy13 found that only 3 of 43 (7%) 
long-stay patients required nursing in bed. 
Moreover, although most agree that the 
long-stay patients do not require acute 
care,11"15 the types of care needed are not 
often reported. In our study, most (85%) 
of the long-stay patients were in bed when 
interviewed and compared with short-stay 
patients more were restrained, had uri­
nary catheters and were fed by nasogas­
tric tube.
Many of the elderly long-stay patients 
nursed in bed or in “ gerichairs”  were con­
sidered capable of relatively independent 
living. Notwithstanding Asher’s 40-year- 
old warning about the dangers of 
bedrest,23 its prevalence in the hospital­
ized elderly is still quite high.17,24 As with 
urethral catheterization, this often reflects 
practices undertaken for easier patient 
care.17,24
In summary, the typical elderly long- 
stay patient on the surgical service is one 
who is dependent, cognitively impaired 
and required emergency surgery. Thus, 
little can be done to prevent admission. 
It is, therefore, imperative that practical 
strategies o f management be developed 
for these patients25 so that the quality of 
care can be improved and further depen­
dency avoided.
FIG. 2—Type of admission for long- and short-slay elderly surgical patients. White bars 
= short stay, hatched bars = long stay.
Table Ill-Hospital Care in 54 Long-Stay and 56 Short-Stay Elderly Patients*
Long stay, Short stay,
Care no. (%) no. (%) P value
In bed, sides raised 46 (85) 29 (52) < 0.05
"Gerichairs" at bedside 16 (30) 6 (11) < 0.05
Restrained 5 (9) 3 (5) > 0.05
Urinary catheter in place 21 (39) 6 (11) < 0.05
Nasogastric tube feeding 3 (6) 1 (2) > 0.05
*110 patients. Only in second year were short stay patients interviewed. Data are missing on 3 short-stay 
patients.
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Le syndrome des loges de la jambe et le scorbut
II importe aux professionnels de la sante 
de se souvenir des maladies d'autrefois 
et de savoir reconnaTtre la population d 
risque dans notre societe. Les auteurs 
decrivent le cas d'une mere immigrante 
agee de 42 ans, vivant sous le seuil de 
la pauvrete, qui a subi une fasciotomie a 
I'hopital Hotel-Dieu de Montreal pour un 
syndrome des loges posterieures de la 
jambe. Elle presentait des ecchymoses 
de la peau de la jambe et un hematome 
intermusculaire du mollet. Trois semaines 
plus tard, la malade est revenue avec 
une recidive de la douleur et une enflure 
de la jambe, une gingivite hypertrophi- 
que, une folliculite hemorragique, des 
petechies et une hemorragie digestive.
La reponse Clinique a la vitamine C fut 
remarquable et a confirme le diagnostic 
de scorbut.
Old people living alone and in poverty 
are most at risk for developing scurvy, 
but the diagnosis may be missed unless 
the physician is aware of it. A 42-year- 
old immigrant living in poverty was 
treated surgically at the Hotel-Dieu 
Hospital in Montreal for a compartment 
syndrome of the leg. She had 
ecchymoses on the skin of the leg and 
an interstitial hematoma in both posterior 
compartments. Three weeks later, she 
was readmitted with more swelling in 
the leg, gingivitis, hemorrhagic folliculi­
tis, petechiae and gastrointestinal hemor­
rhage. Her response to vitamin C was 
remarkable and confirmed the diagnosis 
of scurvy.
Le scorbut est une maladie qui se rencon­
tre rarement dans notre societe. Aussi 
peut-elle se manifester avec des signes cli- 
niques capables de nous la faire confon- 
dre avec d’autres pathologies plus couran- 
tes comme une vasculite, une diathese 
hemorragique ou une thrombophlebite 
profonde.1
De Section d ’orthopedie, hopital Hotel- 
Dieu de Montreal, Montreal, PQ
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Le diagnostic precoce ne peut etre fait 
que si le medecin traitant considere cette 
possibility dans l’eventail des diagnostics 
differentiels. Pour illustrer cette affirma­
tion, nous presentons l’histoire d ’une 
patiente qui fut traitee pour un syndrome 
non traumatique des loges de la jambe 
sans que Ton puisse reconnaTtre l’etiolo- 
gie exacte de ce syndrome.
Histoire de cas
II s’agit d’une patiente de 42 ans d’origine 
Portugaise, mere de huit enfants, issue d ’un 
milieu social defavorise, qui se presente au ser­
vice d’urgence en mai 1985 pour des douleurs 
persistantes a la jambe gauche. L’examen 
physique est considere comme normal et elle 
re?oit des analgesiques mineurs.
Cette patiente se presente de nouveau en juin 
1985 pour persistance des douleurs a la jambe 
avec, comme elements nouveaux, un gonfle- 
ment important et une ecchymose au niveau 
du mollet gauche. Le diagnostic soupconne est 
alors une thrombophlebite ou une rupture du 
plantaire grele. On precede a une radiographie 
simple, une echographie du mollet et une phle- 
bographie qui s’averent normales. L’hemoglo- 
bine sanguine est mesuree a 117 g/L et l’hema- 
tocrite a 35.3.
Quelques jours plus tard, le gonflement du 
mollet progresse a un point tel qu’on pose un 
diagnostic de syndrome de la loge posterieure 
de la jambe gauche et la malade est vue en 
orthopedie.
La prise des pressions dans la loge poste­
rieure superficielle (38 mm Hg) et profonde (60 
mm Hg) confirme le diagnostic et on precede 
sous anesthesie generate a une fasciotomie des 
deux loges posterieures. Les muscles superfi- 
ciels et profonds sont normaux sauf pour la 
decouverte d’un hematome inter- et intra- 
musculaire dissequant les plans des differents 
fascias.
La plaie chirurgicale cicatrise apparemment 
normalement par la suite.
Vingt jours plus tard, la patiente se presente 
de nouveau a l’urgence avec atteinte de l’etat 
general: asthenie marquee, gingivite hypertro- 
phique, folliculite hemorragique, petechies et 
hemorragie digestive avec hematemese. II y a 
aussi une recidive de la douleur et du gonfle­
ment au mollet gauche, et une dehiscence de 
plaie. L’hemoglobine est alors a 63 g /L  avec 
une leucopdnie associee.
Un bilan nutritionnel confirme que la 
patiente ne consomme aucun fruit ou legume. 
L’apport quotidien de vitamine C est etabli a 
0.5 mg/d tandis que le taux normal est de 60 
mg/d. Le taux plasmatique etait a 17 /rmol/L,
a la limite inferieure de la normale (normale: 
11.4 a 113.6 /imol/L).
La patiente est traitee par des doses quoti- 
diennes de vitamine C (500 mg/d) par voie 
orale. La reponse clinique est remarquable.
Discussion
Le syndrome des loges secondaire a une 
coagulopathie, comme I’hemophilie est 
bien connu,2 mais le scorbut ne fut 
jamais rapporte comme pouvant etre a 
l’origine de ce syndrome.
Le scorbut etait autrefois une maladie 
endemique parmi les marins et les immi­
grants car ceux-ci manquaient de legumes 
et de fruits frais pendant des semaines ou 
des mois d’affiles lorsqu’ils etaient en 
mer. Actuellement le scorbut ne se ren­
contre qu’exceptionnellement dans les 
milieux soci-economiques defavorises.3
Jacques Cartier4 fut 1’un des premiers 
europeens a connaltre le traitement du 
scorbut. En 1535, alors qu’il passait 
1’hiver au bord de la riviere St-Charles ou 
se trouve aujourd’hui la ville de Quebec, 
plusieurs de ses marins souffrirent de 
scorbut et 26 d’entre eux moururent.
Un indien leur a alors enseigne com­
ment guerir cette maladie avec des extraits 
de feuilles de coniferes. Ce mysterieux 
remede s’appelait “Anneda” . Apres quel­
ques jours les symptomes ont commence 
a regresser et la maladie disparut.
Par la suite, les europeens ont oublie 
ce remede pendant pres de deux siecles, 
et ce n ’est qu’en 1753 que le docteur 
James Lind5 etudia cette maladie chez 
des groupes selectionnes de marins et 
constata une incidence diminuee de scor­
but au sein d’un groupe de marins ayant 
consomme des agrumes. Le capitaine 
James Cook appliqua les etudes de Lind 
et reussit a se proteger du fleau du scor­
but lors des periples en mer. Le privilege 
d’identifier 1’agent anti-scorbutique revint 
a Harden et Zilva6 en 1918 qui nomme- 
rent cet agent la vitamine C.
On sait aujourd’hui que la vitamine C 
agit comme agent reducteur permettant 
une hydroxylation de la proline et lysine 
et favorisant par-dela la biosynthese du 
collagene. La plupart des manifestations 
cliniques, d ’ailleurs, s’expliquent par 
l’instabilite des fibrilles de tropocollagene, 
dont les liaisons transversales sont affai-
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blies, et qui produisent en consequence la 
degradation du tissu conjonctif vasculaire 
et des espaces perivasculaires.1-7 Les 
manifestations cliniques apparaissent 
habituellement lorsque la reserve corpo- 
relle totale de vitamine C approche 300 
mg (la normale est de 1500 mg). Un 
apport quotidien de 10 mg peut mainte- 
nir la reserve corporelle totale a 350 mg. 
La dose minimale recommandee pour 
prevenir cette maladie est de 60 mg/d. 
Pour corriger une deficience deja exis- 
tante, de 300 a 500 mg/d sont necessaires.
Le scorbut est generalement cause par 
une carence nutritionelle en fruits et legu­
mes frais, et peut prendre de 4 a 6 mois 
avant de se manifester. Les signes clini­
ques sont une diathese hemorragique par 
fragilite capillaire pouvant se manifester
par des gingivites et folliculites hemorra- 
giques, ecchymoses, petechies et hemor- 
ragies gastro-intestinales. Chez l’enfant 
on peut rencontrer une hemorragie sous- 
periostee avec glissement epiphysaire aux 
membres inferieurs et deformation du 
thorax en baionnette. Le niveau urinaire 
et plasmatique d ’acide ascorbique se situe 
alors sous la limite inferieure, quoique 
dans le cas presente le niveau plasmati­
que de vitamine C etait juste a la limite 
inferieure de la normale. Finalement, la 
reponse clinique et biochimique s’avere 
dans I’ensemble favorable a l’apport sou- 
tenu de vitamine C.
En conclusion, il importe aux profes­
sionals de la sante de se souvenir des 
maladies d ’autrefois et de savoir recon- 
naitre la population a risque eleve dans
notre societe: personne agee, isolee, 
vivant sous le seuil de pauvrete avec une 
alimentation deficiente.1’8
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Thrombin as an Adjuvant to Reanastomosis of the 
Fallopian Tubes Reduces Implantations in the Rabbit
To study the efficacy of topically 
administered thrombin as an adjuvant in 
tubal microsurgery, 24 rabbits under 
went a 1-cm resection and microsurgical 
anastomosis of both fallopian tubes and 
were randomized to either thrombin or 
cautery for hemostasis. Ovarian wedge 
biopsies were done on the left ovary. 
The animals were mated 4 to 5 weeks 
postoperatively with a buck of proven 
fertility. They were killed at 2 to 3 
weeks' gestation to note the number of 
fetuses per patent tube and presence or 
absence of pelvic adhesions. There was 
no effect of topical thrombin on the 
crude pregnancy rate but it was 
associated with a marked reduction in 
the number of fetuses per patent tube, 
despite similar rates of pelvic adhesions 
between groups. Topically administered 
thrombin appeared to reduce fertility in 
this experimental model by an undefined 
mechanism.
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Dans une etude portant sur I'administra- 
tion de thrombine par voie topique 
comme traitement d'appoint en microchi- 
rurgie tubaire, 24 lapines ont subi une 
resection d'un segment de 1 cm, puis 
une anastomose microchirurgicale des 
deux trompes uterines. Pour realiser 
Themostase, les animaux ont ensuite, 
apres attribution au hasard, ete soit cau­
terises, ou ils ont recu de la thrombine 
topique. Une biopsie cuneiforme de 
I'ovaire gauche fut pratique. Les lapines 
furent accouples de 4 a 5 seniaines 
apres I'operation avec un male de fertilite 
certaine. Elies furent sacrifices a la 2e ou 
3e semaine de gestation pour permettre 
I'observation du nombre de foetus par 
trompe permeable et la presence ou 
I'absence d'adhesions pelviennes. On n'a 
constate aucun effet de la thrombine 
topique sur le taux brut de grossesse 
mais le traitement fut relie a une diminu­
tion marquee du nombre de foetus par 
trompe permeable, malgre des taux simi- 
laires d'adhesions pelviennes chez les 
deux groupes. Dans ce modele experi­
mental, la thrombine administree par voie 
topique semble diminuer la fertilite par 
un mecanisme qui demeure inexplique.
The prevention of postoperative pelvic 
adhesions remains a fundamental goal in 
microsurgical repair of the fallopian 
tube.1,2 There is increasing evidence that 
the cause of peritoneal adhesions is 
trauma and ischemia of the tissues being 
dissected.3-4 Inadequate hemostasis has
similarly been associated with pelvic adhe­
sions, particularly when ischemic tissue is 
present.3-4 While such adhesions do not 
necessarily produce sterility in women, 
they are frequently associated with failure 
to conceive postoperatively.5
For many years a large number of adju­
vant treatments have been used to prevent 
adhesions.6,7 It is of interest that 
although many have been used exten­
sively, very few studies have evaluated the 
ability of these agents to preserve fecun­
dity rather than simply inhibit adhesions. 
Topically administered thrombin has been 
suggested as an adjuvant to microsurgery 
to prevent adhesions by reducing capil­
lary oozing and maintaining hemos­
tasis.8-9
The purpose of this study was to inves­
tigate the effects of topical thrombin on 
the reproductive capacity of New Zealand 
white rabbits that had undergone resec­
tion and repair of the fallopian tubes.
Material and Method
Twenty-four female New Zealand 
white rabbits, maintained on food and 
water ad libitum, were randomly allo­
cated to receive either topical thrombin 
or bipolar cautery for hemostasis after 
surgery.
On the day of operation, the rabbits 
were anesthetized intramuscularly with 
200 mg ketamine and 25 mg prometha­
zine, then intubated and ventilated with 
enflurane. Under general anesthesia, the
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abdomen was opened through a midline 
incision, the uterine horns were identified 
and a 1-cm segment of each fallopian tube 
was resected 1 to 2 cm distal to the tubal- 
uterine junction, after methylene blue 
injection of the tubes. Standard microsur- 
gical reanastomosis of the tube ends was 
performed using 8-0 Vicryl interrupted 
sutures in a one-layer closure. Wedge 
biopsy of the left ovary was also done in 
all rabbits. During the procedure, 
hemostasis was maintained with either 
bipolar microcautery or topical adminis­
tration of thrombin in saline (1000 
units/ml). The abdomen was closed with 
interrupted polyglycolic acid sutures and 
the rabbits underwent a period of recov­
ery. They were mated 4 to 5 weeks 
postoperatively with a single buck of 
proven fertility.
The rabbits were killed 2 to 3 weeks 
after mating. At autopsy, the presence or 
absence of pregnancy, the number of 
implantations per tube, the patency of the 
tubes (determined by methylene blue 
injection), the presence or absence of 
ovarian or nonovarian adhesions were all
noted by an observer blinded to the 
grouping of the rabbits.
A 1-cm segment of the tube in the 
region of the anastomosis was removed, 
placed longitudinally in paraffin and sec­
tioned at 10 fim through its entire length. 
Sections were prepared by alcohol 
dehydration and hematoxylin and eosin 
staining. One blinded observer evaluated 
each tube to identify the anastomotic site. 
Luminal (L), submucosal (S) and mus- 
cularis (M) areas were measured on a Bio­
quant Digitizing System (R. and M. Bio­
metrics Inc., Nashville, Tenn.). To 
determine the proportion of tube that was 
submucosal tissue, the following equation 
was used:
% submucosal area = ( S - L ) x l O O  ^ m 2 
M
The coefficient of intra-observer variation 
in measurement was 2.2%.
Results
Seven rabbits died during the proce­
dure, five in the cautery group and two
Table 1-Comparison of Animals and Surgical Procedures 
(Means ± Standard Error of Mean)
Cautery Topical thrombin
Weight, kg 3.97 ± 0.24 4.11 ± 0.30
Operator experience* 18.3 16
Time for procedure, min
Right 26.3 ± 14.5 33.0 ± 1 5
Left 28.1 ± 15.4 25.9 ± 12.9
Number of sutures
Right 4.5 ± 1.8 4.2 ± 0.4
Left 3.8 ± 0.3 4.1 ± 0.7
*The numbers refer to the graded total number of procedures done by all operators.
Table II— Comparison of Bipolar Cautery and Topical Thrombin 
Pregnancy Rate
on
Bipolar cautery Topical thrombin
No. randomized 13 11
No. deaths due to anesthetic 5 2
Pregnant rabbits 6 5
Nonpregnant rabbits 2 4
Table III--Incidence of Nonovarian Adhesions in Rabbits With
Patent Right Tube
Cautery Thrombin
Left Right Left Right
Ovarian adhesions 6 1 7 1
Nonovarian adhesions 3 8
Both ovarian and nonovarian 2 5
adhesions 
Patent tubes 8 5 6 9
Implant/patent tube 
Patent tube
16/8 27/5 6/6 24/9
No adhesions* 1 4 1 1
Adhesions 
Implant/patent tube
7 1 5 8
No adhesions! 6 22 2 4
Adhesions 10 5 4 20
‘ Neither ovarian (that side) nor nonovarian.
tNo. of implants in rabbits with patent tubes and neither ovarian nor nonovarian adhesions.
in the topical thrombin group. The deaths 
were thought due to anesthetic complica­
tions in all but one rabbit which died of 
enflurane hepatotoxicity.
No differences were noted between 
groups with respect to animal weight, 
specific operator experience, the time 
taken for the procedure or the number of 
sutures used (Table I) (p > 0.05).
There was no difference in the overall 
pregnancy rate: six of eight rabbits in the 
cautery group became pregnant as did 
five of nine in the topical thrombin group 
(p > 0.05) (Table II). There was no 
difference in tubal patency rates between 
the groups.
Topical administration of thrombin 
produced a significantly (p < 0.05) lower 
number of implantations per patent tube 
on the horn contralateral to the ovarian 
biopsy when compared with the number 
in rabbits treated with bipolar cautery 
(Fig. 1). A similar trend was noted on the 
ipsilateral side but the difference was not 
significant. Ovarian biopsy markedly 
lowered the total number of implanta­
tions per patent tube in animals receiv­
ing bipolar cautery (p < 0.5) but had no 
effect on animals treated topically with 
thrombin.
(43) (30)
FIG. 1—Comparison of bipolar cautery and 
topical thrombin implantation rates per patent 
tube. Topical thrombin reduces number of 
implantations per patent tube on side con­
tralateral to ovarian biopsy (i.e., right side). 
Ovarian biopsy was associated with reduction 
in implantations per patent ipsilateral tube. 
This reached significance only in cautery 
treated group. Numbers in brackets refer to 
total number of implantations per group.
FIG. 2—Comparison of bipolar cautery and 
topical thrombin with respect to percentage 
submucosal area at anastomosis. No differ­
ences were noted.
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There was no difference in the overall 
incidence of ovarian or nonovarian adhe­
sions between the cautery and thrombin 
groups. However, in rabbits with patent 
tubes, there was a significant (p < 0.05) 
increase of nonovarian adhesions in those 
that received thrombin (Table III).
The percentage of cross-sectional area 
taken up in submucosal tissues is shown 
in Fig. 2. At autopsy in 17 rabbits, the 
anastomosis could be identified in 14. All 
other sections appeared to be completely 
healthy and were not measured. There 
was no difference between the groups.
Discussion
The purpose of this experiment was to 
compare the use of topical throipbin 
(Thrombostat; Parke-Davis Canada Inc., 
Scarborough, Ont.) to current therapy, 
bipolar microcautery, with respect to 
efficacy and safety. The results of these 
procedures are consistent with those of 
other reports using rabbits for models of 
tubal microsurgery, particularly with 
reference to survival from general 
anesthesia.10 Nonoperative mating con­
trols were not included in this efficacy 
trial, yet the numbers of implantations 
per patent tube in the cautery group did 
not differ appreciably from those in other 
studies of mating rabbits.11
The crude pregnancy rates were simi­
lar in both groups. Thrombostat, how­
ever, was associated with a measurable 
reduction in the number of implantations
per patent tube. The mechanism of the 
reduction is not apparent from our data. 
It does not appear to be a consequence 
of either tubal obstruction or ovarian 
adhesions. Contrary to previous reports, 
there was no difference in the percentage 
of the area of submucosal tissues between 
groups.8 Significantly more rabbits with 
patent tubes who were treated with topi­
cal thrombin had nonovarian adhesions, 
and the reduction in implantation rate in 
thrombin-treated animals may be a con­
sequence of disordered tubal motility. 
Alternatively, the adhesions may be 
unrelated to the outcome and could sug­
gest other nonspecific and poorly defined 
factors regulating pregnancy.
Ovarian biopsy was associated with a 
substantial reduction in implantation per 
patent tube, particularly in the cautery 
group. This reduction was possibly due 
to ovarian adhesions which consistently 
occurred with greater frequency on the 
side of the ovarian biopsy. Such obser­
vations are in agreement with studies of 
fertility after ovarian wedge resection.12
In summary, topically administered 
thrombin is associated with a significant 
reduction in implantation per patent tube, 
possibly because more frequent nonovar­
ian adhesions are associated with its use. 
These data do not support the application 
of this agent as an adjuvant to microsur- 
gical tubal reconstruction. Moreover, the 
presence of a measurable reduction in 
fecundity, as measured by implantation 
per patent tube, suggests that the
reproductive toxicity of an adjuvant may 
not be fully appreciated without an evalu­
ation of the effects on mating outcome.
We acknowledge the help provided by Jane 
Bennett, Marge Gibbons, Karen Gourlay, Dr. 
Joanne Johnson, Avril McMahon and Dr. 
Nabil Namis. Sutures were supplied by Ethi- 
con Ltd., Peterborough, Ont.
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SESAP V Critique
ITEMS 51-53
Crohn’s disease and tuberculous enteritis may mimic each other’s clinical and roentgenographic 
manifestations. Both chest roentgenogram and purified protein derivative, which may be nega­
tive in a significant number of cases of intestinal tuberculosis, are unreliable diagnostic aids. 
For the patient described, Crohn’s disease was initially the most likely diagnosis. This dis­
order is much more common than tuberculous enteritis and no absolute clues pointed to the 
diagnosis of tuberculous enteritis. The patient was treated with the usual supportive measures 
plus corticosteroids, but her condition rapidly deteriorated, necessitating celiotomy.
With the other findings, the presence of subserosal nodules or granulomas should have 
made the surgeon strongly suspicious of tuberculous enteritis. Excision of a lymph node with 
immediate examination was indicated. The slide showed caseation necrosis in the node, which 
confirms the disease, and no further definitive operation is indicated. The patient should be 
treated with antituberculous drugs postoperatively. Sarcoidosis, small bowel lymphoma, and 
Whipple’s disease have clinical and roentgenographic manifestations that do not resemble 
Crohn’s disease and tuberculous enteritis.
51 B 52 53 F.
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BOOK REVIEWS 
continued from  page 15
Instructions to Contributors
description of pelvic anatomy and a fine dis­
course on the value of the extraperitoneal 
approach to pelvic surgery. The account of 
abdominal hysterectomy does not mention the 
intrafascial hysterectomy but digresses into the 
treatment of endometriosis and the staging of 
endometrial cancer.
In our experience, far less than 50% of 
patients with ectopic pregnancy are admitted 
to hospital in shock. This was true as far back 
as 1970 and it is certainly true today. Postoper­
ative management should mention the use of 
RhoGAM rather than concentrating on the 
need for concurrent appendectomy. The 
differential level o f human chorionic 
gonadotropin is 6500 mlU/ml not 65 mlU/ml 
as described. In our experience, far less than 
30% of pelvic abscesses merit colpotomy.
I found most worthwhile the description and 
illustrations on the recognition of the sub­
mucosa of the intestine by its resistance to, and 
the white circle it causes to form at, the point 
of the penetrating needle.
There are a number of areas in the section 
on urology that engaged my interest. I have 
never before seen two types of the Burch proce­
dure described, one in which the urethra is 
compressed and one in which this is avoided; 
it is interesting to find that the first Marshall- 
Marchetti-Krantz procedure was done on a 
man who suffered urinary stress incontinence 
after an abdominoperineal resection. The oper­
ation described for urethral lengthening is old- 
fashioned, as is the use of 2-0 chromic suture 
for the urethral suspension. End-to-end ure­
teric anastomosis has better results today than 
the 20-year-old reference quoted suggests.
In summary, the text is beautifully produced 
and interesting to read. Resident staff in gyne­
cology would especially gain from its purchase.
M ark E. Bo y d , m d , fr c sc ,
FRCOG,FACOG 
Vice chairman,
Department of Obstetrics and Gynecology, 
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
H3A 1A1
ROB & SMITH’S OPERATIVE SURGERY. 
4th ed. Edited by Hugh Dudley and David 
Carter. Thoracic Surgery. Edited by John 
W. Jackson and D.K.C. Cooper. 380 pp. 
Illust. Butterworth and Co. (Publishers) 
Ltd., London; Butterworth Publishers, 
Stoneham, Mass., 1986. $99.95 (US). ISBN 
0-407-00661-3.
Readers will note an important change in this 
the fourth edition of the series Operative Sur­
gery, namely, the division of cardiac and 
thoracic surgery into two separate volumes.
The volume on thoracic surgery is divided 
into three sections: general thoracic, pulmo­
nary and esophageal surgery. The objective of 
the general editors to give this book an inter­
national flavour is definitely achieved; well- 
known authors from many countries have con­
tributed. Most chapters have an identical pat­
tern which makes quick reference easy. There 
is little critique and few descriptions of alter­
native methods, except for the many variations
A ll initial communications should be addressed to the Coeditors, Canadian Journal 
of Surgery, PO Box 8650, Ottawa, Ont. K1G 0G8.
Manuscripts o f original articles and other contributions, including a limited num­
ber o f  case reports, should be submitted, in triplicate, in English or French, with 
a covering letter requesting consideration fo r  publication. Authors must also include 
a statement indicating that the manuscript is not under consideration by any other 
journal and has not been published previously. The manuscript should be typed on 
one side o f  plain paper, double spaced with wide margins. Measurements should be 
expressed according to the Systeme international d ’unites.
Illustrations (e.g., photographs o f  clinical material, roentgenograms, photomicro­
graphs, graphs and diagrams), in triplicate, should be in the form  o f  glossy, unmounted 
and untrimmed prints, not larger than 20 x 25 cm. A legend must be supplied fo r  
each; the legend(s) should be typed on a page separate from  the text o f  the article. 
For a roentgenogram submit a print rather than the original; fo r  a photomicrograph 
include details o f  the stain used and the magnification in the legend. Lettering iden­
tifying parts o f  the illustration should be large enough to remain visible when the 
illustration is reduced in size for publication. A patient must not be recognizable unless 
written consent has been obtained; otherwise facial features may require blocking. 
Colour work can be published only at the author’s expense. I f  an illustration is taken 
from  a source other than the author’s, letters o f  permission to reproduce must be 
obtained from  the original publisher and author.
Tables, the design o f  which is best considered in regard to the rectangular form at 
o f  the Journal, should be submitted separate from  the text, one to a page.
References should be cited by number in the text, in order o f  occurrence, and listed 
at the end o f  the article in the style used in this issue o f  the Journal.
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accompany each article, on a separate page.
Authors will receive a copy o f  the edited manuscript fo r  approval before publica­
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futpaspublie auparavant. Veuillez les dactylographier sur une seule face d ’une feuille 
non re glee avec double interligne et grandes marges. Les unites de mesure doivent 
etre exprimees selon le Systeme international d ’unites.
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une reduction de I’image fournie. II ne fau t pas qu 'on puisse identifier un patient 
grace a une illustration a moins q u ’il n ’y  ait expressement consentipar ecrit; fau te  
de permission les traits de sa physionomie doivent etre obliteres. Les illustrations en 
couleur ne seront publiees qu’aux frais de l ’auteur. Si Pillustration provient d ’une 
autre source, il convient d ’obtenir tant de Pauteur que de Pediteur de Pouvrage dont 
elle est tiree, Pautorisation de s ’en servir aux fins de la publication.
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sur des feuilles separees du texte, un tableau par feuille.
Les references doivent etre citees dans le texte au moyen d ’un chiffre et groupes 
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Un resume, en frangais et aussi en anglais, qui ne doit pas depasser 125 mots doit 
accompagner chaque article sur une feuille separee.
A litre d ’approbation, un exemplaire du manuscrit redige sera envoye a Pauteur 
mais non les epreuves.
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The Royal College of Physicians 
and Surgeons of Canada
Examinations
The exam in a tio n s  o f th e  Roya l C o llege  
are he ld  in Sep tem ber o f each  year. C an ­
d ida te s  w ish in g  to  s it fo r  the exam ina ­
t io n s  shou ld  no te  the fo llow in g :
1. E ve ry  cand ida te  fo r adm iss ion  to  the 
ex am in a tio n s  m ust su bm it an app li­
c a t io n  fo r a s se s sm e n t o f tra in ing .
2. C an d id a te s  in tra in ing  in Canada 
sh o u ld  app ly  fo r  p re lim inary  a s se s s ­
m en t o f tra in in g  at lea st one year 
be fo re  the date on w h ich  they  expect 
to  s it  fo r the exam ina tion s , th a t is to  
say  no t later than  Sep tem ber 1 o f the 
preceding year. Cand idates w h o  have 
had tra in ing outs ide  o f Canada shou ld 
su b m it the ir in itia l app lica tion  for 
a sse ssm en t a t le a s t 18 m on ths 
b e fo re  they  e x p e c t to  s it  fo r the  e x a ­
m ina tio n s , th a t is by M a rch  1 o f the 
p re ced in g  year. O n ly  can d id a te s  
w h o se  a sse ssm en t o f c red en tia ls  is 
co m p le te  w ill be a cce p ted  to  s it  fo r 
the  exam ina tion s .
3 . C an d id a te s  w h o  des ire  to  s it  fo r  an 
e xam ina tion , hav ing  com p lied  w ith  
the  above  requ irem ent o f pre lim inary  
a sse ssm en t o f tra in ing , m u st no tify  
the  Roya l C o lle g e  in w r it in g  o f the ir 
in ten t before  Feb rua ry  1 o f the  year 
o f th e  exam ina tion . U pon  rece ip t o f 
th is  n o t ic e  o f in ten t, th e  eva lua tion  
o f th e  c a n d id a te 's  p e rfo rm an ce  
du ring  tra in ing  w ill be added to  the  
p rev iou s ly  com p le ted  a sse ssm en t of 
c reden tia ls . Each  can d ida te  w ill then 
re ce ive  no t if ica tio n  as to  e lig ib ility  
tog e the r w ith  an app lica tion  fo rm  for 
adm iss ion  to  th e  exam ina tion  to  be 
co m p le te d  and returned.
4 . T he  fo llo w in g  d o cu m e n ts  m ay be 
ob ta in ed  from  the  Roya l C o lle ge  
o ffice :
(a) A p p lica t io n  fo rm s fo r assessm en t 
o f tra in ing;
(b) G ene ra l in fo rm a tion  book le t on 
tra in in g  requ irem en ts  and exam i­
na tion s;
(c) S p e c if ic  requ irem en ts fo r tra in ing 
and regu la tion s  re la ting  to  the 
ex am in a tio n s  o f each  spec ia lty . 
R equests  shou ld  ind icate the spe ­
c ia lty  or sp e c ia lt ie s  o f in te rest to  
the  app lican t;
(d) L is t in g  of sp e c ia lty  tra in ing  p ro ­
g ram s in C an ada  a cc red ited  by 
th e  Roya l C o llege .
5. A d d re s s  all en qu ire s  to:
Dr. R.F. Maudsley, Director, 
Office of Training and Evaluation, 
The Royal College of Physicians 
and Surgeons of Canada,
74 Stanley,
Ottawa. Canada 
K1M 1P4.
(613) 746-8177.
in thoracic drainage found throughout the 
book — from the historic use of the Tudor- 
Edwards empyema trocar to the simpler and 
safer hemostat and finger method, which is our 
preference. There is no mention of helpful 
adjunctive measures such as fluoroscopy, 
echography or computerized tomography for 
localizing loculated fluid.
The book is abundantly illustrated. Most of 
the drawings are very good and many are excel­
lent but a few, such as those in the extended 
chapter on hydatid cyst, are not worthy of a 
quality publication.
Most chapters in the general thoracic section 
have been rewritten or updated. The chapter 
on management of blunt thoracic injuries is 
excellent.
In the pulmonary section, the investigative 
techniques are well described and illustrated. 
Although most chapters are new, there is much 
emphasis on techniques that are less in use 
today, such as bronchography and scalene- 
node biopsy. The excellent sections on tracheal 
resection for stricture and thoracoplasty have 
changed very little. Many chapters, such as 
those on tracheotomy, decortication of the 
lung, excision of empyema, mediastinoscopy 
and resection of the lung, have a completely 
new face — new text and new illustrations. In 
the section on management of spontaneous 
pneumothorax, the popular axillary thoracot­
omy approach is not mentioned. There are 
some completely new chapters on thoracoscopy 
and thoracostomy for permanent chest 
drainage. Although some subjects are treated 
rather briefly, this section covers pulmonary 
surgery adequately.
The essentials of esophageal surgical tech­
niques are well described with the exception of 
those related to the cervical esophagus. In our 
opinion, surgery of the cervical esophagus, 
related to diverticula or cricopharyngeal dys­
function should be included in order to have 
a more comprehensive coverage of esophageal 
surgery. The chapter on esophagoscopy has 
been entirely updated, taking into considera­
tion the great strides made in flexible 
endoscopy and the palliative treatment of 
tumours by this method. Unfortunately, the 
better chapters are not necessarily the ones 
covering more frequently used techniques, such 
as treatment o f gastroesophageal reflux 
without stenosis or short esophagus, and, 
often, the illustrations in chapters describing 
more frequently used techniques are less 
numerous and less explicit. The best pages in 
this section concern esophageal stenosis, cover­
ing the more recent knowledge and use of 
autosutures. Esophagectomy without thoracot­
omy is well described but unfortunately has no 
critique or discussion.
From our point of view a book on surgical 
technique should be useful to the surgical resi­
dent who must acquire knowledge and gradu­
ally mould opinions and to the practising sur­
geon for use as a reference tool. Although the 
objectives are not necessarily reached in all 
chapters for the student, this book will be use­
ful to the surgeon.
Arthur Page, md, frcsc 
Michel Allard, md, frcsc
Departement de chirurgie,
Hopital du Sacre-Coeur de Montreal,
5400, boul. Gouin ouest,
Montreal, PQ 
H4J 1C5
SILVERGIRL’S SURGERY. THE VEINS. 
Edited by Harold Laufman. 273 pp. Illust. 
Silvergirl, Inc., Austin, Tex.; Year Book 
Medical Publishers, Inc., Chicago, 1986. 
$39.95 (US). ISBN 0-941432-18-1.
This book is a collection of papers, in English, 
French or German, relating to venous disease 
over the centuries. Except to present the 
papers, the editors have made no comment.
The layout of the book is good and the head­
ings are appropriate. The editor has set 
himself a huge task in trying to cover the 
development of treatment and surgery of 
the veins from their beginning to the present, 
and has unfortunately fallen short of the stated 
objectives. He would have done better to look 
at the history of venous surgery and offer 
a better presentation. The more recent 
papers selected are not sufficiently represen­
tative of the development of a scientific basis 
for the treatment of venous disease in the last 
30 years. The obvious papers that were omit­
ted were those relating to injection treatment 
of varicose veins, one by Fegan and the other 
by Hobbs, the former being a landmark paper 
in the treatment of varicose veins.
This book will be of interest to vascular and 
general surgeons who deal with venous disease 
and are also interested in its historical aspects. 
It may also be useful for medical libraries as 
a reference book only, thus limiting its 
audience. It is unfortunate that the editor did 
not select more appropriate papers and pro­
vide some editorial comment with each, which 
would have been useful.
Overall, I would not recommend this book 
for a general medical audience.
F. Michael Ameli, mb, ch b, 
FRCS(EDIN), FRCSC, FACS
Ste. 313,
E.K. Jones Building,
The Wellesley Hospital,
160 Wellesley St. E,
Toronto, Ont.
M4Y 1J3
SKELETAL METASTASES. C.S.B. Galasko. 
160 pp. Illust. Butterworth and Co. (Pub­
lishers) Ltd., London; Butterworth Pub­
lishers, Stoneham, Mass., 1986. $115.00 
(US). ISBN 0-407-00409-2.
Drawing on 20 years’ experience of research 
in the field, Galasko, professor of orthopedic 
surgery at the University of Manchester in 
England, has written a slim monograph that 
compiles the current information on this dis­
tressing condition.
Skeletal metastases are the commonest forms 
of malignant bone tumour. They may cause 
severe pain and major complications but are 
seldom fatal. The aim of this book is to 
describe recent advances in the understanding 
of these lesions, to indicate methods of detec­
tion and to discuss treatment.
The book breaks down into two sections. 
The first half contains a description of the ori­
gin of metastases and possible explanations of 
the targets chosen by a particular tumour, and 
its local and general reaction. Professor 
Galasko also discusses in detail the detection 
of skeletal metastases by radioactive isotopes
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and other ancillary devices. This section is obvi­
ously of interest to oncologists and specialists 
in nuclear medicine.
The last half of the book is devoted to local 
and general m anifestations o f skeletal 
metastases and their treatment. This section is 
of interest to residents, orthopedic surgeons 
and oncologists who have to deal with these 
conditions.
The book is well written and lavishly illus­
trated with roentgenograms. It is essentially a 
“ why to” book, covering the reasons behind 
the choice of a specific implant in a particular 
situation. The numerous references at the close 
of every chapter help to provide an easy solu­
tion to the “ how to” .
Professor Galasko has succeeded in his 
objectives and I think that this monograph is 
a worthwhile endeavour.
Hugh U. Cameron, mb, ch b, frcsc
Ste. 318,
43 Wellesley St. E,Toronto, Ont.M4Y 1H1
STROKE. Pathophysiology, Diagnosis, and 
Management. 2 volume set. Edited by 
Henry J.M. Barnett, Bennett M. Stein, J.P. 
Mohr and Frank M. Yatsu. 1293 pp. Illust. 
Churchill Livingstone, Edinburgh; Aca­
demic Press Canada, Don Mills, Ont., 
1986. $254.50 (set). ISBN 0-443-08260-X 
(set).
The various aspects of stroke have provided 
much excitement over the past two decades 
because of expanding knowledge and the pace 
of technologic change. This encyclopedic work, 
dealing with the genesis and management of 
cerebral disease, is, therefore, timely and 
welcome.
The pathophysiology, clinical manifesta­
tions, investigation, medical and surgical 
management of the various entities falling 
under the heading of stroke are covered in 
detail in two volumes. Sixty-one chapters by 
authoritative authors deal with the common as 
well as the less-common but interesting and 
important causes of ischemic and hemorrhagic 
stroke such as fibromuscular dysplasia and 
Moyamoya disease.
The text is well organized, detailed, concise 
and readable. Illustrations are appropriate and 
references are extensive and well chosen, guid­
ing the interested reader deeper into areas of 
particular concern.
The clinical epidemiologic sections are 
detailed and will be of interest, particularly in 
regard to the declining incidence o f stroke, to 
readers in many disciplines. Chapters on 
specific disease entities and on medical dis­
orders associated with stroke stand alone and 
are readily referred to in the course of every­
day practice.
The therapeutic sections are current and 
detailed. Surgical treatment is well covered, 
including specific indications for surgery and 
surgical complications. In most instances, con­
troversial matters are well and extensively han­
dled. The chapter on cerebral bypass opera­
tions, for example, includes the findings of the 
International Cooperative Study of Extra­
cranial to Intracranial Anastomosis and the
chapter on asymptomatic carotid stenosis is an 
excellent summary of current epidemiologic 
findings and presents clear conclusions. Some 
controversial areas, for example intraoperative 
monitoring and intraluminal bypass in carotid 
endarterectomy and consideration of emer­
gency thromboendarterectomy for internal 
carotid occlusion, might have been dealt with 
less dogmatically by means of balanced dis­
cussion.
Most sections of these two volumes will be 
of great interest to, and deserve detailed read­
ing by, practising neurologists and neurosur­
geons, to interested vascular surgeons and to 
trainees in these disciplines. Internists and 
general practitioners will find investigation and 
current therapy well covered, and the sections 
on particular lesions like intracranial 
aneurysms serve as a concise and well- 
organized reference for emergency physicians 
and others who are required to deal with 
cerebrovascular problems occasionally but not 
on a daily basis. Chapters like “ coagulopathy 
and stroke” and “ stroke and substance abuse” 
may interest a wide range o f practitioners.
These two volumes fill a real need for an 
extensive but readable work on all aspects of 
cerebrovascular disease, and the editors and 
authors are to be commended on meeting this 
need superlatively.
D.W. Rowed, md, frcsc
Head, Division of Neurosurgery, Sunnybrook Medical Centre,University of Toronto,2075 Bayview Ave.,Toronto, Ont.M4N 3M5
SURGERY OF THE FOOT. Kent K. Wu. 537 
pp. Illust. Lea &  Febiger, Philadelphia, 
1986. $86.50. ISBN 0-8121-0995-3.
The author of this book is a member o f the 
orthopedic staff of the Henry Ford Hospital 
in Detroit. He trained under C. Leslie Mitch­
ell, who popularized the Mitchell’s bunionec- 
tomy, and took over Dr. Mitchell’s busy prac­
tice. He writes on his experience with tens of 
thousands of patients suffering from various 
congenital and acquired foot problems.
Although entitled Surgery o f  the Foot, the 
text deals with all aspects and principles of non- 
surgical treatment. It encompasses the clinical 
symptoms and signs, radiologic manifestations, 
pathologic anatomy and treatment of each foot 
disorder.
All conditions of the foot are covered; the 
final 145 pages are presented as an atlas of 
common, unusual and rare foot disorders, 
along with a brief discussion of the clinical 
manifestations.
The text is well planned and organized. The 
author uses hundreds of detailed line diagrams 
and provides extensive, up-to-date references 
at the end of each chapter for easy access to 
more-detailed information.
I think the information in the book is 
accurate and I highly recommend it as an 
authoritative reference for the family practi­
tioner and specialist.
Max Vechter, md
Department of Orthopedic Surgery,
Ottawa Civic Hospital,1081 Carling Ave.,Ottawa, Ont.K1Y 4G2
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept suitable classified advertisements. The deadline is 1 month before issue 
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HAWAII-KAUAI — Beach, pool, tennis, golf. Poly­
nesian blossoms. OCEANFRONT one bedroom 
condominium. Sleeps 4. Two season rates. Reply 
to: Condominium, PO Box 57j, Sherman, Connec­
ticut, US 06784. -S 88-04
CLINICAL BURN FELLOWSHIP: ON -  available 
July 1, 1 988, for six months or tw elve months. 
Regional adult burn centre treating 120 patients 
per year. Clinical research. New ultra-modern burn 
centre, very well staffed, extensive research fund­
ing. Please contact: Dr. Walter J. Peters, Ste. 224, 
Turner Wing, Wellesley Hospital, 160 Wellesley 
St. E., Toronto, ON M4Y 1J3. -S88-05
GENERAL SURGEON: NWT — required for ex­
panding northern community. One active surgeon 
on staff. Expansion of surgical work w ill occur 
w ith  opening of new hospital shortly. This post is 
both challenging and lucrative. The city has ex­
cellent facilities and schools. Please forward en­
quiries to: Family Medical Clinic, PO Box 1559, 
Yellowknife NWT X1A 2P2. -S 88-06
MICROSURGICAL COURSE -  The Department of 
Surgery, McMaster University, Hamilton, Ontario, 
is now offering one week, on-going courses in 
microsurgery, using animal facilities and video­
tapes. These courses are for anyone interested in
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small vessel anastomosis, nerve repairs, vas and 
fallopian tube reconstructions. The laboratory is 
organized to guide you through the basic microsur- 
gical techniques to  more advanced tasks with the 
help of an assistant on a one-to-one basis. Please 
call: Dr. A. Thoma, (416) 523-0019 for further in­
formation. — S88-09
CHIEF OF SURGERY: ON -  The Hospital for Sick 
Children, the largest pediatric hospital in North 
America, invites applications for the position of 
surgeon-in-chief. Located in downtown Toronto, 
the hospital is in close proximity to  the University 
of Toronto and other major teaching hospitals. The 
department of surgery is organized into 6 divisions 
each of which is highly productive in clinical, 
teaching and research activities. Essential require­
ments for the position include a clear commitment 
to patient care, demonstrated clinical and manage­
ment expertise and proven leadership in teaching 
and research. Applicants must have (or be eligi­
ble for) certification by the Royal College of Phy­
sicians and Surgeons of Canada. The successful 
candidate w ill be eligible for cross-appointment to 
the departments of surgery and pediatrics in the 
faculty of medicine at the University of Toronto. 
In accordance with the immigration requirements, 
priority will be given to Canadian citizens and per­
manent residents of Canada. Please apply w ith 
curriculum vitae by February 1 5, 1988 to: Chair­
man, Search & Review Committee, Chief of Sur­
gery, c/o the Hospital Secretary, The Hospital for 
Sick Children, 555 University Ave., Toronto, ON 
M5G 1X8. -S 88-08
HEAD OF VASCULAR SURGERY: ON -  The
University o f Ottawa, Department of Surgery in­
vites applications for the position of Chairman of 
the Division o f Vascular Surgery. The Division cur­
rently has 6 geographic full-time members based 
at the major teaching hospitals, is involved in un­
dergraduate teaching, has a fully accredited post­
graduate training program in vascular surgery and 
has an active clinical and basic research program. 
The applicants are expected to be active vascu­
lar surgeons w ith  experience in teaching and have 
a strong background in basic and clinical research. 
The academic rank will be commensurate with the 
candidate's qualification and experience. In accor­
dance with Canadian immigration requirements, 
this advertisement is directed to Canadian citizens 
and permanent residents. Please respond in w rit­
ing by February 15, 1988 to: Dr. W.J. Keon, 
Professor and Chairman, Department of Surgery, 
Parkdale Clinic, Room 111, Ottawa Civic Hospi­
tal, 1053 Carling Ave., Ottawa, ON K1Y 4E9.
-S 88-10
L'UNIVERSITE D'OTTAWA ouvre un concours 
pour le poste de directeur de la division de chirur- 
gie vasculaire. Les personnes q u a lifie s  devront 
avoir un certificat du College royal des m6decins 
et chirurgiens du Canada et etre admissibles aux 
permis d'exercer du College des medecins et 
chirurgiens de I'Ontario. La personne choisie aura 
la responsabilit6 de voir au d§veloppement du 
programme de recherche en plus de voir a la sur­
veillance des programmes de formation au niveau 
pr6diplom6 et postdoctoral et & la coordination des 
programmes d'enseignement integr6s dans les 
hopitaux affili6s, soit & I'Hopital g6n§ral d'Ottawa, 
I'Hopital Civic d'Ottawa, I'Hopital pour enfants de 
I'Est de I'Ontario et le Centre medical de la defence
nationale. Conform6ment aux exigences prescri- 
tes en matiere d'immigration au Canada, cet avis 
de concours s'adresse aux citoyens canadiens et 
aux residents permanents. Priere de faire parve- 
nir votre curriculum vitae et la liste des referen­
ces avant le 1 5 fevrier 1988 a I'attention de: Dr 
W . J. Keon, Directeur, D6partement de chirurgie, 
Clinique Parkdale - piece 111, Hopital Civic 
d'Ottawa, 1053, avenue Carling, Ottawa, Onta­
rio, K1Y 4E9. —S88-12
CARDIO-THORACIC SURGEON: US -  North­
eastern, busy non-cardiac thoracic surgical group 
w ith  university affiliation has position leading to 
early partnership available now or July 1988. 
Please reply to: Box S115 CJS. —S87-58
RESIDENCY IN 
CARDIOVASCULAR 
AND THORACIC SURGERY
Opening available July 1, 1988 and 1 989 for three- 
year training program in busy adult (600) and pedri- 
atric (150) cardiac surgery program including arrhyth­
mia surgery, heart and heart/ lung transplantation, and 
vascular and thoracic surgery. Outstanding facilities 
and fully accredited program at a major Canadian 
university. ABS certification or eligibility required. If 
not graduate of North American medical school, 
MCCQE required. Please reply to:
Patricia A. Penkoske, MD
Department of Surgery
Room 2D2.09 Walter MacKenzieCenter
University of Alberta
Edmonton, AB
T6G 2R7
Tel: (403) 432-8057 S88-01
First Canadian Symposium od 
Multi-Organ Transplantation 
University Hospital, London, Ontario, Canada 
April 21 and 22, 1988  
First Announcement and call for Abstracts 
TOPICS
• Organ Transplantation
• Organ Donation
• Organ Retrieval and Preservation
• Transplant Immunobiology
• Ethical Issues
• Perioperative Patient Management
• Resource Requirements
Contact:
Continuing Medical Education 
Faculty of Medicine 
The University of Western Ontario 
London, Ontario N6A 5C1 
(519) 661-2074 
or
Dr. David Grant 
University Hospital
(519) 663-2926 S88-02
CLINICAL FELLOWSHIP 
Ewart Angus Intensive Care Unit 
Wellesley Hospital 
Toronto
Available July 1, 1988 for a one-year period 
in a medical-surgical unit. Duties cpmprise clin­
ical research in a strong academic and teach­
ing unit. Present research includes the clinical 
epidemiology of ICU care, nutrition and 
respiratory muscle physiology.
Reply to: Dr. I.A. Fraser, Director
EAICU 
Ste 246 
EK Jones Bldg.,
160 Wellesley St. East 
Toronto, ON M4Y 1J3 
Tel: (416) 926-7747 -S88-03
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